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ABSTRACT 
Bcl-2 proteins are very well known regulators of the programmed cell death. 
Accumulating evidence suggests that they are also involved in regulation of calcium 
signalling events. Bcl-2 has been reported to affect calcium release from the 
intracellular calcium stores through regulation of inositol trisphosphate receptors and 
endoplasmic reticulum calcium pumps. Physiological and pathological processes in 
pancreatic acinar cells are controlled by calcium. Intracellular Ca
2+
 signals regulate 
not only gene expression and trigger enzyme secretion but also might contribute to 
premature trypsinogen activation and development of pancreatitis, which is 
characterised by extensive necrosis of the pancreatic tissue. Detailed investigation of 
Bcl-2 family-dependent mechanisms of intracellular Ca
2+
 regulation and its 
association with cell death induction is required for understanding of the basic 
physiological signalling pathways as well as pathophysiological processes leading to 
development of severe diseases of pancreas. This study investigates the effects of 
Bcl-2 family proteins on intracellular calcium homeostasis, with particular focus on 
their involvement in Ca
2+
 fluxes and CICR phenomenon. Also, the Ca
2+
-related 
actions of different doses of ethanol in pancreatic acinar cells and their contribution 
to pancreatitis are presented and assessed. 
The results indicate that pharmacological inhibition of anti-apoptotic Bcl-2 and 
Bcl-xL proteins with BH3 mimetics BH3I’-2' or HA14-1 sensitizes pancreatic acinar 
cells to CICR; and overexpression of Bcl-2 has the opposite effect significantly 
decreasing rising phase of CICR-types of responses in pancreatic cell line AR42J. 
Responses to BH3 mimetics are at least partially dependent on both IP3Rs and RyRs, 
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since inhibition of either of them results in a substantial decrease in Ca
2+
 release 
from the intracellular stores. However, simultaneous blockade of IP3Rs and RyRs did 
not completely abolish BH3 mimetic-elicited Ca
2+
 release, which indicates 
engagement of other factors in the development of the response.  Importantly, the 
effects of BH3 mimetics on intracellular Ca
2+
 were effectively inhibited by loss of 
Bax protein, suggesting Bax involvement in the regulation of Ca
2+
 release from 
the ER. 
Further, the results presented here demonstrate that moderate concentrations of 
ethanol (10 - 100 mM), although having only a minor effect on intact cells, induce 
substantial Ca
2+
 release from both the ER and the acidic store in permeabilized cells, 
and trigger intracellular trypsinogen activation - the hallmark of acute pancreatitis. 
The data suggest that calmodulin, which is present in intact cells but is lost in 
permeabilized cells, constitutes a part of natural defence mechanism responsible for 
the differences in the severity of the responses to ethanol. What is more, the evidence 
indicates that specific pre-activation of calmodulin by Ca
2+
-like peptides boosts this 
defence and reduces the pathological calcium responses to ethanol as well as to BH3 
mimetics in pancreatic acinar cells decreasing necrosis. Finally, the effects of Bcl-2 
protein on calcium fluxes in pancreatic acinar cells were investigated. Cells lacking 
functional Bcl-2 showed substantially more rapid clearance of thapsigargin / 
high Ca
2+
-induced cytosolic calcium plateau as compared to wild type cells. This 
effect has been explained by increased activity of the PMCA that results in a marked 
increase of apoptosis / necrosis ratio in oxidative stress induced cell death. 
Overexpression of Bcl-2 in AR42J cells reduces ER calcium content, while silencing 
of Bcl-2 expression by siRNA results in substantially increased releasable calcium 
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pool in the ER. The data indicate that at least a fraction of Bcl-2 in both AR42J cells 
and pancreatic acinar cells locates in the ER and is present in close proximity to the 
plasma membrane, making possible the direct regulation of the PMCA. 
In conclusion, this study provides new insights into roles of Bcl-2 family proteins 
and calmodulin in intracellular calcium homeostasis. This thesis presents evidence 
for involvement of anti-apoptotic Bcl-2 members in Ca
2+
-induced Ca
2+
 release; 
demonstrates previously unknown regulation of the PMCA by Bcl-2; and suggests 
involvement of Bax protein in regulation of Ca
2+
 release from the intracellular stores. 
The study also proposes that Ca
2+
-like peptides can boost natural protective 
mechanisms and suggests their potential applications as therapeutic agents. 
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Chapter 1: Introduction 
 
1.1. Pancreas 
The pancreas is a crucial organ in the digestive as well as endocrine system in all 
vertebrates. However its structure substantially varies between different species. In 
humans, and also in rodents such as rats and mice, the pancreas is a separate organ 
closely located to the duodenum. In contrast, in certain other species, for instance 
rabbits, pancreatic tissue does not form a discrete organ but is distributed at the small 
intestine wall, liver and spleen. 
The name of the organ originates from two Greek words: "pan" meaning "all" and 
"kreas" - "flesh", which probably reflects its macroscopic homogeneous structure. 
Human pancreas (as depicted in Fig. 1.1) is an elongated organ, slightly irregular in 
shape, where three different parts can be easily distinguished: broad end at the 
duodenum is called the head (caput pancreatis); the main portion of the organ is 
called the body (corpus pancreatis); and thin end of the pancreas forms the tail 
(cauda pancreatis). Usually the length of human pancreas does not exceed 15 cm 
with its weight ranging from 70 to 100 g.  
The pancreas is engaged in production and secretion of both endocrine hormones and 
digestive enzymes. Endocrine functions are performed by islets of Langerhans, 
which are cell clusters that contain α, β, δ and PP cells. They secrete two types of 
hormones: (1) those involved in blood glucose homeostasis such as glucagon (α 
cells) and insulin (β cells); (2) and hormones involved in regulation of pancreatic
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Fig. 1.1. Schematic illustration of human pancreas 
See full description in text. 
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secretion:  somatostatin (δ cells) and pancreatic polypeptide (PP cells). In contrast, 
exocrine functions are performed by pancreatic acinar cells. These cells produce 
digestive enzymes (such as trypsin, chymotrypsin, pancreatic amylase and lipase) 
and secrete them to the small intestine in response to small intestine hormones: 
cholecystokinin (CCK) and secretin; or in response to acetylcholine (ACh) released 
from parasympathetic nerve synapses in pancreatic tissue. 
The structure of exocrine pancreas is reflected by its functions. Morphologically it 
bears high resemblance to salivary glands, being more diffuse and softer in texture. 
The exocrine part forms more than 90 % of the organ and mainly consists of acinar 
and ductal cells. Clusters of pancreatic acinar cells are organized in grape-like 
lobular forms called acini, which are attached to intralobular ducts. Intralobular ducts 
merge into slightly bigger extralobular ducts, which in turn are connected to the main 
collecting duct that empties into the duodenum
1
. 
Pancreas originates from endoderm, which is one of the three germ layers that 
develop after gastrulation in all vertebrates. The first apparent event of its 
development in embryogenesis is a condensation of mesenchyme that surrounds the 
dorsal side of the endodermal primitive gut tube. Then shortly after (in the 9th or 
26th day of gestation in mice and humans, respectively
2
) the gut thickens and 
endoderm evaginates into the mesenchyme forming a dorsal bud. Simultaneously, in 
the 10th day of mouse and 32nd day of human embryogenesis ventral bud arises 
laterally from the gut, close to hepatic and bile duct endoderm
3
. The buds thicken 
and develop further, which, after gut rotation, eventually leads to their fusion and 
subsequent branching into the surrounding mesenchyme. Importantly, both exocrine 
and endocrine portions of pancreas have a common origin
4
. Glucagon-positive 
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endocrine cells are present as early as 10th day in mouse and in the third month of 
human embryonic development
5
. Subsequently, endocrine cells amplify; also acinar 
cells differentiate and rapidly increase in number. Interestingly, pancreatic acinar 
cells can perform their secretive functions already in prenatal life. 
Although pancreatic tissue is highly specialized, its differentiation is not a 
completely irreversible process. Pancreatic acinar cells have the potential to re-
differentiate into ductal cells. However, this seems to be rather a pathological process 
that occurs during pancreatitis or carcinogenesis. What is more, pancreatic acinar 
cells in some conditions can undergo transdifferentiation into hepatic cells
6
. Pancreas 
and liver share a common developmental lineage. 
1.2. Pancreatic acinar cell 
1.2.1. Structure and functions of pancreatic acinar cell 
Functions of pancreatic acinar cells correspond with their highly specialized 
structure. Each pyramid-shaped pancreatic acinar cell is polarized with two visible 
areas: basolateral and apical (Fig. 1.2). The basolateral pole is larger (even up to 
90 % of the cell volume) and contains most of the endoplasmic reticulum; the apical 
pole faces the acinar lumen and contains secretory granules, where digestive 
enzymes are stored. Generally, receptors at the basolateral plasma membrane receive 
stimuli for secretion (such as acetylcholine and cholecystokinin) leading to 
generation of a second messenger response, which in turn releases calcium from the 
intracellular stores. This signal triggers fusion of secretory granules with the apical 
membrane and release of digestive enzymes into the tiny intercalated duct. 
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Fig. 1.2. Structure of a pancreatic acinar cell 
(A) Transmitted light image from the confocal microscope showing a typical 
pancreatic acinar cell doublet isolated from mouse pancreas. (B) Schematic 
illustration of pyramid-shaped structure of a pancreatic acinar cell. The basolateral 
pole contains most of the ER; zymogen granules are stored in the apical pole. 
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As was previously mentioned, pancreatic acinar cells produce, store and release three 
classes of digestive enzymes: α-amylase, pancreatic lipase and proteases, which 
perform hydrolysis of  carbohydrates, lipids and proteins, respectively. The enzymes 
are stored and secreted as inactive zymogens and under physiological conditions are 
only activated by low pH in the duodenum. Since pancreatic acinar cells store and 
perform controlled release of digestive enzymes, any damage to the organ or 
impaired regulation of digestive enzyme secretion is potentially very dangerous. 
Premature enzyme activation inside the cells might lead to autodigestion of the 
pancreas and injury of other organs and tissues. 
1.2.2. Synthesis and sorting of secretory proteins 
The actual synthesis of pancreatic digestive enzymes is performed by ribosomes. The 
process is initiated by formation of a translation complex in the cytosol. Soon after 
the ER sorting sequence of the growing polypeptide is recognized by a cytosolic 
protein called SRP (signal recognition particle) and the translation is temporarily 
inhibited. This allows docking of the ribosome at the ER and interaction between 
SRP and SRP receptor localized at the ER membrane. This interaction opens a 
translocon (translation channel) in the ER, which leads to translocation of the 
growing polypeptide across the membrane to the ER lumen. After their synthesis and 
folding secretory proteins are targeted into the Golgi network, where they undergo 
maturation and where they are sorted from the constitutively secreted proteins and 
packed into the granules. Two models have been proposed to explain this process
7
. 
The "sorting for entry" model states that there is a specific, pH-dependent 
recognition of secretory proteins by receptors in the trans-Golgi network, which 
separates them from other proteins and directs into secretory granules. On the other 
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hand, the "sorting by retention" model assumes that secretory proteins spontaneously 
aggregate at acidic pH in trans-Golgi compartment, which itself is a signal for their 
packaging into granules. 
Once the dense aggregates of zymogens are formed within the trans-Golgi 
compartment, they interact with the Golgi membranes. This process eventually leads 
to their separation as immature granules. However, the factors mediating that 
interaction have not yet been identified. 
1.2.3. Membrane fusion and secretion. 
At the plasma membrane, vesicle fusion may occur constitutively or it might be sub-
jected to strict control, as in regulated exocytosis performed by pancreatic acinar 
cells. In general, exocytosis consists of the same series of events: recruitment of the 
vesicle to the membrane; tethering at the membrane; priming and fusion
8
. 
Among all proteins engaged in exocytosis, SNAREs (soluble N-etylmaleimide-sen-
sitive factor attachment protein receptors) were shown to be completely 
indispensable for fusion in all investigated species from yeast to mammals
9
. 
SNAREs form a superfamily of proteins defined by the presence of characteristic 
60 - 70 amino acid sequence, called the SNARE motif, which has high potential to 
form coiled-coil complexes
10
. There have been 25 SNARE members identified in 
Saccharomyces cerevisiae and 36 members are currently known to be present in 
humans
11
. Most of them posses a single transmembrane domain located close to the 
C-terminal end. Some SNAREs have additional domains positioned between N-
terminus and SNARE motif. Traditionally, SNAREs have been classified as v- and t-
SNAREs, because fusion requires v-SNARE proteins (e.g. VAMP2/synaptobrevin-2) 
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on the vesicle membrane and t-SNAREs (e.g. syntaxin-1, SNAP25) on the target 
membrane. Another classification of these proteins is based on their structure – 
mainly, on the central amino acid residue present in the SNARE motif. Since this 
amino acid can be glutamine (Q) or arginine (R), SNAREs are divided into Q-
SNAREs (syntaxin, SNAP25) and R-SNAREs (synaptobrevin)
12
. 
Assembly of SNAREs generates the force for membrane fusion – ‘zippering’ of the 
SNARE proteins from donor and acceptor membranes releases enough energy to 
overcome hydrophilic barrier that keeps membranes separate
13
. After fusion, both v- 
and t-SNAREs are present on the target membrane in so called cis-complexes, which 
are extremely stable. To recover the functional SNAREs that can enter another fusion 
cycle, the activity of NSF (soluble N-ethylmaleimide-sensitive adapter protein) is 
required. NSF is an ATPase that binds to SNARE complexes and mediates ATP-
dependent conformational change of the complexes leading to their dissociation
14
. 
Although SNAREs have been shown to be sufficient to drive fusion in vitro
15
, in 
physiological conditions other proteins interact with SNAREs and enhance the speed 
of the process. Out of those fusion regulators Sec1/Munc18 (SM) family of proteins 
is probably the most important. The SM proteins usually contain about 600 amino 
acid residues and are characterised by high sequence homology, but without any spe-
cific motifs. They are soluble cytoplasmic proteins, which bind to SNAREs, 
becoming an established component of the fusion machinery. Members of SM 
proteins are present in all investigated species – for example three different Munc18s 
can be found in mammals, among which Munc18-1 plays the major role in regulated 
exocytosis. The importance of Sec1/Mun18 proteins is very well demonstrated by the 
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fact that a null mutation of the gene encoding Munc18-1 results in strong fusion 
defects
16
. 
Indeed it has been confirmed that the v-SNARE synaptobrevin-2 is present on the 
membranes of zymogen granules in pancreatic acinar cells
17
 . The cells also contain 
three isoforms of t-SNARE syntaxin, each of which has a strictly defined 
distribution. Syntaxin-2 is present on the apical plasma membrane, whereas syntaxin-
4 is on the basolateral membrane; and syntaxin-3 is localized only to the zymogen 
granules
18
. Therefore it is believed that regulated exocytosis in pancreatic acinar cells 
is dependent on syntaxin-2 and -3. Syntaxin-2 is responsible for the actual release of 
digestive enzymes mediating fusion between the zymogen granules and the apical 
plasma membrane. On the other hand, syntaxin-3 is most likely involved in 
homotypic fusion between granules. An equivalent of neuronal SNAP25, SNAP23 is 
expressed in many cell types including pancreatic acinar cells. Interestingly, 
SNAP23 was found on the basolateral membrane and seems to be absent on the 
apical membrane. Therefore it is unlikely to play a role in enzyme secretion under 
physiological conditions
19
. This function is probably performed by a still unidentified 
homologue of SNAP23. Out of three known mammalian isoforms of Munc-18 two of 
them, Munc-18-2 and -3, have been found in acini
20
. Their exact functions have not 
yet been studied in detail. 
Interestingly, exocrine tissues including pancreas appear to possess a unique protein 
called syncollin, which is not related to any other protein engaged in membrane 
fusion. Syncollin was found inside the zymogen granules attached to the inner 
leaflets of their membranes
21
 and it seems to form pH-sensitive oligomers. Syncollin 
  
 
 
30 
 
  
was postulated to regulate exocytosis through binding to syntaxin in calcium-
dependent manner
22
. 
1.3. Calcium signalling in pancreatic acinar cells 
1.3.1. Calcium as an intracellular messenger 
In eukaryotic cells resting cytosolic calcium concentration is maintained around 
100 nM, whereas extracellular calcium is as high as 1 mM. This very tight control is 
possible due to the coordinated functions of various proteins: membrane calcium 
pumps, channels and exchangers; and proteins that regulate their activity. Sudden 
changes in cytosolic calcium concentration encode stimulus-induced messages and 
trigger specific cell responses. There are two major sources of calcium influx to the 
cytosol that cause [Ca
2+
] increase: 1) the endoplasmic reticulum and 2) extracellular 
environment. 
The endoplasmic reticulum is the main intracellular calcium store and the most 
important regulator of intracellular calcium fluxes. Storage of ER calcium depends 
on its binding to Ca
2+
-binding proteins such as calreticulin or calsequestrin. 
Movement of calcium across ER membranes is tightly regulated: transport into the 
ER is dependent on the action of the sarco- / endoplasmic reticulum calcium-ATPase 
(SERCA), which pumps Ca
2+
 ions from the cytosol to the ER lumen; whereas efflux 
is mediated by ligand-activated channels, which transiently release calcium to the 
cytosol. 
Calcium influx from the extracellular space is dependent on the calcium channels 
located on the plasma membrane. These channels can be divided into three classes 
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based on the mechanism gating: 1) the voltage operated Ca
2+
 channels (VOCs), 
which are found in excitable cells and thus are not present in pancreatic acinar cells; 
opening of these channels is triggered by a decrease in the plasma membrane 
potential; 2) the receptor operated Ca
2+
 channels (ROCs), which open after binding a 
specific external ligand; 3) and the second messenger operated channels (SMOCs), 
which conduct Ca
2+
 ions only upon binding a specific second messenger at their 
cytosolic site
23
. 
1.3.2. Store operated calcium entry (SOCE) 
The increase in cytosolic calcium above resting values is cleared by the combined 
activities of extrusion mechanisms, which include components located both at the 
plasma membrane and the ER. The sarcoplasmic / endoplasmic reticulum calcium-
ATPase (SERCA) refills the intracellular stores, whereas the plasma membrane 
calcium ATPase (PMCA) and the Na
+
-Ca
2+
 exchanger (NCX) transport Ca
2+
 against 
its electrochemical potential from the cytosol to the external space. Thus not all Ca
2+
 
released from the ER is taken back to the store. A substantial portion of that released 
Ca
2+
 is transported out of the cell through the plasma membrane and is inevitably 
lost. Therefore a specific pathway must exist by which cells can replenish their 
intracellular calcium stores using extracellular Ca
2+
. In 1986 J. Putney defined the 
mechanism, where depletion of the intracellular stores triggers Ca
2+
 flux from the 
extracellular space
24
. Initially, the process was named the capacitative Ca
2+
 entry 
(CCE); currently it is referred in the literature as the store operated calcium entry 
(SOCE). Pharmacological inhibition of the SERCA by reagents such as thapsigargin 
(Tg) or cyclopiasonic acid (CPA) blocks replenishment of the ER and leads to store 
depletion due to passive leak of Ca
2+
 from the ER
25
. That in turn activates inward 
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calcium flux from the extracellular space identified as Ca
2+
 release - activated Ca
2+
 
current (CRAC). It was clear that the SOCE machinery requires three main 
components: (1) a regulated channel that mediates Ca
2+
 influx, (2) a calcium sensor 
in the intracellular stores, (3) and an efficient mechanism that allows communication 
between them. Until recently these components remained a mystery unsolved for 
almost two decades. 
In 2006 S. Feske identified and named ORAI1 (Ca
2+
 release-activated Ca
2+
 channel 
protein 1) as the crucial component of SOCE mediating Ca
2+
 influx upon store 
depletion
26
. ORAI1 and other members of the family: ORAI2 and ORAI3 are 
transmembrane proteins of 28 - 33 kDa
27
. They are highly glycosylated, contain four 
transmembrane domains, whose C- and N-terminus are located at the cytoplasmic 
site
28
. Most likely four ORAIs build a functional tetrameric calcium channel
29
. 
STIM1 (stromal interaction molecule 1), the ER calcium store sensor, turned out to 
be GOK protein initially described in 1996
30
 and was eventually linked to calcium 
homeostasis in 2005
31,32
. There are two known mammalian orthologs: STIM1 and 
STIM2, which both are single pass transmembrane proteins containing two EF hand 
motifs directed toward the ER lumen
31
. STIM1 is believed to be the actual sensor and 
responder to ER calcium depletion. Significant decrease in [Ca
2+
]ER leads to 
dissociation of Ca
2+
 bound to the EF hand motif at the N-terminus of STIM1. This 
triggers STIM1 association into multimers via SAM (sterile α-motif) domain and 
subsequent translocation of STIM1 oligomers within the ER membranes to areas 
located close to the plasma membrane, which initiates CRAC channel activation
33
. In 
the literature there is some evidence that STIM1 can also regulate members of TRP 
channels such as TRPC1
34-36
. STIM1 has also been found inserted into the plasma 
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membrane; however, it is still not entirely clear what the functional reason of this 
insertion might be, especially because it does not seem to be required for ORAI 
regulation
28,33
. The role of STIM2 is less clear. The protein exclusively located to the 
ER membranes and when expressed at physiological levels it appears to increase 
SOCE
37
. On the other hand its overexpression leads to decrease in calcium influx
38
. 
Since STIM2 becomes fully activated earlier during store depletion than STIM1, it 
was postulated that STIM2 might have regulatory functions sensing basal ER Ca
2+
 
levels and regulating Ca
2+
 influx in response to low intensity stimulation
37,39
. 
1.3.3. The role of Ca
2+
 in physiology and pathology of pancreatic acinar cells 
Physiological functions of pancreatic acinar cells are predominantly controlled by 
calcium. Calcium also plays an important role in development of pancreatitis
40,41
. 
Therefore different patterns of cytosolic calcium responses, dependent on calcium 
release from the intracellular stores, differentiate between physiology and pathology 
of pancreatic acinar cells. Acetylcholine (ACh) and cholecystokinin (CCK) are two 
secretagogues that control physiological functions of pancreatic acinar cells. They 
induce various types of intracellular calcium responses depending on the intensity of 
stimulation. Physiological doses of ACh and CCK evoke small cytosolic [Ca
2+
] 
oscillations, which are often confined only to the apical area of the cell; or global 
calcium waves that originate in the apical area and spread toward the basolateral 
area
42,43
. On the other hand excessive doses of ACh and CCK or treatment with 
menadione (induction of oxidative stress)
44,45
 cause large sustained increases in 
cytosolic [Ca
2+
], which are toxic and might lead to cell death
40,46
 (Fig. 1.3.A-C). A 
specific cell response is strongly dependent on the type of the calcium signal. For
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Fig. 1.3. Physiological and pathological calcium responses in pancreatic acinar 
cells 
(A) Schematic illustration of differences in pathological (left) and physiological 
(right) Ca
2+
 signals in the cytosol of pancreatic acinar cells. (B) Physiological 
calcium responses to small doses of ACh in pancreatic acinar cells are restricted to 
granular area [Adapted from Gerasimenko OV, 1996]
47
. 
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Fig. 1.3. (continues) 
(C) Excessive doses of ACh induce sustained global Ca
2+
 rise in the cytosol of 
pancreatic acinar cells [Adapted from Gerasimenko OV, 1996]
47
. (D) Schematic 
illustration of calcium signalling events occurring at (a) the plasma membrane, (b) 
and the ER membrane [Based on Petersen OH 2006]
48
. See full description in text. 
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example, local calcium oscillations are associated with enzyme secretion; whereas 
global calcium waves control gene expression
49
. The receptors for pancreatic 
secretagogues belong to the family of G-protein coupled metabotropic receptors, 
which are characterised by seven transmembrane domains (Fig. 1.3.D). Many 
different G proteins are present in pancreatic acinar cells, each of which is composed 
of three subunits: α, β and γ. From that variety of G proteins, Gq family members 
mediate responses associated with pancreatic secretion
50
. Upon ligand binding, the 
intracellular part of the receptor changes conformation and activates the specific G 
protein by facilitating exchange of GDP to GTP. Activated G protein (usually its α 
subunit) triggers production of a specific intracellular second messenger. Upon 
activation of phospholipase C (PLC) by the α subunit, phosphatidylinositol 4,5-
bisphosphate (PIP2) is cleaved and as a result inositol 1,4,5-trisphosphate (IP3) and 
diacylglycerol (DAG) are formed. G proteins can also activate ADP-ribosyl
 
cyclase, 
which catalyses synthesis of cyclic ADP ribose (cADPR) from nicotinamide adenine 
dinucleotide (NAD
+
). Both IP3 and cADPR bind to their intracellular receptors, 
which effectively are calcium sensitive ligand - gated calcium channels (Fig. 1.3.D). 
That initiates calcium release from the intracellular stores. There are two major types 
of channels responsible for calcium release from the ER: inositol 1,4,5-trisphosphate 
receptors (IP3Rs) and ryanodine receptors (RyRs). IP3 binds to IP3 receptors and 
cADPR is an endogenous regulator of ryanodine receptors. Out of three isoforms of 
RyRs, type 2 and 3 are sensitive to cADPR, whereas type 1 is not
51
. What is more, 
calcium release induced by cADPR seems dependent on calmodulin
51
. Once 
generated, IP3 and cADPR act on IP3Rs or RyRs, respectively, which leads to release 
of calcium from the intracellular stores. This small increase in cytosolic calcium 
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activates even more IP3Rs and RyRs leading to further release of calcium from the 
intracellular stores in a process called calcium-induced calcium release (CICR). 
NAADP is another important messenger, synthesized from NADP
+
 by the ADP 
ribosyl cyclase, that has been shown to have calcium releasing potential
51,52
. It is 
believed that NAADP might mediate its actions through a still unidentified receptor. 
The existence of this receptor is indicated by the facts that: (1) NAADP can release 
calcium from a thapsigargin-insensitive store in sea urchin eggs
53
; (2) NAADP-
induced calcium release can be blocked by dihydropyridines, gallopamil or 
diltiazem, which do not affect IP3Rs or RyRs
54,55
; (3) it has very specific binding 
kinetics; (4) and it has capability to undergo self-desensitization
49
. In contrast to 
IP3Rs and RyRs, NAADP receptor does not seem to be sensitive to activation by 
calcium
56
. However, since effects of NAADP can be blocked by inhibition of RyRs 
in pancreatic acinar cells it is possible that NAADP also affects RyRs opening
55
. 
1.3.4. CCK signalling 
CCK can be considered as a hormone and a neuropeptide at the same time, since it is 
secreted not only by small intestine endocrine cells after food ingestion
57
, but also by 
neurons from gastrointestinal tract and central nervous system
58
. There are two types 
of CCK receptors named as CCK-A and CCK-B (the latter is also called gastrin 
receptor). In most mammals, including mouse and human, only CCK-A receptor is 
present in pancreatic acinar cells. CCK-B receptor, whose expression is usually 
restricted to the brain, can be found in pancreatic acinar cells of only certain species, 
such as guinea pig and dog
49
. 
  
 
 
38 
 
  
CCK-A receptors are slightly more sensitive to sulfated than unsulfated CCK and are 
characterised by only very low sensitivity to gastrin. They have two CCK binding 
sites, one of which binds CCK with high affinity and the other one is a low affinity 
binding site. The high affinity site stimulates physiological responses of pancreatic 
acinar cells, including enzyme synthesis and secretion; whereas the low affinity 
binding site most likely has inhibitory functions
49
. CCK receptors are coupled 
through G proteins to various enzymes, such as adenylate cyclase and 
phospholipases C, D and A2
50,57,59
. Physiological concentrations of CCK (1 - 10 pM), 
that lead to activation of the high affinity binding site of the receptor, induce calcium 
oscillations within the pancreatic acinar cell without generating detectable amounts 
of IP3; even though DAG is present (possibly due to breakdown of choline 
metabolites such as phosphorylcholine)
60
. Only strong stimulation, which activates 
low affinity site of CCK receptor, leads to intracellular IP3 production
60
. cADPR is 
an important and specific calcium releasing messenger of CCK
61
. What is more, 
NAADP has been proposed to be a second messenger of CCK-mediated actions. 
Effects of stimulation with physiological doses of CCK can be easily blocked with a 
cADPR agonist - 8-amino-cADPR
62
. 
1.3.5. ACh signalling 
Acetylcholine (ACh) is a neurotransmitter present in both the central and peripheral 
nervous system. Its synthesis is performed in certain neurons by choline 
acetyltransferase from choline and acetyl-CoA. There are two main types of ACh 
receptors: (1) nicotinic, which are ionotropic receptors permeable to Na
+
, K
+
 and to a 
lesser extent to Ca
2+
; (2) muscarinic - typical metabotropic receptors, stimulated by 
both ACh and muscarine and inhibited by atropine. In pancreatic acinar cells ACh 
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binds to M3 type muscarinic receptors at the cell membrane and induces mainly IP3 
production, which releases calcium from the ER through IP3Rs
63,64
.  
1.3.6. Distribution of IP3Rs and RyRs in pancreatic acinar cells 
Localization of IP3Rs and RyRs in the ER of pancreatic acinar cells is not identical. 
IP3Rs are mainly present in the apical pole of the cell
65,66
, whereas RyRs are evenly 
distributed at the ER membranes in the apical as well as basolateral area
67,68
. As was 
previously mentioned, despite the stimulus acting on the basolateral membrane, the 
calcium response originates in the apical region of the cell. Therefore the observed 
pattern of calcium responses is due to (1) distribution of calcium release channels in 
pancreatic acinar cell; (2) Ca
2+
 buffering role of mitochondrial belt surrounding the 
apical area; and (3) phenomenon of calcium-induced calcium release (CICR), where 
small increase in cytosolic [Ca
2+
] induces further release of calcium from the 
intracellular stores via activation of additional calcium channels. Accumulation of 
both IP3Rs and RyRs in the granular area is associated with increased sensitivity of 
this region for CICR as compared to the basolateral pole. This differential sensitivity 
has been previously demonstrated by local calcium uncaging  experiments: calcium 
uncaged in the basolateral region did not induce CICR; whereas calcium uncaging in 
the apical area led to a long-lasting CICR type of response
69
 (Fig. 1.4). IP3Rs and 
RyRs are both necessary for CICR because inhibitors of each of the receptors 
effectively prevented CICR triggered by local release of caged calcium
69
. 
 
 
 
 
 
  
 
 
40 
 
  
 
 
 
 
 
 
Fig. 1.4. Local calcium uncaging experiments 
Experiments of Ca
2+
 uncaging in different parts of pancreatic acinar cells 
demonstrate that different sensitivity of granular and basolateral areas to CICR. Blue 
traces represent Ca
2+
 responses recorded in basolateral region and red traces - in 
granular area [Adapted from Ashby M, 2002]
69
. See description in text. 
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1.4. Calcium Imaging 
Application of calcium-sensitive fluorescent probes made possible the real-time 
detection of [Ca
2+
] changes inside the cell, in cytosol as well as in various cell 
compartments. A simple detection system can be composed of a fluorescence 
microscope, a relatively sensitive CCD camera and a computing hardware able to 
store and process recorded images. Application of confocal microscopes gives an 
advantage of significantly better spatial resolution over conventional fluorescence 
microscopes; and is suitable for more advanced tasks, when for example imaging of 
small organelles is required
70
. Having a confocal pinhole makes the microscope 
reject out of focus fluorescent light from the specimen, which effectively leads to 
acquisition of light from only a thin section of the sample. 
1.4.1. Basis of fluorescence 
Fluorescence is a type of luminescence, the term which is used to described the 
property of certain molecules, called fluorophores, to emit light upon excitation as a 
result of absorption of electromagnetic radiation
71
. The process of fluorescence takes 
place only when emission of the photon by a fluorophore is associated with its return 
to the ground state from an excited singlet state. Such transitions are permitted and 
happen relatively quickly; therefore fluorescence is a rapid process that takes place 
on a timescale of nanoseconds. 
The photons of electromagnetic radiation absorbed by fluorophores are always of 
certain energy range (which corresponds to the certain wavelength), that is equal to 
the energy needed for promotion of an electron in the ground state of the fluorophore 
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to one of the vibrational levels of an excited state, usually the first excited state S1. 
Immediately after absorption of a photon several processes may occur, but the most 
common is transition to the lowest vibrational energy levels of the state S1. This 
phenomenon is defined as vibrational relaxation or internal conversion and describes 
loss of energy in a form of kinetic energy (in the absence of light emission) due to 
collisions with other molecules. Internal conversion usually occurs within 
picoseconds. Transition of the molecule from the lowest vibrational levels of excited 
singlet state to one of the vibrational energy levels of the ground singlet state S0, 
accompanied by emission of a photon constitutes the principle of fluorescence. 
Energy of the emitted photon will be equal to the difference in energy of the levels 
between which the transition took place. Since the distance between the vibrational 
levels of the excited state resembles that of the ground state, the emission spectrum 
of a fluorophore is a mirror image of absorption spectrum, but it is moved to the 
higher wavelengths (Stokes shift). 
Other relaxation transitions may occur and they compete with the process of 
fluorescence. The energy of the excited state can be lost either as heat or as kinetic 
energy upon collisions with other molecules. What is more, an interesting 
phenomenon called intersystem crossing can take place with a low probability. 
Intersystem crossing defines the transition between the lowest excited singlet state 
and the lowest excited triplet state. This process may result in emission of a photon 
through phosphorescence upon transition from the T1 (excited triplet state) to the S0 
(ground singlet state). Since such transitions are effectively forbidden, 
phosphorescence is much slower than fluorescence ranging from milliseconds to 
seconds. Alternatively, a transition from the excited triplet state  back  to  the  excited 
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Fig. 1.5. Schematic illustration of Jablonski Energy Diagram 
Dark blue arrows represent absorption / excitation (10
-15 
s); orange arrows - 
vibrational relaxation (10
-14
 - 10
-11
 s); red arrows - fluorescence (10
-9
 - 10
-7
 s); light 
blue arrows - intersystem crossing; green arrows - non-radiative relaxation and 
violet arrow - phosphorescence (10
-3
 - 10
2
 s). 
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singlet  state  can occur, which causes delayed fluorescence. All described transitions 
are presented on Jablonski Energy Diagram (Fig. 1.5). 
Most fluorophores can be excited multiple times repeating the excitation - emission 
cycles till they are eventually photobleached, which results in destruction of 
fluorophore and thus loss of fluorescent response upon excitation. 
1.4.2. Calcium-sensitive fluorescent probes 
Three types of calcium sensitive fluorescent probes can be distinguished: (1) 
fluorescent dyes, (2) recombinant aequorins, (3) probes based on green fluorescent 
protein (GFP) and its engineered analogues
70
. 
Currently used fluorescent dyes for Ca
2+
 imaging were derived from popular ion 
chelators such as bis-(2-aminophenoxy)-ethane tetraacetic acid (BAPTA) or bis-(2-
aminoethyl ether) tetraacetic acid (EGTA)
72
. The chelator backbone is responsible 
for Ca
2+
 binding and is conjugated to a fluorescent residue. Calcium-sensitive 
fluorescent dyes can be divided into different groups depending on their physical and 
chemical properties such as absorption / emission spectrum (UV light- vs. visible 
light- excited indicators; ratiometric vs. non-ratiometric dyes) and Kd value (high 
affinity vs. low affinity for Ca
2+
). 
For efficient delivery of fluorescent indicators into the living cells, the probes need to 
be able to penetrate the plasma membrane, and / or the intracellular membranes when 
loading to organelles is required. For that purpose carboxylic acid moieties are 
chemically modified with acetoxymethyl (AM) groups resulting in uncharged 
molecules that more efficiently cross cell membranes. Inside cells, AM groups are 
removed by nonspecific esterases, which again apply charge to the molecule of 
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indicator preventing its leak from the cell. However, use of AM esters forms of 
calcium indicators is associated with a problem: hydrophobic AM esters are poorly 
soluble in aqueous solution. Therefore to support efficient cell loading often 
dispersing agents are used, such as Pluronic F-127. 
Ratiometric calcium indicators are characterised by a shift in either excitation or 
emission spectral peak upon Ca
2+
 binding. This property is very useful as it allows 
recording of ratio of fluorescence measured at two different wavelengths. Depending 
on the type of the dye either fluorescence is measured at one emission peak upon two 
sequential excitations at different wavelengths, or one excitation results in two 
emission peaks - for high and low calcium conditions. Ratiometric measurements 
compensate for various artefacts such as photobleaching, differences in loading or 
cell thickness. The most widely used ratiometric dyes include fura-2 and indo-1. 
Fura-2 is relatively photostable, easy to load and, with Kd = 224 nM, is useful for 
detecting Ca
2+
 changes in physiological range
73
. For ratiometric measurement with 
fura-2, sequential excitation at 340 nm and 380 nm is often used and fluorescence is 
recorded at about 510 nm. Upon calcium binding the excitation maximum is shifted 
to 340 nm. In contrast to fura-2, indo-1 has a single excitation peak at 338 nm but 
dual emission peak, which shows a shift from 485 nm to 405 nm upon calcium 
binding
73
. 
Alternatives to UV-excited ratiometric calcium indicators are long-wavelength dyes, 
which lack Ca
2+
-dependent spectral shifts, but show changes in fluorescence 
intensity. Although such calcium indicators do not allow ratiometric measurements 
they offer an advantage of lower autofluorescence. Fluo-4 is frequently used as a 
non-ratiometric calcium indicator, whose excitation peak is at 488 nm and emission 
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peak is at 515 nm
74
. It is characterised by lower affinity for calcium than fura-2 
(Kd = 345 nM) and very low fluorescence in unbound state
74
. For ratiometric 
measurements it is possible to combine fluo-4 with another dye such as fura red, 
which exhibits opposite shifts in fluorescence intensity upon Ca
2+
 binding. 
Alternatively use of Ca
2+
-insensitive dye together with fluo-4 provides a reference 
line for semi-ratiometric measurements. 
The second group of calcium indicators is based on luminescent recombinant 
aequorins originally obtained from jellyfish Aquoria victoria
75
. In this organism 
aequorin is a protein working together with GFP to produce bioluminescent green 
light. Aequorin consists of: non-luminescent apoaequorin of a size of 21 kDa; and 
coelenterazine - a tightly bound prosthetic group (0.4 kDa).  Ca
2+
 binding to aequorin 
induces peroxidation of coelenterazine that breaks the link between apoaequorin and 
coelenterazine, which is associated with emission of a single photon of blue light 
(emission peak at 470 nm). This blue light  normally in the jellyfish excites acceptor 
GFP utilizing the biophysical process called bioluminescence energy transfer 
(BRET), which eventually leads to emission of green fluorescence by Aquoria 
victoria. The rate of aequorin peroxidation exhibits dependence on Ca
2+
 
concentration within certain Ca
2+
 range (less than 100 µM)
75
. Recombinant 
apoaequorin can be expressed in various cell types or even specifically targeted to 
organelles; addition of exogenous colenterazine leads to reconstitution of fully 
working holoprotein. However, a serious limitation of aequorin applications is the 
irreversible nature of the peroxidation reaction. Therefore during a single experiment 
only one photon of blue light can be collected from one photoprotein molecule. For 
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that reason during recent years fluorescent calcium dyes have gained more 
appreciation and popularity than aequorin-based probes. 
The third type of calcium indicators is based on another protein of Aquorea victoria: 
green fluorescent protein (GFP). GFP absorbs short wavelength light (blue) and 
emits light of a longer wavelength (green)
76
 . It has a structure of a beta barrel 
constructed from a single β-sheet surrounding α-helix that contains chromophore 
formed by the tripeptide Ser65-Tyr66-Gly67
77
. Spontaneous formation of the 
chromophore means that no other non-peptide cofactors are required for fully 
functional protein, and that all elements needed for fluorescent properties are 
encoded by a single gene. Therefore engineered versions of GFP can be easily 
expressed in various cell types and cell compartments. Targeted mutagenesis helped 
to improve GFP expression in mammalian cells by replacing rare codons in gene 
sequence with those that are more common. Further, "enhanced" versions of GFP 
were created, which exhibit increased light emission upon excitation. Eventually, 
substitution of certain amino acids in chromophore group or in its neighbourhood led 
to development of the whole family of fluorescent proteins, which includes blue BFP 
(Y66H), cyan CFP (Y66W) and yellow YFP (T203Y). 
Currently GFP-derived fluorescent proteins have multiple applications. They can be 
used as fluorescent tags for visualisation and tracking various proteins inside living 
cells
78,79
. They might also serve as a tool for assessment of transfection efficiency 
both in prokaryotic and eukaryotic cells
80
. Applications of fluorescent proteins are 
even extended by the process of fluorescence resonance energy transfer (FRET), 
which can take place between two different fluorescent proteins when emission 
spectrum of the donor protein overlaps with the excitation spectrum of the acceptor 
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protein. Additionally, another requirement for FRET to occur is close location of the 
donor and acceptor proteins, usually in the range of a few nanometres. Among other 
uses, FRET found an application in intracellular Ca
2+
 concentration monitoring. For 
this purpose reporters, called cameleons, were developed in the laboratory of Roger 
Y. Tsien and subsequently improved
81-83
. Cameleons usually consist of two 
fluorescent proteins capable of FRET, connected with a linker composed of N-
terminal fragment of calmodulin and M13 peptide, which associated with calmodulin 
in a Ca
2+
-dependent manner
84,85
. Calcium binding by cameleon changes the 
orientation of fluorescent proteins and increases FRET between them, which can be 
observed as increased signal from the acceptor and decreased signal from the donor. 
cameleon can be expressed inside the cytosol of living cells or specifically targeted 
into cell compartments and thus it can be used as ratiometric calcium indicator. 
 1.5. Diseases of pancreas 
The most common pancreatic acinar cell dysfunctions include pancreatitis (chronic 
and acute) and pancreatic cancer. Among them acute pancreatitis is the most frequent 
disease of pancreas and pancreatic cancer is the most fatal. 
1.5.1. Pancreatic cancer 
Pancreatic cancer is a malignant neoplasm of pancreatic tissue. Up to 99 % of the 
cases of pancreatic cancer are associated with the exocrine pancreas, with ductal 
adenocarcinoma  being the most common
86
. Pancreatic cancer has a very poor 
prognosis, with survival rate lower than 5 % in five years post diagnosis. One of the 
main problems is detection of pancreatic cancer. Since it gives no obvious symptoms 
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in early stages of development and in late stages the symptoms are nonspecific (such 
as abdominal pain, loss of appetite, vomiting or jaundice) pancreatic cancer is often 
called a "silent killer". 
Causes of pancreatic cancer are still not clear. Several risk factors have been 
identified, including smoking, obesity, diabetes or Helicobacter pylori infection
87
. 
Also the incidence of pancreatic cancer increases with age, affects more males than 
females, and is substantially potentiated by chronic pancreatitis. 
Up to now there is no effective cure against pancreatic cancer. Treatment approach 
depends of the stage of development and localization of the cancer. Malignancies of 
the tail of pancreas can be surgically removed. When the cancer is localized to the 
head of pancreas, the surgery aims to remove both pancreatic head and a fragment of 
duodenum attached to it. Surgery is often followed by chemotherapy with 
gemcitabine. Gemcitabine is also used for palliative treatment in patients who do not 
qualify for surgical intervention.  
1.5.2. Acute pancreatitis 
Acute pancreatitis affects annually on average 1 individual out of 2000
88
 and 
continues to increase showing a strong correlation with chronic heavy alcohol intake 
and gallstones
89
. Initial symptoms usually include severe upper abdominal pain, 
nausea and vomiting
90
. Approximately one out of four patients suffering from 
pancreatitis develops even more severe stage of the disease, characterised by 
extensive pancreatic necrosis or even a systemic inflammatory response, which often 
leads to injury of multiple organs and eventually to death
90
. Currently there is still no 
effective pharmacological treatment available, which could specifically and 
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effectively target and cure pancreatitis. Developed stages of the disease with infected 
pancreatic necrosis are an indication for surgical intervention
91
. 
Acinar cell injury has been found to be very often associated with migrating 
gallstones. According to the hypothesis gallstones might obstruct the common 
channel (which binds common bile duct and the pancreatic duct) and therefore they 
can potentially induce biliary reflux into the pancreas
92,93
. Some findings indicate 
that bile salts can be toxic for pancreatic acinar cells and induce pancreatic cell 
death
94
. In contrast, other findings do not support a role of biliary reflux in the 
pathogenesis of gallstone-induced acute pancreatitis, indicating that high pressure of 
bile would be crucial for pancreatic injury to occur
93
. What is more, the size of the 
common channel seems to be too short for efficient bile reflux
95
. Therefore although 
association of acute pancreatitis and gallstones is very strong, the exact pathogenesis 
of gallstone-induces pancreatitis remains unclear. 
Alcohol abuse is known to be associated with acute as well as chronic pancreatitis. 
Risks of developing pancreatitis show a linear increase with the amount of alcohol 
intake
96
. However, since only a small fraction of alcoholics suffers from pancreatitis, 
additional factors are required for the effective development of the disease
97
. Effects 
of ethanol on pancreatic cells have been studied in several animal models, mainly in 
rodents. It was demonstrated that ethanol both infused in vivo to rats or given 
simultaneously with high fat diet causes vacuolisation, inflammation and oedema of 
the pancreas
98,99
. However, now it is believed that the main source of acinar injury 
lies not in ethanol itself but in its non-oxidative metabolites - fatty acid ethyl esters 
(FAEEs)
100
. 
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Pancreas can metabolise ethanol through two pathways: oxidative and non-oxidative. 
In the oxidative pathway, ethanol is converted to acetaldehyde by an enzyme called 
alcohol dehydrogenase (ADH). Oxidation of ethanol is associated with the formation 
of reactive oxygen species (ROS), which are short-lived, extremely reactive and thus 
potentially harmful. Under normal conditions cells efficiently remove ROS via 
reactions catalysed by catalase, peroxidases or superoxide dismutase. However, 
oxidative stress caused by an imbalance between ROS and protective mechanisms of 
the cell can result in induction of pancreatic cell death. 
FAEEs are products of non-oxidative pathway of ethanol metabolism. They are 
formed by pancreatic ester synthases from ethanol and fatty acids. It has actually 
been shown that FAEEs are produced in pancreatic acinar cells upon ethanol 
treatment
101,102
. They have been found to promote trypsinogen activation in rat 
pancreatic acinar cells and extracellular matrix deposition in pancreas
103-105
. 
Potentially, FAEEs can utilize a different mechanism of toxicity
93
. For example, 
having a hydrophobic component, FAEEs may physically interact with cellular or 
lysosomal membranes destabilizing them
106
. FAEEs might also support inflammation 
in pancreas by promoting induction of NF-κB and AP-1, which are transcription 
factors regulating pro-inflammatory cytokine production
101
. Further, FAEEs might 
be hydrolysed to fatty acids (FAs), which are involved in induction of mitochondrial 
dysfunction
107
. And, importantly, FAEEs and FAs significantly affect calcium 
homeostasis in pancreatic acinar cells. 
Both FAEEs and FAs have been demonstrated do induce slow but substantial 
increase in cytosolic calcium concentration in pancreatic acinar cells
100
. FAEEs 
release calcium from the ER,
108
 most likely via activation of IP3Rs
109
 . On the other 
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hand, FAs might block ATP production in mitochondria, which would inhibit ATP-
dependent Ca
2+
 pumps in the plasma membrane and the ER, and as a result - calcium 
extrusion from the cytosol
109
.  
It is agreed, that acinar cell death represents a key event in pathology of acute 
pancreatitis. Importantly, severe acute pancreatitis involves extensive acinar cell 
necrosis, but only very little apoptosis
110
. On the other hand, cases of mild acute 
pancreatitis were found to be associated with apoptotic acinar cell death rather than 
necrotic
110
. Therefore it is now believed that the balance between apoptosis and 
necrosis can influence the severity of the disease
111
. It has been even observed that 
pancreatic acinar cells might be protected against cerulein-elicited pancreatitis by 
induction of apoptosis
112
. 
1.6. Cell death 
Cell death can be a physiological process as well as a pathological event. Therefore, 
it can be divided into two main categories: apoptosis and necrosis. Necrosis is a form 
of uncontrolled premature cell death induced by severe external stimuli, such as an 
injury, inflammation or chemical agents. In contrast, apoptosis is a mechanism of 
programmed cell death, which is tightly regulated, dependent on different stimuli and 
cellular insults and, as a physiological process, it is essential for successful 
development and tissue homeostasis. Apoptosis serves in removal of damaged or 
excessive cells during embryogenesis and is crucial for fighting infections. The 
importance of strict control of cell death can be demonstrated by the facts, that 
failure to eliminate undesired cells leads to cancer or various autoimmune diseases; 
on the other hand, excessive cell death is characteristic for degenerative disorders
113
. 
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Generally, apoptosis can occur via two pathways: intrinsic (classical, mitochondrial) 
and extrinsic (receptor-mediated). They both consist of cascades of events that lead 
to membrane blebbing, DNA fragmentation, cell shrinkage and removal of the dead 
cells from the tissue. These events are not present in necrosis, during which the 
intracellular content is released from the cell usually triggering inflammation and 
tissue damage
114
. The crucial mediators of apoptosis are caspases (cysteinyl-aspartic 
acid proteases), which can function as initiators of the cascade (caspase 8 and 9) that 
eventually leads to activation of executioner caspases (caspase 3, 6 and 7) 
responsible for proteolytic cleavage of target proteins. 
From the two above described apoptotic cell death pathways, only the intrinsic 
pathway is tightly regulated by Bcl-2 family proteins. It is triggered by various 
cytotoxic insults including viral infections, DNA damage and deprivation of growth 
factors. Activation of intrinsic pathway is a result of alteration of mitochondrial 
function and structure – pro-apoptotic Bcl-2 proteins, Bax and Bak, are believed to 
initiate the outer mitochondrial membrane permeabilization, which leads to the 
formation of PTP (permeability transition pore). As a result, apoptogenic factors, 
such as cytochrome c, are released from the mitochondria
115
. Cytochrome c is then 
involved in the formation of Apaf-1 complex that promotes activation of 
caspase 9
116
, which in turn activates the downstream executioner caspases 3, 6 and 7. 
The second apoptotic pathway, the extrinsic pathway, does not involve Bcl-2 
proteins. It is dependent on the activation of death-receptors, such as TNF-R, Fas and 
other related receptors
117
. This leads to activation of the initiator caspase 8, which 
subsequently activates the downstream effector caspases. Importantly, caspase 8 can 
not only cleave the downstream caspases, but also Bid, a proapoptotic protein.
  
 
 
54 
 
  
 
 
 
 
 
 
Fig. 1.6. Schematic illustration of intrinsic and extrinsic apoptotic pathways 
(full description in text). 
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C-terminal truncated Bid (t-Bid) translocates to mitochondria and causes cytochrome 
c release, which promotes further caspase activation (caspase 9 and then 6, 7 and 
3)
118
. This mechanism constitutes an important crosstalk between intrinsic and 
extrinsic pathways (see Fig. 1.6). 
1.7. Bcl-2 family proteins 
The Bcl-2 (B cell lymphoma-2) family proteins are the most important regulators of 
intrinsic apoptotic pathway.  Based on their structure and functions they are grouped 
into three classes: (1) Inhibitors of apoptosis (Bcl-2, Bcl-xl, Bcl-w, Mcl-1, A1); (2) 
pro-apoptotic proteins (Bax, Bak); (3) and divergent class of BH3-only proteins 
(such as Bad, Bid, Bik, Bim, PUMA and other members) (Fig. 1.7). Almost all anti-
apoptotic Bcl-2 proteins contain four BH (Bcl-2 Homology) domains along with a 
single transmembrane domain. Pro-apoptotic proteins have three BH domains (BH1-
3); and BH3-only members, as the name suggests, are characterised by the presence 
of only one conserved BH3 domain. 
Current general understanding of the process of apoptosis induction states that 
various cytotoxic insults result in transcriptional or post-transcriptional activation of 
one or more BH3-only proteins, which in turn interact with other Bcl-2 family 
members leading to activation of proapoptotic Bax and Bak. The latter pro-apoptotic 
Bcl-2 family members are crucial for induction of outer mitochondrial membrane 
permeabilization, which is a key event in intrinsic apoptotic pathway. Pro-apoptotic 
Bax and Bak undergo conformational changes followed by oligomer formation and 
their insertion into the outer mitochondrial membrane. 
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Fig. 1.7. Schematic domain structure of Bcl-2 family proteins 
Anti-apoptotic proteins posses BH1 - BH4 domains; pro-apoptotic proteins have 
three BH domains: BH1 - BH3; and BH3-only proteins are characterised by only one 
BH3 domain. 
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1.7.1. Bcl-2 family members 
In all mammals there are five pro-survival Bcl-2 family members that antagonise the 
pro-apoptotic functions of Bax and Bak. These are: Bcl-2, Bcl-xL, Bcl-w, Mcl-1 and 
A1. They exhibit different tissue distribution and are involved in control of specific 
processes. For example Bcl-2 is crucial for survival of lymphocytes
119
; Bcl-xL 
regulates embryogenesis of neuronal cells and erythroid progenitors
120
; whereas Bcl-
w controls spermatogenesis
121
. 
Bcl-2 protein, the first member of the whole family, was identified in 1980s during 
analysis of a frequent chromosomal translocation in B cell lymphoma
122
. In those 
cells a portion of chromosome 18 with the actual bcl-2 locus translocates onto 14th 
chromosome in the way that places the bcl-2 gene under the control of antibody 
heavy chain gene enhancer. Another pro-survival protein Bcl-xL was the first family 
member, whose three dimensional structure was determined by NMR and X-ray 
crystallography
123
. 
Pro-survival Bcl-2 proteins contain N-terminal BH4 domain followed by so called 
"Bcl-2 core"
124
, which is common for anti-apoptotic and multi domain pro-apoptotic 
proteins. The only exception is Mcl-1, which has N-terminal unstructured domain in 
a place of BH4 motif. Bcl-2 core is a 20 kDa structure consisting of 7 to 8 α-helices, 
which in turn compose three BH domains: BH1, BH2 and BH3. Together these 
domains build up a hydrophobic groove, into which the BH3 domain of pro-
apoptotic proteins binds. This interaction is believed to be the hallmark of the 
mechanism by which pro-survival Bcl-2 members neutralize the apoptotic functions 
of Bax and Bak. 
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It has been observed that anti-apoptotic proteins bind pro-apoptotic Bax and Bak 
with different affinities. Bcl-xL and Mcl-1 were found to interact preferentially with 
Bak
125,126
. In the absence of Bcl-xL and Mcl-1 Bak-mediated apoptosis can 
proceed
125
. In contrast, Bax interacts with all pro-survival Bcl-2 members; therefore 
Bax-mediated apoptosis requires neutralization of each anti-apoptotic protein present 
in a cell
115
. 
BH3-only proteins are the initial stress signal responders, which serve as a 
connection between various stress or cytotoxic stimuli and apoptosis. Every BH3-
only member responds to a different set of apoptotic stimuli in its specific manner 
(described later in the text). What is more, existence of many members of BH3-only 
proteins provides high degree of redundancy in terms of the response to the signal 
they recognize. 
As was previously stated, BH3-only members have only one BH motif: BH3 domain. 
Apart from that, at the level of primary protein structure they do not share much 
similarity with each other or with other Bcl-2 members. BH3 domain usually consists 
of 9 to 16 amino acids and forms an amphipathic α-helix
127
. The hydrophobic side of 
that helix is responsible for the interaction with the hydrophobic pocket formed by 
BH1-BH3 domains of anti-apoptotic Bcl-2 members. Peptides derived from BH3 
domains of certain BH3-only proteins were shown to interact with anti-apoptotic 
Bcl-2 members. For instance, Bad and Bim peptides have been found to bind to Bcl-
xL
128,129
; and Bid peptide have been demonstrated in complex with Bcl-w
130
. What is 
more, molecular modelling approach revealed possibilities for other partners between 
anti-apoptotic and BH3-only members
131,132
. Amino acids forming BH3 domains are 
not strictly conserved. This diversity of BH3 domains seems to be responsible for 
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some binding selectivity of pro-apoptotic and BH3-only proteins to anti-apoptotic 
Bcl-2 members
133,134
. Consistently, it has been demonstrated that for example Bad 
and Bmf more specifically bind to Bcl-2, Bcl-w and Bcl-xL; on the other hand Noxa 
interacts only with A1 and Mcl-1
135
. Further, Puma, Bid and Bim appear to be 
stronger inducers of cell death over other BH3-only proteins
136
. However, for 
complete apoptosis induction all BH3-only proteins require Bax or Bak, which 
underlines the fact that multi-domain pro-apoptotic Bcl-2 members act downstream 
to BH3-only proteins
137
. 
Since pro-apoptotic proteins Bax and Bak have three BH domains they could 
potentially bind BH3 domain of BH3-only proteins. However, in contrast to very 
well documented interaction between BH3-only proteins and anti-apoptotic proteins, 
there is only little data demonstrating BH3-only and pro-apoptotic protein binding. 
Some of the examples include  Bid/Bax and Bid/Bak
138
, or Bim/Bax
139
. What is 
more, it is not entirely clear whether the whole BH1-BH3 hydrophobic pocket of 
pro-apoptotic proteins is absolutely required for this interaction
140
. 
Since BH3-only proteins are responsible for triggering the process of programmed 
cell death, their functions and activity require very strict regulation. These proteins 
are present in cells under normal physiological conditions; however they do not 
induce apoptosis, because (1) their expression is kept at a very low level which is 
insufficient for overcoming inhibitory functions of anti-apoptotic Bcl-2; (2) they are 
inactive and require further post-translational modifications in order to exert their 
effects; (3) or they are physically separated from mitochondria. Therefore triggering 
apoptosis usually requires either induction of expression of certain BH3-only 
proteins (e.g. PUMA, Noxa); or their post-transcriptional alteration such as 
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dephosphorylation (e.g. Bad); release from sequestering proteins (interaction of Bim 
and Bmf with dynein)
141,142
 or proteolytic cleavage that promotes translocation 
(truncation of Bid by caspase-8 and subsequent translocation of tBid from cytosol to 
outer mitochondrial membrane)
143
. 
Bax (Bcl-2 associated x protein) and Bak (Bcl-2 antagonist killer) belong to pro-
apoptotic Bcl-2 members that contain three BH domains: BH1, BH2 and BH3. They 
both are the main effectors of apoptosis and they are believed to be actively involved 
in the permeabilization of the outer mitochondrial membrane and the release of 
cytochrome c. Although their functions appear to be similar, localization of Bax and 
Bak in healthy cells is different. Bax exists predominantly as an inactive cytosolic 
monomer
144,145
, whose BH3 domain is hidden inside, and thus is unavailable for 
interactions with other Bcl-2 protein members. Activation of Bax involves 
conformational change that exposes the BH3 domain; translocation to the 
intracellular membranes, predominantly (but not only) to the outer mitochondrial 
membrane; and subsequent oligomerization
146
. In contrast to Bax, Bak is localized to 
the mitochondrial membrane even in healthy cells
147,148
 and a fraction of it is bound 
to anti-apoptotic Bcl-2 members (predominantly Bcl-xL and Mcl-1)
125
. Indeed, 
application of 16-amino acid peptide derived from BH3 domain of Bak protein 
demonstrated that BH3 α-helix of Bak binds into the hydrophobic pocket of Bcl-xL, 
formed by its three BH1-3 domains
126
. In contrast, some recent data indicate that in 
one of the conformations of Bak BH3 domain can also be hidden inside the protein 
and thus Bak might not be binding anti-apoptotic proteins in healthy cells
149
. 
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1.7.2. Apoptosis induction 
Early stages of Bcl-2 protein family dependent apoptotic pathway are still intensively 
debated. Currently there are two models describing how BH3-only proteins transfer 
apoptotic signal to the mediators of apoptosis. The first one assumes that BH3-only 
proteins by binding to anti-apoptotic BH1-4 members can 'neutralize' them and 
displace pro-apoptotic proteins, which leads to activation of the latter. Indeed, Bak 
fits well into this model. Most of the time Bak is bound to anti-apoptotic proteins, 
mainly Bcl-xL; and its release is associated with oligomerization. However, 
activation of Bax cannot be simply explained by 'neutralization' of anti-apoptotic 
Bcl-2 proteins. Bax has been found in complex with Bcl-2
150
. Nevertheless, as was 
previously mentioned, a substantial fraction of Bax exists as inactive monomers in 
the cytosol. Therefore displacement from anti-apoptotic partners cannot be the only 
requirement for Bax activation.  
The second model of apoptosis supports the opposite idea, which explains that 
activation of Bax and Bak is dependent on direct binding to BH3-only proteins. A 
BH3-only protein Bid would be a perfect example of such mechanism, since Bid 
does not interact with anti-apoptotic Bcl-2 members, but maintains interaction with 
Bax and has strong pro-apoptotic properties. However, there is no strong structural 
evidence for actual complex formation between pro-apoptotic members and native 
BH3-only proteins. What is more, such interaction appears to be restricted only to a 
small fraction of BH3-only members: isoforms of Bim can interact with Bax
139
; and 
above mentioned Bid, which can bind to Bax and Bak in its processed active form of 
tBid
138
. Additionally, so far BH3-only proteins have not been detected in oligomers 
formed by Bax and Bak. 
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Taken the two models together, BH3-only proteins were divided into two subgroups: 
activators (e.g. Bim and Bid) and sensitizers (eg. Bad, Noxa). Activators activate 
anti-apoptotic proteins through direct interaction; whereas sensitizers compete for 
binding site and therefore displace BH3-only activators from pro-survival Bcl-2 
members. Since both of these models have limitations and neither of them cannot 
alone be applied to all BH3-only members, it is possible that neutralization of anti-
apoptotic Bcl-2 and direct activation of pro-apoptotic Bax and Bak happen 
simultaneously and thus can be used to explain induction of intrinsic apoptotic 
pathway.  
1.7.3. Subcellular localization of the Bcl-2 family members 
Although their main apoptotic function is associated with mitochondria, Bcl-2 family 
proteins are present in various intracellular compartments. As was previously 
mentioned, pro-apoptotic Bax and BH3-only proteins are primarily localized to the 
cytosol. In contrast, Bak as well as anti-apoptotic Bcl-2 members have a C-terminal 
hydrophobic transmembrane domain, which anchors them to the intracellular 
membranes. Bax also contains such transmembrane domain, which most of the time 
is internalized into hydrophobic core of the protein and becomes exposed only after 
Bax activation. Accumulating evidence indicate that Bak is present not only on the 
surface of mitochondria but also at the endoplasmic reticulum
151
. What is more, Bcl-
2 and Bcl-xL were found on the mitochondrial membrane, the ER and the nuclear 
envelope
152,153
. 
In the ER Bcl-2 family proteins perform additional functions related to apoptosis. For 
example they play a role in unfolded protein response, which is an adaptive ER stress 
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response induced by protein misfolding. Pro-apoptotic proteins Bax and Bak were 
demonstrated to directly interact with one of the ER stress sensor protein - IRE1
154
. 
This interaction stabilizes IRE1 in its active form and thus enhances unfolded protein 
response. When the apoptotic stress reaches certain threshold apoptosis is induced. 
Anti-apoptotic proteins Bcl-2 and Bcl-xL are involved in regulation of ER stress-
dependent autophagy. They were shown to bind beclin-1, which is an essential 
autophagy inducer
155
. Interaction between anti-apoptotic Bcl-2 / Bcl-xL and beclin-1 
inhibits starvation-induced autophagy
156
. 
Since the ER is the major intracellular calcium store, Bcl-2 proteins have been 
proposed to be engaged in the regulation of cellular calcium homeostasis. For 
example it has been observed that Bcl-2 overexpression decreases Ca
2+
 concentration 
in the ER and diminishes Ca
2+
 entry to this cell compartment
157,158
. However, other 
studies support the opposite effects of Bcl-2 on ER calcium: preservation of ER 
calcium by upregulation of the SERCA
159
. What is more, the interaction between 
Bcl-2 and IP3Rs is well established and is believed to inhibit calcium release from 
the ER
160
. On the other hand, overexpression of Bax and Bak (that localize both to 
mitochondria and ER) leads to mobilization of Ca
2+
 from the ER to mitochondria 
during apoptosis
161
. And cells deficient in these two pro-apoptotic proteins have 
dramatically reduced calcium concentration in the ER and decreased Ca
2+
 uptake by 
mitochondria. In general, Bax and Bak seem to be involved in regulation of calcium 
release from the ER, which might contribute to the initiation of apoptosis
162
. 
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1.8. BH3 mimetics 
Pathways controlling apoptosis are usually altered in cancer cells. Human cancers 
commonly have different mutations in p53 tumour suppressor gene, all of which 
disturb the ability of p53 protein to induce apoptotic cell death
163
. What is more, 
increased levels of anti-apoptotic Bcl-2 members are found in wide variety of 
tumours
164,165
. Defective regulation of apoptosis promotes acquisition of further 
tumorigenic characteristics, such as extensive genetic mutations, extended lifespan, 
angiogenic and metastatic properties. 
Anti-cancer agents induce apoptosis mainly through the mitochondrial pathway 
regulated by the Bcl-2 protein family
166
. Therefore overexpression of these proteins 
in cancer is associated with resistance to chemotherapy. Importantly, apoptosis in 
tumours is almost always affected only upstream of Bax / Bak, whereas downstream 
apoptotic machinery remains functional
166
. Based on this fact, manipulating the 
equilibrium between pro- and anti-apoptotic Bcl-2 family members is a promising 
therapeutic approach. The strategy aiming to inhibit anti-apoptotic functions of Bcl-2 
proteins should potentially restore normal apoptotic processes in the tumour cells and 
make them sensitive to cytotoxic drugs
167
. 
Initial attempts to inhibit anti-apoptotic Bcl-2 members involved antisense 
technology applied in order to block protein translation, unfortunately with little 
success. Another approach was the application of BH3 inhibitors in order to disrupt 
the interaction between anti- and pro-apoptotic Bcl-2 members. Initially several short 
peptides derived from BH3 domains of BH-only proteins were designed. However, 
due to their limited length the peptides did not have correct helical structure 
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characteristic to native BH3 domains
168
. Longer peptides, on the other hand, usually 
have unfavourable pharmacological properties (permeability, solubility, 
bioavailability), which makes their use as therapeutic agents very limited. 
Replacement of less essential amino acids from the sequence by synthetic amino 
acids having carbon chain with double bounds and connecting them in metathesis 
reaction gives the peptides more rigid structure, enhances their helicity, membrane 
permeability and resistance to serum proteases
169
. 
BH3 mimetics are small molecule synthetic inhibitors of Bcl-2 and Bcl-xL. They are 
terphenyl-based compounds that reproduce spatial arrangement of key amino acids in 
BH3 domain. They were initially developed as potential anti-cancer agents that 
would inhibit heterodimerization of anti- and pro-apoptotic Bcl-2 family members, 
and therefore sensitize cells to apoptosis. In contrast to BH3 peptides, BH3 mimetics 
seem to have greater therapeutic potential for controlled inhibition of anti-apoptotic 
Bcl-2 members. 
The first BH3 mimetic obtained with aid of molecular modelling and computer 
screening was HA14-1
167
. It was confirmed that HA14-1 was able to displace Bax 
protein from Bcl-2 and induce apoptosis in cultured cells, which was characterised 
by loss of mitochondrial potential and activation of caspases
167
. A family of BH3 
mimetics called BH3 inhibitors (BH3Is) was discovered in a fluorescence 
polarization-based screening
170
. BH3Is contain seven members that belong to two 
structurally unrelated groups: one group is derived from BH3I-1 and the other one 
from BH3I-2. All the members of BH3I family were found to displace Bak peptide 
from Bcl-xL and induce apoptosis with cytochrome c release and caspase 
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activation
170
. Fig. 1.8 shows molecular structure of two BH3 mimetics described 
above: HA14-1 and BH3I-2'. 
The main application of BH3 mimetics is associated with anti-cancer approach. 
Overexpression of Bcl-2 protein has been reported in multiple cancer types and it 
correlates with chemotherapy resistance and poor prognosis
171
. Simultaneous 
application of a BH3 mimetic and a chemotherapeutic agent could potentially 
overcome drug resistance in these cancer types increasing the success rate of the 
treatment. In fact, BH3I-2’ and HA14-1 compounds have been demonstrated to act 
as sensitizers for TRAIL-induced apoptosis in leukemic cells
172
. BH3 mimetic-based 
therapy might preferentially target cancer cells, since they often exhibit increased 
sensitivity to inhibition of pro-survival proteins than the normal cells and tissues
173
. 
What is more, it might be possible to develop BH3 mimetics of the structure that 
specifically interacts only with the anti-apoptotic proteins overexpressed in target 
cancer cells
166
. 
From perspective of pancreas, BH3 mimetics are a particularly exciting approach, 
because by their pro-apoptotic properties they can target two serious conditions of 
the organ: acute pancreatitis and pancreatic cancer. What is more, controlled 
inhibition of anti-apoptotic Bcl-2 members is a useful tool for investigation of Bcl-2 
family protein functions in cellular calcium homeostasis. 
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Fig. 1.8. Chemical structures of BH3 mimetics 
(A) HA14-1 = ethyl 2-amino-6-cyclopentyl-4-(1-cyano-2-ethoxy-2-oxoethyl)-4H-
chromene-3-carboxylate; 
(B) BH3I-2' = (3-iodo-5-chloro-N-[2-chloro-5-((4-chlorophenyl) sulphonyl)phenyl]-
2-hydroxybenzamide). 
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1.9. Aims of the study 
The main aim of this study was to investigate the role of Bcl-2 family proteins in 
calcium homeostasis in pancreas, with particular focus on Bcl-2 itself and Bax. Bcl-2 
proteins appear to perform multiple functions in cells. Their mitochondria-related 
actions are well reported; however Bcl-2 proteins are also engaged in control of ER 
calcium levels and calcium fluxes in the cell, which are still unclear. Therefore this 
study aims to determine potential roles of Bcl-2 family members in the regulation of 
calcium pumps and / or channels as well as their involvement in the passive calcium 
leak from the intracellular stores. Different strategies, such as pharmacological 
inhibition of pro-apoptotic Bcl-2 members, knockout mice, techniques of gene 
silencing and overexpression together with confocal microscopy, are expected to 
provide reliable experimental data. Investigation of Bcl-2-regulated calcium 
signalling pathways might shed more light on our understanding of both 
physiological and pathological processes in pancreatic acinar cells and help to 
develop new therapeutic approaches against pancreatic cancer and pancreatitis. 
Importantly, those questions are not exclusive to pancreatic acinar cells, but can be 
extrapolated to other cell types and different tissues as (1) ubiquitously expressed 
Bcl-2 proteins; (2) proper regulation of apoptosis; (3) and calcium signalling are 
important for all cells. Possible involvement of Bcl-2 proteins in regulation of 
intracellular channels and pumps is particularly exciting; therefore these issues have 
long been attracting substantial attention in calcium signalling area, but the answer 
still remains elusive
174,175
. Nevertheless, this thesis focuses mainly on physiology and 
pathology of pancreatic acinar cells. Therefore it also aims to test the effects of 
ethanol on the intracellular calcium homeostasis and its role in the pathogenesis of 
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pancreatitis. Alcohol abuse is known to be associated with both acute and chronic 
pancreatitis; however the mechanisms of ethanol-induced pancreatitis are still 
unclear. Understanding the actions of ethanol on the cellular functions as well as 
identification of native cell defence mechanisms against alcohol poisoning might 
substantially contribute to the development of new therapeutic approaches against 
pancreatitis.  
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Chapter 2: Materials and Methods 
 
2.1. Reagents and materials 
Fluorescent dyes for calcium measurement fluo-4, AM (cat. F14201), fluo-5N, AM 
(cat. F14204) and fura-2, AM (cat. F1221) and rhod-2, AM (cat. R1245MP) were 
obtained from Molecular Probes, Invitrogen. 
BH3 mimetics were purchased from different sources: HA14-1 (cat. 430-101-M005) 
was bought from Alexis Biochemicals, Switzerland; BH3I-2’ (cat. 286891) from 
Calbiochem; and gossypol (cat. sc-200501) from Santa Cruz Biotechnology. Ca
2+
-
like peptides: CALP-1 (cat. 2090) and CALP-3 (cat. 2321) were obtained from 
Tocris. 
Other chemicals used in experiments, such as caffeine (cat. 205548), thapsigargin 
(cat. 586005), ionomycin (cat. 407952), 2-aminoethoxydiphenyl borate (cat. 100065) 
and Ru360 (cat. 557440) were supplied by Calbiochem. Ruthenium red (cat. 1439) 
was obtained from Tocris. 
Collagenase (various batches) for tissue digestion came from Worhington. 
Cover glass 32 x 32 mm, thickness No 1 (cat. 631-0129) and cover class 13 mm 
thickness No 1 (cat. 631-0149) were supplied by VWR International. Trypsin 
inhibitor TypeI-S from soybean, poli-L-lysine 0.01 % solution (cat. P4832) and 
acetylcholine chloride (cat. A6625-25G) all came from Sigma; and calcium chloride 
(cat. 2114) - from Fluka. 
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PCR reagents were supplied by Promega: 5x Green GoTaq reaction buffer 
(cat. M791B), GoTaq DNA Polymerase 2,500u (cat. M830C), dNTPs mix 10 mM 
(cat. U151B). Also, all restriction enzymes were purchased from Promega: 
EcoR I (cat. R4014), Bgl II (cat. R4084) and Hind III (cat. R6041). SYBR
®
Safe 
DNA gel stain was obtained from Molecular Probes, Invitrogen (cat. S33102) and 
GelRed nucleic acid gel stain 10,000x from Biotium (cat. 41003). Agarose tablets 
(cat. BIO-41028), DNA marker HyperLadder I (cat. BIO-33025) and Crystal 
5x DNA Loading Buffer Blue (cat. BIO-37045) came from Bioline. Tris Acetate-
EDTA buffer 10x (cat. 099K8410) was bought from Sigma. Media for bacterial 
culture: ImMedia
TM
 Kan Agar (cat. Q61120), ImMedia
TM
 Kan Liquid (cat. Q61020), 
ImMedia
TM
 Amp Agar (cat. Q60120), ImMedia
TM
 Amp Liquid (cat. 60020) and 
SOC Medium (cat. 15544-034) were purchased from Invitrogen. 
Tissue culture media and reagents such as RPMI 1640 medium (cat. 21875), FBS 
(cat. 10108-157), Fungizone (cat. 15290-018), Trypsin-EDTA 0.05% (cat.25300), 
MEM Amino Acids (cat. 11130) were obtained from GIBCO. PBS (cat. BE17-516F) 
was bought from Cambrex. 1 M HEPES solution (cat. 17-737F) was purchased from 
Lonza, Walkersville, MD, USA. PromoFectin 2000 transfection reagent (cat. PK-
CT-2000-100) came from PromoKine. Antibiotic Antimycotic Solution 100x 
containing 10,000 units/ml penicillin, 10 mg/ml streptomycin and 25 µg/ml 
amphotericin B was obtained from Sigma (cat. A5955). 
pEGFP-C1 containing human Bcl-2 insert (often referred later in text as Bcl-2-GFP 
plasmid) was obtained through Addgene (Addgene plasmid 17999), courtesy of 
Clark Distelhorst
176
. pcDNA3 expressing human Bcl-2 protein were obtained 
through Addgene (Addgene plasmid 8768
177
. CellLight Plasma Membrane-RFP 
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BacMam 2.0 was supplied by Invitrogen (cat. C10608). Calcium sensitive ER 
targeted cameleon D1 probe was a kind gift from Roger Y. Tsien laboratory. 
Reagents for specific gene silencing: Bcl-2 siRNA (cat. sc-29215) and control 
siRNA-A (cat. sc-37007) were obtained from Santa Cruz Biotechnology. 
All the other chemicals were supplied by Sigma, unless otherwise stated. 
2.2. Animals 
Wild type CD1 male mice and wild type C57BL6/J male mice were supplied by 
Charles Rivers. Transgenic animals B6.129-Bak1
tm1Thsn/J
 (stock no: 004183), 
B6.129X1-Bax
tm1Sjk/J
 (stock no: 002994), B6.129S2-BCL-2 (stock no: 002265) were 
obtained from Jackson Laboratories and were bred in house: null x null (Bak); or het 
x het (Bax, Bcl-2). Fig. 2.1 shows photographs of a wild type C57BL6/J mouse and 
all three types of transgenic animals used in this study. Bax KO mice (Bax nulls), 
which contain two alleles of disrupted bax gene, do not display immediately 
noticeable physical features. However, loss of Bax causes cell lineage-specific 
aberrations in cell death pathway. As a result males are infertile due to 
aspermatogenesis and thus cannot be used as breeders
178
. Oocyte development in 
females is relatively normal. Interestingly, the gray coat color loci (tyr) and pink eyes 
(p) are both linked to the bax gene
179
. Statistically, a Bax null should be 99.6 % 
C57BL/6-like at all loci not linked to the bax gene, but they might retain the tyr allele 
and the p allele from the 129-derived RAW-4 ES cell line originally used for targeted 
disruption of bax gene. As a result, a small percentage of Bax nulls can be gray in 
colour and have pink eyes. A Bax null of such phenotype is shown in Fig. 2.1.B.
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Fig. 2.1. Photographs of transgenic mice used in the study 
(A) wild type, (B) Bax KO, (C) Bak KO (D) and Bcl-2 KO. 
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Bak KO mice (Bak nulls) do not show any physical or behavioral abnormalities; they 
are normal in size, viable and fertile, which makes possible using nulls as breeders 
(Fig. 2.1.C). Finally, Bcl-2 KO mice (Bcl-2 nulls) exhibit severe phenotype 
characterised by growth retardation (30 % - 90 %), small external ears and immature 
front head features (Fig. 2.1.D)
119
. The smallest individuals often become ill and die 
around the 3rd – 4th week of age usually as a result of renal failure due to the 
development of polycystic kidney disease. Another typical trait of the nulls is hair 
pigmentation loss during the second follicle cycle, which results in their coat colour 
turning gray and eventually white. 
2.3. Tissue culture 
AR42J cells (rat exocrine pancreatic tumour cells) were obtained from ECACC 
General Collection (cat. 93100618). AR42J cells were maintained in RPMI 1640 
medium with 10 mM HEPES, 10 % FBS, 50 µg/ml gentamycin (GIBCO) and 
2.5 µg/ml Fungizone; at 37
o
C, 5 % CO2 in 25 cm
3
 tissue culture flasks. Cells were 
split once a week:  trypsin was used to detach the cells and 1/10 of the total cell 
suspension was transferred to a new flask with 10 ml fresh medium. For the purpose 
of microscope visualization, cells were plated onto 5 cm
3
 glass bottom dishes, 
allowed to attach for 2 days, then transfected with Bcl-2-GFP plasmid, ER CaM 
plasmid or siRNA and incubated for another 48 h. 
2.4. Bcl-2-GFP plasmid amplification 
Bcl-2-GFP plasmid was supplied in bacterial stabs. Bacterial culture was streak out 
onto LB-agar plate with Kanamycin (100 µg/ml) and incubated overnight at 37
o
C. 
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The following day selected colonies were transferred into 3 ml LB medium with 
Kanamycin (100 µg/ml) and incubated overnight at 37
o
C with vigorous agitation. On 
the next day 3 ml of overnight culture were transferred into 100 ml LB medium 
containing Kanamycin and again incubated in 37
o
C. 
2.5. pcDNA-Bcl-2 plasmid amplification 
pcDNA-Bcl-2 plasmid was also supplied in bacterial stabs. Bacterial culture was 
streak out onto LB-agar plate with Ampicillin (100 µg/ml) and incubated overnight 
at 37
o
C. The following day selected colonies were transferred into 3 ml LB medium 
with Ampicillin (100 µg/ml) and incubated overnight at 37
o
C with vigorous 
agitation. On the next day 3 ml of overnight culture were transferred into 100 ml LB 
medium containing Ampicillin and again incubated in 37
o
C. 
2.6. Plasmid isolation 
EndoFree Plasmid Maxi Kit (cat. 12362) was supplied by Qiagen. Isolation was 
performed according to manufacturer's protocol. In order to confirm the presence of 
Bcl-2 insert pcDNA3 plasmid and in Bcl-2-GFP plasmid DNA digestion reactions 
was prepared as follows: 
For pcDNA3-Bcl-2 plasmid: 
dH2O 32.6µl 
Promega Buffer "H" 4 µl 
BSA 0.4µl 
Plasmid DNA 2µl 
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EcoR I 1µl 
 
For Bcl-2-GFP plasmid: 
dH2O 31.6µl 
Promega Buffer "D" 4 µl 
BSA 0.4µl 
Plasmid DNA 2µl 
EcoR I 1µl 
Bgl II 1µl 
The samples were incubated for 3 h at 37
o
C and then run on 1 % agarose gel for 
70 min at 90 V. Fig. 2.2 shows restriction pattern obtained after digestion of 
pcDNA3-Bcl-2 plasmid with EcoR I enzyme and Bcl-2-GFP plasmid with EcoR I 
and Bgl II. 
2.7. Preparation of NaHEPES solution 
NaHEPES solution was prepared as follows: 140 mM sodium chloride (cat. S3014-
500G, Sigma); 4.7 mM potassium chloride (cat. 529552, Calbiochem); 1.13 mM 
magnesium chloride (1 M stock, cat. M1028-10X1ML, Sigma); 10 mM HEPES, Free 
Acid (cat. 391338, Calbiochem); 10 mM D(+)glucose (cat. G-5400, Sigma). pH was 
adjusted to 7.2 with NaOH. For pancreatic acinar cell isolation and experiments with 
the presence of extracellular calcium NaHEPES solution was supplemented with 
1 mM calcium chloride. 
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Fig. 2.2. Digestion patterns of pcDNA3-Bcl-2 and Bcl-2-GFP plasmids 
Digestion of pcDNA3-Bcl-2 plasmid with EcoR I and digestion of Bcl-2-GFP 
plasmid with EcoRI and BglII restriction enzymes resulted in removal of hBcl-2 
inserts. The inserts had about 750 bp and are clearly visible on the gel. Supercoiled 
uncut pcDNA3-Bcl-2 and GFP-Bcl-2 plasmids (on right) migrated further on the gel 
than their cut backbones (left). 
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2.8. Preparation of KHEPES solution 
KHEPES solution was prepared as follows: 130 mM KCl; 18 mM NaCl; 1.13 mM 
MgCl2; 10 mM HEPES, Free Acid; 3 mM ATP (Calbiochem, cat. 1191); 100 µM 
EGTA; and 50 µM CaCl2. pH was adjusted to 7.2 with KOH. 
2.9. Preparation of NMDG-HEPES solution 
NMDG-HEPES solution was prepared as follows: 140 mM N-methyl-D-glucamine 
(cat. 66930, Fluka); 4.7 mM potassium chloride; 1.13 mM magnesium chloride; 
10 mM HEPES; 10 mM D(+)glucose. pH was adjusted to 7.2 with HCl. 
2.10. Preparation of collagenase 
20 ml of NaHEPES (supplemented with Ca
2+
) buffer were added to 4000 u 
collagenase stock resulting in 200 u/ml collagenase solution. The solution was 
aliquoted into 20 x 1.5 ml tubes and stored at -20
o
C. 
2.11. Preparation of BH3 mimetics 
BH3I-2', HA14-1 and gossypol were all supplied as powders. Stock concentrations 
of BH3 mimetics were prepared by dissolving powders in DMSO, which resulted in 
15 mM BH3I-2', 30 mM HA14-1 and 30 mM gossypol. 
2.12. Isolation of pancreatic acinar cells 
CD1 or C57BL6/J mice were sacrificed by cervical dislocation in accordance with 
the Animal (Scientific Procedures) Act, 1986. The pancreas was isolated from a 
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mouse and washed two times with NaHEPES buffer supplemented with 1 mM Ca
2+
. 
Then the tissue was injected with 1 ml 200 u/ml collagenase and incubated in 1.5 ml 
eppendorf type tube in collagenase solution for 15 min at 37
o
C (water bath). After 
incubation the tube was filled up with NaHEPES + 1 mM Ca
2+
 and agitated for about 
20 s. The tissue suspension was pipetted up and down to release single cells and the 
supernatant was collected to a 15 ml tube. Fresh NaHEPES buffer (+ 1mM Ca
2+
) was 
added to the tube and the procedure of supernatant collection was repeated several 
times. Then, the cells were spun for 1 min at 1000 RPM in a ‘swinging bucket’ type 
centrifuge. The supernatant was discarded and the cell pellet was resuspended in 
10 ml of NaHEPES buffer (+ 1 mM Ca
2+
). The cell suspension was filtered through 
the filter mesh and spun again for 1 min. The final pellet was resuspended in 2 ml 
NaHEPES buffer (+ 1 mM Ca
2+
). 
2.13. Calcium measurements in intact cells 
Freshly isolated pancreatic acinar cells were loaded with AM form of calcium 
sensitive dye fluo-4 dye for 30 min at room temperature; the final concentration of 
the dye was 5 µM in DMSO (5 µl of 2 mM stock into 2 ml of cell suspension)
65,180
. 
After incubation the dye was replaced by fresh NaHEPES buffer supplemented with 
1 mM Ca
2+
 and cytosolic calcium changes were recorded in real time using 
fluorescence microscopy (excitation 488 nm; emission > 510 nm). 
For ratiometric cytosolic calcium measurements, freshly isolated pancreatic acinar 
cells or AR42J cells were loaded with AM form of calcium sensitive dye fura-2 for 
45 min at room temperature or for 1 h at 37
o
C, respectively. The final concentration 
of the dye was 10 µM. After incubation, the dye was replaced with fresh NaHEPES 
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buffer supplemented with 1 mM Ca
2+
 and calcium changes in the cytosol were 
recorded in real time using Nikon Diaphot 200 imaging system (excitation 340 nm 
and 380 nm, green emission with a peak at 510 nm; or with LED excitation 365 nm 
and 385 nm, green emission at 510 nm). 
For ER calcium measurements AR42J cells were transfected with ER-targeted 
cameleon plasmid using PromoFectin reagent. ER calcium measurements were 
performed on the third day after transfection using Leica confocal microscope. For 
accurate collection of FRET signal only CFP part of cameleon was excited with 
458 nm laser and emission was collected at both 465-505 nm for CFP and 525-
600 nm for YFP. Multiple images were taken in order to assess the resting ER 
calcium concentration and decrease of YFP / CFP ratio in time was recorded upon 
20 µM CPA treatment. 
For calcium measurement in mitochondria freshly isolated pancreatic acinar cells 
were loaded with AM form of calcium sensitive dye rhod-2 for 45 min at room 
temperature. The final concentration of the dye was 5 µM. Rhod-2 preferentially 
accumulated into the mitochondria; however a substantial fraction of it was also 
present in the cytosol. After incubation the cells were spun for 1 min at 1200 RPM 
and resuspended in fresh NaHEPES buffer supplemented with 1 mM Ca
2+
. Changes 
of both mitochondrial and cytosolic calcium in rhod-2-loaded pancreatic acinar cells 
were recorded using confocal imaging system (excitation 532 nm; and emission was 
collected between 552 – 652 nm). 
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2.14. Calcium measurements in permeabilized cells 
Freshly isolated pancreatic acinar cells were loaded with AM form of calcium 
sensitive dye fluo-5N dye for 50 min at 37
o
C; the final concentration of the dye was 
5 µM in DMSO (5 µl of 2 mM stock into 2 ml of cell suspension)
181
. In these 
conditions fluo-5N preferentially accumulated in the intracellular stores. After 
incubation the dye was replaced by fresh NaHEPES buffer supplemented with 1 mM 
Ca
2+
. Just before the experiments the cells were washed with an intracellular solution 
- KHEPES; and subsequently permeabilized using two-photon laser pulses. 
Localized membrane perforation resulted in loss of cytosolic content (including 
cytosolic fraction of fluo-5N); whereas the intracellular stores remained intact and 
loaded with the calcium-sensitive dye. 
2.15. Two-photon permeabilization 
The technique of cell permeabilization with high intensity two-photon light was 
developed in our laboratory as a modification of previously described method of 
temporal cell perforation for foreign DNA delivery
182
. Before permeabilization, 
pancreatic acinar cells were perfused with intracellular solution KHEPES. Then two-
photon light (720 – 750 nm) at high intensity was applied at a small area of the 
plasma membrane of pancreatic acinar cell. The area was preferentially chosen at the 
apical region of the acinar cell in order to preserve the ER, which is mainly localized 
in the basolateral region. Application of the two-photon laser pulse at the membrane 
area resulted in heating of that area followed by its disruption. Successful 
permeabilization can be confirmed by monitoring the localization of fluorescently 
labelled dextran (such as Texas Red dextran or Alexa Fluo 647 dextran): present in 
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the extracellular medium, dextran can penetrate inside the cell only after the 
membrane has been broken. 
2.16. Measurements of trypsinogen activation in permeabilized cells 
Pancreatic acinar cells were permeabilized with two-photon laser beam as described 
above. Then 10 µM BZiPAR (rhodamine 110, bis-(N-CBZ-L-isoleucyl-L-prolyl-L-
arginine amide), dihydrochloride) was added to the perfusion chamber. BZiPAR acts 
as a substrate for trypsin and becomes fluorescent when the enzyme cleaves two 
oligopeptide residues. BZiPAR fluorescence was monitored upon excitation by 
488 nm laser light, and the signal was collected at 510 - 600 nm. 
2.17. Calculation of cytosolic calcium extrusion rates 
For calculation of calcium extrusion rates in fura-2-loaded pancreatic acinar cells, 
fura-2 ratio obtained upon excitation with 340/380 nm light was converted into free 
calcium concentration using Grynkiewicz equation
183,184
: 
RR
RR
KCa d
−
−
××=+
max
min2 ][ β  
Symbols: 
Kd – dissociation constant of Ca
2+
 binding site 
β – coefficient equal to the ratio of fluorescence intensity of fura-2 at the first 
and at the second wavelength 
R – ratio value 
Rmin – minimal ratio value 
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Rmax – maximal ratio value 
Coefficient β was calculated for known [Ca
2+
] values. Separate calibration 
experiments were performed in order to obtain extreme ratio values: Rmax was 
obtained by treatment of fura-2-loaded cells with 20 µM ionomycin in the presence 
of Ca
2+
; and Rmin – by perfusion with 2 mM EGTA for 30 min after permeabiliation 
with ionomycin. Examples of the traces are shown on Fig. 2.3.  
2.18. Transient transfection of AR42J cells with plasmids 
In one 1.5 ml tube, 2 µg DNA were added to 100 µl RPMI medium (without FBS 
and antibiotics). In a second 1.5 ml tube, 6 µl PromoFectin were added to 100 µl 
RPMI medium. Both tubes were vigorously shaken and briefly spun, then combined 
together. The mixture was again vortexed and briefly centrifuged and then incubated 
at room temperature for 30 min. After incubation the solution was added drop-wise 
to AR42J cells, which had been previously plated on glass bottom petri dishes in 
2 ml RPMI medium (supplemented with 10 % FBS, gentamycin and fungizone). 
Cells were incubated at 37
o
C, 5 % CO2 for 6 - 8 h. Medium was then replaced with 
2 ml of fresh RPMI (with FBS, gentamycin and fungizone) and incubated for another 
48 h at 37
o
C, 5 % CO2 before visualization using confocal imaging system. 
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Fig. 2.3. Calcium calibration experiments 
Three sample traces showing the results of Ca
2+
 calibration experiments in WT 
pancreatic acinar cells. Rmax is the maximum ratio value obtained upon treatment 
with 20 µM ionomycin, whereas Rmin refers to the minimum ratio value obtained 
upon long perfusion with 2 mM EGTA. 
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2.19. Stable transfection of AR42J cells with pcDNA-Bcl-2 plasmid 
AR42J cells were seeded on 6-well plates and transfected in the same way as 
described for transient transfection. On the second day after transfection complete 
RPMI medium (supplemented with FBS, gentamycin and fungizone) was replaced 
by selection medium, which is a complete medium containing 0.8 mg/ml of 
antibiotic G418. Since pcDNA-Bcl-2 plasmid contains neomycin resistance gene, 
transfected cells survive in the presence of G418, whereas untransfected cells 
eventually die. After 21 days of selection, live cells from each 6-well plate were 
pooled together and transferred to a 25 cm
3
 tissue culture flasks. Stably transfected 
AR42J cells were maintained in RPMI medium supplemented with FBS, 
gentamycin, fungizone and 400 µg/ml G418. 
2.20. Silencing Bcl-2 expression in AR42J cells 
In one tube (“1”) 8 µl of 10 µM stock of Bcl-2 siRNA (80 pmols) were added to 
100 µl RPMI medium (without FBS and antibiotics). In the second tube (“2”) 8 µl of 
10 µM stock of control siRNA-A (80 pmols) were added to 100 µl RPMI medium. In 
the third (“3”) and fourth (“4”) tube 6 µl PromoFectin were added to 100 µl RPMI 
medium. All tubes were vigorously shaken and briefly spun, then tube “1” was 
combined with tube “3” and tube “2” was combined with tube “4”. The mixtures was 
again vigorously shaken, briefly centrifuged and then incubated at room temperature 
for 30 min. After incubation the mixtures were added drop-wise to separate glass-
bottom petri dishes with AR42J cells, which had been previously plated in 2 ml 
RPMI medium (supplemented with 10 % FBS, gentamycin and fungizone). Cells 
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were incubated for 48 h at 37
o
C, 5 % CO2 before visualization using confocal 
imaging system. 
2.21. Transduction of AR42J cells with CellLight BacMam 2.0 Plasma 
Membrane-RFP 
CellLight BacMam solution was mixed several times by gentle pipetting. 10 µl of the 
original solution was added directly to the glass-bottom petri dishes containing 
AR42J cells in 2 ml RPMI supplemented with 10 % FBS, gentamycin and fungizone. 
Cells were incubated for 48 h at 37
o
C, 5 % CO2 before visualization using confocal 
imaging system. 
2.22. Transient transfection of pancreatic acinar cells with Bcl-2-GFP 
plasmid by electroporation 
For transfection of freshly isolated pancreatic acinar cells three different buffers were 
prepared as follows: 
Buffer 1 (total volume of 100 ml): NaHEPES supplemented with 1 mM CaCl2, 
0.005 % trypsin inhibitor from soybean (5 mg) and, cat. 11836170001); the solution 
was filtered through 0.45 µm filter and pH was adjusted to 7.3 with NaOH; then 1 ml 
of Sigma Antibiotic Antimycotic Solution (100x) was added to the buffer. 
Buffer 2 (total volume of 10 ml): NaHEPES without Ca
2+
, supplemented with 
0.005 % trypsin inhibitor from soybean (0.5 mg); the solution was filtered through 
0.45 µm filter and pH was adjusted to 7.3 with NaOH; then 0.1 ml of  Sigma 
Antibiotic Antimycotic Solution (100x) was added to the buffer. 
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Buffer 3 (“medium” for short-term culture of pancreatic acinar cells, total volume of 
100 ml): NaHEPES supplemented with 1 mM CaCl2, 2 ml MEM amino acids 50x 
(Sigma, cat. M5550), 1 mM sodium pyruvate (1 ml from 100 mM stock, Sigma, 
cat. S8636), 0.005 % trypsin inhibitor from soybean (5 mg) and 1 tablet of Complete 
mini EDTA-free protease inhibitor cocktail (Roche); the solution was filtered 
through 0.45 µm filter and pH was adjusted to 7.3 with NaOH; then 1 ml of  Sigma 
Antibiotic Antimycotic Solution (100x) was added to the buffer. 
Pancreatic acinar cells were isolated as described above using “Buffer 1”. The final 
centrifugation was performed in “Buffer 2” and then the cells were spun again at 
1200 RPM for 1 min and resuspended in 400 µl of Amaxa Nucleofector Solution 
with supplement (from Amaxa Basic Nucleofector Kit for Primary Mammalian 
Ephithelial Cells, Lonza, cat. VPI-1005). The cell suspension was aliquoted into 4 
tubes, 100 µl per sample. 2 µg of Bcl-2-GFP plasmid were added to each tube and 
gently mixed. The content of each tube was transferred into an Amaxa cuvette (from 
Amaxa Basic Nucleofector Kit, Lonza). Each cuvette was closed, inserted into 
Amaxa Nucleofactor II and the cells were electroporated using programme A-20. 
After elecroporation 400 µl of “Buffer 2” was added to each cuvette; the cuvettes 
were incubated for 5 min at 30-32
o
C. Then the cells were transferred to glass-bottom 
petri dishes with 2 ml of “Buffer 3” and incubated overnight at 30-32
 o
C. 
2.23. Genotyping 
PureLink
TM
 Genomic DNA Mini Kit (Invitrogen, cat. K1820-02) was used for 
genomic DNA isolation from mouse tissue (tail and ear) according to the 
manufacturer's protocol. For purpose of genotyping PCR reaction was performed. 
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Fig. 2.4.A shows sequences of the primers used in the reaction and PCR protocol is 
shown in Fig. 2.4.B Amplified DNA was resolved on 1 % agarose gel for 1.5 h at 
90 V and visualized using BioRad Molecular Imager ChemiDoc XRS+. Fig. 2.4.C 
shows a typical result of Bax / Bcl-2 genotyping.  
2.24. Protein isolation – total protein 
Pancreatic acinar cells were isolated just as described above. Then the cells from one 
pancreas were resuspended in 300 µl of RIPA buffer (Sigma, cat. R0278) containing 
150 mM NaCl, 1 % IGEPAL CA-630, 0.5 % sodium deoxycholate, 0.1 % SDS, 
50 mM Tris, pH 8.0. The buffer was additionally supplemented with Complete mini 
EDTA-free protease inhibitor cocktail (Roche). The cell suspension was vigorously 
vortexed for 1 min and then centrifuged for 5 min at 10,000×g in order to remove 
cell debris. The supernatant was transferred into a fresh 1.5 ml tube and used for 
protein analysis. 
2.25. Determination of protein concentration 
Determination of protein concentration was performed using DC Protein Assay 
(BioRad, cat. 500-0116). Serial dilutions of standard (BSA) in water were prepared 
as follows: 5.0, 2.5, 1.25, 0.625, 0.312, 0.156 and 0.078 mg/ml. 5 µl of standards and 
the same amount of samples were added to the 98-well EIA plate in duplicates. In a 
boat 20 µl Reagent S (Bio-Rad) was added to every 1 ml Reagent A. 25 µl of this 
mixture followed by 200 µl of Reagent B was pipetted to every well. Absorbance 
was measured at 750 nm. Concentrations of the samples were determined based on 
the standard curve equation. 
  
 
 
90 
 
  
A. 
 Name Sequence 
B
ax
 
p
ri
m
er
s common 5’- GTT GAC CAG AGT GGC GTA GG -3’ 
wild type forward 5’- GAG CTG ATC AGA ACC ATC ATG -3’ 
mutant forward 5’- CCG CTT CCA TTG CTC AGC GG -3’ 
B
cl
-2
 
p
ri
m
er
s reverse 5’- CGT CCC GCC TCT TCA CCT TTC AGC -3’ 
wild type forward 5’- GCC CAG ACT CAT TCA ACC AGA CAT -3’ 
PGK 5’- GCC TAC CCG CTT CCA TTG CTC AGC -3’ 
 
B. 
Step Temp [
o
C] Time  
1 94 5 min Initial denaturation 
2 94 30 s 
35 cycles 3 60 1 min 
4 72 1 min 
5 72 2 min Final extension 
6 4 until stopped  
 
C. 
 
 
 
Fig. 2.4. Genotyping of Bax KO and Bcl-2 KO mice 
(A) Sequences of primers used for genotyping of mice from Bcl-2 and Bax colonies. 
(B) PCR protocol used for genotyping. (C) A typical result of Bax / Bcl-2 
genotyping. "WT" refers to a fragment of a wild type allele of Bax or Bcl-2 gene, and 
"M" stands for a mutated allele. 
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2.26. Subcellular fractionation by differential centrifugation 
The protocol of subcellular fractionation of pancreas was a modification of 
previously published medthod
185,186
. The pancreatic tissue isolated from CD1 mice 
was homogenised in 8 ml of homogenization buffer (0.3 M sucrose, 10 mM HEPES 
pH 7.6, 0.1 M EGTA, 10 mM KCl, 1 mM dithiothreitol, 0.5 mM PMSF, 0.74 mM 
spermidine, 15 mM spermine, 2 mg/ml aprotinin, 2 mg/ml lupeptin and 2 mg/ml 
bestatin) by 5 full strokes in glass-Teflon homogenizer. Low speed centrifugation at 
150×g for 15 min, 4
o
C was performed to sediment nuclei, cell debris and unbroken 
cells. In this way obtained post-nuclear supernatant was then spun at 1300×g for 
15 min, 4
o
C in order to pellet zymogen granules. The pellet was removed and the 
supernatant was centrifuged again, this time at 12,000×g for 12 min, 4
o
C and both 
the pellet containing lysosomes / mitochondria and the supernatant containing 
microsomes were collected. 
2.27. Immunoprecipitation 
Pancreatic tissue was isolated form CD1 mice and lysed in lysis buffer, which 
contained 10 mM HEPES, 140 mM KCl, 5 mM MgCl2, 0.5 mM EGTA, 2% CHAPS 
(containing 1 mM dithiotrhreitol, 10 µg/ml leupeptin, 10 µg/ml aprotinin and 1 mM 
PMSF); pH of the buffer was adjusted to 7.4. The lysates were spun at 15,000×g for 
20 min, 4
o
C and the volume of the supernatant containing 500 µg of protein was 
immunoprecipitated overnight with either Bcl-2 or Bcl-xL using Catch and Release 
Reversible Immunoprecipitation System (Millipore, cat. 17-500) and following the 
manufacturer’s protocol. 
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2.28. Immunoblotting 
The volume containing 50 µg of protein lysate was brought to 16 µl by addition of 
dH2O. Then 6 µl 4 x SDS-PAGE loading buffer was added to each sample. Samples 
were vortexed and spun (5 min 8,000 g) following by heating at 95
o
C for 5 min. 
Proteins were then separated by SDS-PAGE (5 % stacking gel, 10 % resolving gel, 
for 50 min at 200 V), then transferred to nitrocellulose (25 V, 2 h) and blocked for 
1 h with 5 % milk. For detection of PDI or COX IV
187
 nitrocellulose membranes 
were incubated for 2 h at room temperature or overnight at 4°C in Tris-buffered 
saline with 0.05 % Tween-20 (TBST), 1 % milk and a 1:1000 dilution of primary 
antibody.  Membranes were then washed three times for 10 min with TBS-Tween 
(0.05 %) and then incubated for 1 h with 1:5000 dilution of HRP conjugated IgG 
secondary antibody. The membranes were washed four times for 10 min with TBS-
Tween (0.05 %). The blots were developed using Enhanced Chemiluminescence 
(ECL) Detection Kit (Pierce, cat. 32209) according to the manufacturer’s protocol. 
2.29. Immunofluorescence 
Immunofluorescence was applied in order to investigate endogenous protein 
distribution in fixed pancreatic acinar cells or AR42J cells. Freshly isolated acinar 
cells or were plated on 13 mm poly-L-lysine coated glass cover slips and allowed to 
adhere for 5 min at room temperature. AR42J cells were plated on 13 mm poly-L-
lysine coated glass cover slips, transfected with Bcl-2-GFP plasmid using 
PromoFectin 2000 and incubated for 48 h in the tissue culture incubator (37
o
C, 5 % 
CO2). The cells were fixed by incubation in 100 % ice-cold methanol for 10 min at -
20°C. After fixation cover slips were washed in 0.1 M phosphate buffered saline 
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(PBS) three times, for 5 minutes each. The first wash was performed in ice-cold PBS, 
and two subsequent washes - in PBS at room temperature. Potential nonspecific 
binding sites were then blocked by incubation in 10 % goat serum in PBS for 30 - 60 
min at room temperature. Then the cells were incubated with 1:100 primary antibody 
solution containing 5 % goat serum in PBS for 1 h at room temperature. Primary 
antibodies used in the study were rabbit anti-Bcl-2 (Abcam) and mouse anti-PMCA 
(Abcam). The cells were washed 3 times with PBS for 5 min each. Subsequently the 
fixed cells were incubated for 1 h at room temperature with 1:500 dilution of 
appropriate secondary antibody prepared in PBS containing 5 % goat serum. 
Secondary antibodies were: goat anti-rabbit conjugated to AlexaFluor 488 
(Invitrogen, Paisley, UK), and goat anti-mouse conjugated to AlexaFluor 635 
(Invitrogen, Paisley, UK). Unbound antibody was removed by four washes, 5 min 
each in PBS. Finally cover slips were mounted on glass microscope slides with a 
droplet of ProlongGold anti-fade mounting medium (Invitrogen, Paisley, UK) and 
left to dry at 4 °C in darkness for 24 hours before viewing. 
2.30. Apoptosis assay 
Freshly isolated pancreatic acinar cells were centrifuged at 1200×g for 1 min and 
resuspended in calcium-free NaHEPES solution: 10 mM HEPES, 140 mM NaCl, 
1 mM MgCl2, 4.7 mM KCl, 10 mM glucose, 1.5 mM EGTA, pH 7.2. The cells were 
loaded with 10 µM general caspase substrate (rhodamine 110, bis-(L-aspartic acid 
amide), Invitrogen, cat. R22122) for 20 min at room temperature. After loading the 
cells were spun again (1200×g for 1 min) and resuspended in standard NaHEPES 
solution supplemented with 1 mM Ca
2+
. Then the cells were treated with apoptosis 
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inducer alone, in this case 15 µM BH3I-2'; or 15 µM BH3I-2' in the presence or of 
100 µM 2-APB and 10 µM ruthenium red in order to inhibit IP3Rs and RyR, 
respectively. The cells were visualized using confocal imaging system (excitation: 
488 nm, emission: 505 - 543 nm). 
2.31. Cell death assay 
Cell death assay was performed on freshly isolated pancreatic acinar cells using 
Sigma Annexin V-FITC Apoptosis Detection Kit (cat. APOAF-20TST). After 
treatment cells were incubated for 15 min at room temperature with appropriate 
concentration of Annexin V-FITC and propidium iodide (according to the 
manufacturer's protocol). Annexin V-FITC staining of apoptotic cells was visualized 
upon excitation with 488 nm laser light and emission was collected between 510 –
 570 nm; propidium iodide staining of necrotic cells was detected by using 535 nm 
laser and collecting emission between 585 – 705 nm. Multiple pictures (20 - 35) per 
treatment group were taken; live, apoptotic and necrotic cells were counted in each 
treatment group. Unless otherwise stated in the result section, three independent 
experiments of each assay were performed; average values and standard errors were 
calculated and presented as bar charts. 
2.32. Equipment 
Cell visualization and cytosolic / ER calcium measurements with fluo-4 and fluo-5N 
dyes were performed using (1) Leica Confocal Two-Photon Microscope SP2 with 
Leica Confocal Software v.2.61, Leica Microsystems, Heidelberg GmbH, (2) Leica 
Confocal SP5 II Multi-Photon with Leica Confocal Software, Leica Microsystems, 
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Heidelberg GmbH and (3) Leica Confocal TCS SPE Workstation, Leica 
Microsystems. Fura-2 recordings were performed on (1) Nikon Diaphot 200 imaging 
system using software Image-Pro Plus, MediaCybernetics; (2) and Photometrics – 
Cairn imaging system using software Image-Pro Plus, MediaCybernetics.  
2.33. Software 
Microsoft Word 2007 served as a main tool for writing and editing this thesis. 
Calculations, graphs and charts were made in Microsoft Excel 2003 and 2007. Origin 
v8.5 was used for fitting exponential functions and calculation of derivatives. Cell 
images were taken using Leica confocal software. Diagrams were prepared in 
Microsoft PowerPoint and Adobe Photoshop Version 9.0. ISIS™/Draw 2.4 was used 
to create schematic representation of chemical structures of compounds used in the 
experiments. The reference list was generated using Reference Manager Professional 
Edition Version 10. 
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CHAPTER 3: 
EFFECTS OF BCL-2 INHIBITION BY BH3 MIMETICS ON 
CALCIUM-INDUCED CALCIUM RELEASE (CICR) PROCESS IN 
PANCREATIC ACINAR CELLS 
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Chapter 3: Effects of Bcl-2 inhibition by BH3 mimetics on calcium-
induced calcium release (CICR) process in pancreatic acinar cells 
 
3.1. Overview of CICR in pancreatic acinar cells 
Calcium-induced calcium release (CICR) is a positive feedback mechanism by which 
a small rise in cytosolic Ca
2+
 triggers further calcium release from the intracellular 
stores. As was described in the introduction, IP3Rs and RyRs are the main players in 
CICR process. Opening of both receptors is regulated by Ca
2+
 in a biphasic mode: 
modest increases in cytosolic Ca
2+
 sensitize the receptors, whereas higher Ca
2+
 
concentration has an inhibitory effect
188-191
. It is generally agreed that Ca
2+
-
dependent regulation is predominantly based on direct binding of Ca
2+
 ions to the 
receptors. Experiments with purified IP3Rs reconstituted into lipid bilayers 
demonstrated clear sensitivity of IP3Rs to Ca
2+
, which supports the direct interaction 
model
192
. Indeed Ca
2+
 binding sites on the cytosolic part of IP3Rs have been 
identified
193
. Interestingly these sites do not exhibit any similarities to other known 
Ca
2+
-binding motifs such as EF-hands. They contain negatively charged residues that 
potentially might coordinate Ca
2+
 ions
194
. RyRs possess two types of Ca
2+
-binding 
sites: high-affinity sites bind Ca
2+
 at nanomolar to low micromolar concentrations 
and activate the receptors, whereas low-affinity sites bind Ca
2+
 at micromolar to 
milimolar concentrations and have an inhibitory effect
195
. The full mechanism for 
Ca
2+
 regulation of IP3Rs and RyRs is not entirely clear. Direct interaction of Ca
2+
 
ions with the receptors cannot completely explain all observed effects and therefore 
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some accessory factors / proteins seem to be involved in the CICR process, with 
calmodulin being one of the candidates
196-198
. 
Pancreatic acinar cells have highly polarized structure, with two distinct regions: 
apical and basolateral. Although most of the ER is localized in the basolateral 
area
199,200
, its thin extensions penetrate into the secretory region
201
. As was described 
in the introductory chapter, these thin extensions of the ER are characterised by high 
concentration of IP3Rs
43,65,66
, whereas RyRs are evenly distributed throughout the 
basolateral and apical area
67,68
 (Fig. 3.1). Consequently, Ca
2+
 responses to 
physiological stimuli always originate in the apical region and propagate to the 
basolateral region. Previously, CICR sensitivity was compared in different regions of 
the pancreatic acinar cells
69
. Local Ca
2+
 uncaging in the basolateral and apical areas 
revealed polarized distribution of Ca
2+
-sensitive Ca
2+
 release sites in pancreatic 
acinar cells. Ca
2+
 uncaging in the basolateral region results in short lasting elevation 
in cytosolic Ca
2+
 (the uncaging spike), but does not trigger CICR. On the other hand, 
Ca
2+
 liberation in the apical region induces a long lasting CICR transient that 
propagates toward the basolateral region
69
. Both IP3Rs and RyRs are crucial for 
CICR, because specific inhibition of these receptors prevents Ca
2+
 release triggered 
by uncaged calcium
69
. Apart from the ER, pancreatic acinar cells contain another 
Ca
2+
 store, which has been attributed mainly to zymogen granules and named as the 
acidic store
181,202,203
. The acidic store is exclusively located in the apical region of 
pancreatic acinar cell and it can be distinguished pharmacologically from the ER, 
since the two stores utilize different refilling mechanisms: the ER accumulates Ca
2+
 
via SERCA activity, whereas the replenishment of the acidic store is dependent on 
vacuolar H
+
 pumps and thus is sensitive to bafilomycin
202
. Uneven distribution
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A B
C D
 
 
Fig. 3.1. Comparison of the subcellular localization of RyR2 and IP3R3 in 
pancreatic tissue 
(A) The plasma membrane of pancreatic acinar cell is labeled with Texas Red-
phalloidin. (B) Distribution of type 2 RyR (immunostaining). (C) Overlay of images 
(A) and (B), demonstrating that RyRs are distributed relatively evenly across the cell. 
(D) Distribution of the type 3 IP3R in pancreatic acinar cells (immunostaining). In 
contrast to RyR2, IP3R3 is concentrated in the apical region. [Adapted from Leite MF, 
1999]
67
. 
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of IP3Rs and two distinct Ca
2+
 stores still cannot fully explain the underlying factors 
responsible for different sensitivity of the basolateral and apical areas in pancreatic 
acinar cells. This chapter attempts to address this issue. There is accumulating 
evidence for the role of Bcl-2 family proteins in cellular calcium homeostasis, 
especially in regulation of ER Ca
2+
 content and Ca
2+
 release
158,160,204
. However, the 
direct roles of Bcl-2 proteins in the regulation of CICR have not yet been fully 
investigated. Considering the facts that Bcl-2 proteins regulate calcium stores and 
interact with receptors involved in CICR, it is reasonable to suspect that they also 
might influence sensitivity to CICR in pancreatic acinar cells. In order to test this 
hypothesis, specific inhibition of anti-apoptotic Bcl-2 proteins by BH3 mimetics has 
been applied. 
3.2. Localization of anti-apoptotic Bcl-2 proteins in pancreatic acinar cells 
As strict regulators of intrinsic pathway of apoptotic cell death, Bcl-2 family proteins 
are known to localize to mitochondria. However, evidence accumulated during 
recent years suggest localization of some Bcl-2 family members in other cell 
compartments, mainly the endoplasmic reticulum
176,204,205
, where they are involved 
in the regulation of cellular calcium homeostasis
158,206
. Since there is no specific data 
demonstrating localization of Bcl-2 family members in pancreatic acinar cells, this 
study aimed to provide independent evidence for the presence of two anti-apoptotic 
proteins Bcl-2 and Bcl-xL in the ER. Both proteins are direct high-affinity targets for 
BH3 mimetics used in this study: BH3I-2' and HA14-1
167,170
. For detection of Bcl-2 
and Bcl-xL Western blot analyses were performed
207
. Pancreas isolated from CD-1 
male mice was homogenized and centrifuged at 1300×g in order to pellet and remove 
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zymogen granules. The supernatant was further spun at 12000×g. This procedure 
aimed to separate mitochondria (pellet) from supernatant enriched in ER 
microsomes. Both the pellet and the supernatant were tested for the presence of Bcl-2 
and Bcl-xL as well as compartment specific markers: mitochondrial cytochrome c 
oxidase (COX IV) and protein disulfide isomerase (PDI), which is a chaperon protein 
characteristic for the endoplasmic reticulum. Western blot results (Fig. 3.2.A) show 
that 12000×g pellet contains both mitochondria and endoplasmic reticulum 
microsomes marked by the presence of PDI and COX IV, respectively. As predicted, 
this fraction also contains Bcl-2 and Bcl-xL. On the other hand, 12000×g supernatant 
contains PDI, but COX IV was not detected, which indicates the presence of the 
endoplasmic reticulum and the absence of mitochondria. Importantly, the supernatant 
has high amounts of Bcl-2 and Bcl-xL, which constitutes an indirect evidence for 
extramitochondrial localization of these proteins. Bcl-2 and Bcl-xL are associated 
with ER membranes, although cytosolic localization cannot be excluded. 
Another piece of evidence for extramitochondrial localization of Bcl-2 protein was 
obtained from experiments on rat pancreatic cancer cell line AR42J. Bcl-2-GFP 
fusion protein was transiently overexpressed in AR42J cells using pEGFP plsamid 
containing bcl-2 insert. On the third day after transfection cell medium was replaced 
with fresh NaHEPES (+ 1 mM Ca
2+
) solution and the cells were stained with ER-
tracker Red (Invitrogen) in order to visualize the endoplasmic reticulum. Fig. 3.2.B 
shows three fluorescent images of AR42J cells. Green fluorescence represents 
cellular localization of Bcl-2-GFP protein, whereas red fluorescence comes from ER-
tracker Red and marks the ER. Overlays of green and red fluorescence result in 
yellow colour showing that substantial fraction of Bcl-2 co-localizes with the ER. 
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A. 
 
B. 
 
Fig. 3.2. Intracellular localization of Bcl-2 and Bcl-xL 
(A) Western blot analysis illustrates localization of Bcl-2 and Bcl-xL in two post-
nuclear fractions of pancreatic tissue. After centrifugation at 12000xg the pellet 
fraction contains mitochondria (marker: COX IV) and the ER (marker: PDI); 
whereas supernatant fraction contains the ER but no mitochondria. Bcl-2 and Bcl-xL 
are present in both fractions [Data obtained in collaboration; adapted from 
Gerasimenko JV, Ferdek PE, 2010]
207
. (B) AR42J cells overexpressing Bcl-2-GFP 
(green) stained with ER tracker Red (red colour); yellow overlay shows that a 
fraction of Bcl-2 protein can be present in the ER. 
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3.3. BH3 mimetics BH3I-2' and HA14-1 disrupt the interaction between 
anti- and pro-apoptotic Bcl-2 family members 
Due to their similarity to BH3 domains, BH3 mimetics bind to the hydrophobic 
pocket of anti-apoptotic Bcl-2 proteins and inhibit their interaction with one of the 
pro-apoptotic Bcl-2 members or a BH3 only protein, which eventually leads to 
liberation and activation of Bax and Bak. Since this study applies BH3 mimetics for 
investigation of cellular calcium homeostasis in pancreatic acinar cells, first it was 
necessary to confirm the effects of two BH3 mimetic:  BH3I-2' and HA14-1 on 
interactions between anti-apoptotic Bcl-2 or Bcl-xL and pro-apoptotic Bax
207
. 
Pancreatic acinar cells were incubated for 1h in the presence of 5 µM BH3I-2' or 
30 µM HA14-1; control cells were incubated for the same time but without any 
inhibitor. After incubation the cells were digested in RIPA lysis buffer and 
immunoprecipitation was performed with antibodies specific for Bcl-xL or Bcl-2. 
Immunoprecipitates were then probed with antibodies against Bcl-xL, Bcl-2 and 
Bax. The results (Fig. 3.3) demonstrate that the treatment with either BH3I-2' or 
HA14-1 markedly decreased the amount of co-precipitated Bax with anti-apoptotic 
Bcl-2 members. Therefore it can be concluded that both BH3I-2' and HA14-1 
effectively displace Bax protein from Bcl-2 and Bcl-xL, which confirms their 
inhibitory activity in pancreatic tissue.  
3.4. BH3 mimetics induce increase in cytosolic Ca
2+
 followed by sustained 
Ca
2+
 plateau formation 
In order to investigate the effects of BH3 mimetics on intracellular calcium 
homeostasis, freshly isolated pancreatic acinar cells were loaded with AM form of
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Fig. 3.3. BH3 mimetics disrupt the interaction between anti- and pro-apoptotic 
Bcl-2 members 
Immunoprecipitation assays demonstrating inhibitory potential of BH3I-2' and 
HA14-1. These BH3 mimetics disrupt the interaction of Bcl-xL (A) or Bcl-2 (B) with 
Bax. [Data obtained in collaboration; adapted from Gerasimenko JV, Ferdek PE, 
2010]
207
. 
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calcium sensitive dye fluo-4 and subsequently treated with 5 µM BH3I-2' or 30 µM 
HA14-1. Changes in cytosolic Ca
2+
 concentration were measured using confocal 
Leica system. The results revealed that both BH3I-2' and HA14-1 caused substantial 
increase in green fluorescence of the calcium sensitive dye fluo-4, which indicates an 
increase in cytosolic Ca
2+
 concentration (Fig. 3.4.A-D). Many responses were 
initiated by steep CICR (43 % to BH3I-2' and 45 % to HA14-1); the rest of the tested 
cells also developed cytosolic Ca
2+
 elevation, but without obvious CICR phase. In all 
cases, however, the initial increase was followed by sustained cytosolic calcium 
plateau (Fig. 3.4.A-D). Addition of 5 nM CCK (supramaximal dose) on the top of the 
cytosolic calcium plateau did not induce further release of calcium (Fig. 3.4.E-F), 
which suggests that treatment with BH3I-2' and HA14-1 substantially reduced the 
content of the intracellular calcium stores. In contrast, after treatment of pancreatic 
acinar cells with 5 nM CCK, which led to calcium release from the ER and global 
calcium increase in the cytosol, 5 and 30 µM BH3I-2' and 30 µM HA14-1 were still 
able to release even more calcium from the intracellular stores (Fig. 3.4.G-H). 
3.5. Inhibitors of anti-apoptotic Bcl-2 proteins release calcium from the 
intracellular stores 
Simultaneously with the intact cell experiments, investigations on two photon-
permeabilized pancreatic acinar cells were performed in order to determine BH3 
mimetic-dependent calcium changes in the intracellular stores. The cells were loaded 
with calcium sensitive indicator fluo-5N, permeabilized with two photon laser and 
perfused with KHEPES buffer that mimics the intracellular environment. Treatment 
with 5 µM BH3I-2' caused reduction in green fluorescence (18.5 % ± 2.2 SE, n = 12)
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Fig. 3.4. Calcium responses to BH3 mimetics in pancreatic acinar cells 
(A) Average calcium response to 5 µM BH3I-2' in C57BL6/J wild type pancreatic 
acinar cells (n = 14, mean values ± SE) in the absence of extracellular Ca
2+
. 
(B) Examples of the traces showing responses to 5 µM BH3I-2' in form of CICR 
(blue) or gradual increase (green), both concluded with sustained calcium plateau. 
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Fig. 3.4. (continues) 
(C) Average calcium response to 30 µM HA14-1 in C57BL6/J wild type pancreatic 
acinar cells (n = 11, mean values ± SE) in the absence of extracellular Ca
2+
. 
(D) Examples of the traces showing responses to 30 µM HA14-1 in form of CICR 
(blue) or gradual increase (green), both concluded with sustained calcium plateau. 
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Fig. 3.4. (continues) 
Traces show typical cytosolic calcium responses to treatments with (E) 5 µM BH3I-
2’ and (F) 30 µM HA14-1 in pancreatic acinar cells. Subsequent application of 5 nM 
CCK did not induce any additional response. (G) Treatment with 5 nM CCK resulted 
in global calcium response in the cytosol. Subsequent additions of 5 µM and 30 µM 
BH3I-2’ induced slow elevation of cytosolic calcium and plateau formation. 
(H) 5 nM CCK elicited global cytosolic calcium response. Addition of 30 µM HA14-
1 induced slow elevation of cytosolic calcium and plateau formation. [Adapted from 
Gerasimenko JV, Ferdek PE, 2010]
207
. 
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of the calcium sensitive dye indicating a decrease of calcium content in the 
intracellular stores (Fig. 3.5.A). Similarly, 30 µM HA14-1 induced a decrease 
(21% ± 1.5 SE, n = 10) in calcium concentration in the intracellular stores 
(Fig. 3.5.B). This decrease was sustained and corresponded to the previously 
measured cytosolic calcium plateau. Since all responses were recorded in the 
basolateral area, they are attributed mainly to the ER. 
In order to investigate whether Ca
2+
 release caused by BH3 mimetics is dependent on 
the effects of these inhibitors on conditions of mitochondria, ATP production in 
pancreatic acinar cells was blocked using two chemicals: 1) rotenone, which inhibits 
electron transport chain in mitochondria; and 2) oligomycin – a potent blocker of F0 
subunit of ATP synthase
207
. For the experiments, freshly isolated pancreatic acinar 
cells were loaded with fluo-5N and permeabilized with 2-photon laser. Pretreatment 
of the cells with a mixture of 10 µM rotenone and 10 µM oligomycin in KHEPES 
solution did not prevent BH3 mimetic-induced calcium release from the intracellular 
stores (Fig. 3.5.C-D), which indicates that the effects of BH3I-2’ and HA14-1 are not 
dependent on ATP or mitochondrial functions. 
In pancreatic acinar cells thapsigargin-insensitive acidic store contains substantial 
amount of Ca
2+
 and has been demonstrated to be involved in pathophysiological 
responses
181,202,203
. In order to test whether Ca
2+
 release from the acidic store 
contributes to BH3-mimetic responses, the ER of intact pancreatic acinar cells was 
depleted of Ca
2+
 by treatment with 2 µM thapsigargin. Subsequent application of 
10 µM BH3I-2' failed to induce Ca
2+
 release from thapsigargin-insensitive store 
(Fig. 3.5.G). Therefore it has been concluded that BH3 mimetics release calcium 
mainly from the endoplasmic reticulum. 
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Further, calcium was clamped with 10 mM BAPTA and 2 mM CaCl2 in KHEPES 
buffer in order to eliminate CICR from the intracellular stores. Under these 
conditions the responses to BH3I-2’ (6.8 % ± 0.3 SE, n = 6) and HA14-1 
(6.1 % ± 0.3 SE, n = 6) were significantly reduced in permeabilized pancreatic acinar 
cells (Fig. 3.5.E-F). This experiment demonstrates that CICR component is crucial 
for proper development of BH3 mimetic-elicited responses. 
Since BH3 mimetics mobilize Ca
2+
 from the endoplasmic reticulum leading to its 
empting, sustained character of cytosolic Ca
2+
 plateau is not entirely clear. In 
principle, when there is no Ca
2+
 in the extracellular solution cytosolic Ca
2+
 should be 
cleared from the cytosol, thus quickly returning to its basal levels. However, the 
results consistently show that the elevation in cytosolic Ca
2+
 persists for more than 
1000 s after treatment with BH3 mimetics. In order to exclude the possibility that 
sustained Ca
2+
 signal is in fact an artefact introduced by BH3 mimetics, fluo-4-
loaded pancreatic acinar cells were treated with 5 µM BH3I-2' in NaHEPES 0 Ca
2+
 
solution that contained 100 µM of the calcium chelator EGTA. Under these 
conditions the responses to BH3I-2' returned to the baseline within few hundred 
seconds after application of the BH3 mimetic (Fig. 3.5.H). The experiment confirms 
that recorded plateau is a result of increased cytosolic Ca
2+
 and it can be removed by 
calcium chelators. 
3.6. BH3 mimetic-induced Ca
2+
 release from the intracellular stores is 
only partially dependent on IP3Rs and RyRs 
Since calcium responses to BH3 mimetics are dependent on CICR process, 
engagement of IP3Rs and RyRs has been assessed. Pancreatic acinar cells isolated 
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Fig. 3.5. BH3  mimetics release calcium from the intracellular stores 
Typical traces of calcium release from the intracellular stores in response to BH3 
mimetics: (A) 5 µM BH3I-2’ and (B) 30 µM HA14-1 in permeabilized pancreatic 
acinar cells. Pretreatment of permeabilized cells with mixture of 10µM rotenone and 
10 µM oligomycin did not prevent calcium release induced by (C) BH3I-2’ and (D) 
HA14-1. Grey dashed lines show amplitudes of the responses to BH3 mimetics 
alone. [Adapted from Gerasimenko JV, Ferdek PE, 2010]
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Fig. 3.5. (continues) 
In the conditions of clamped calcium (10 mM BAPTA / 2 mM CaCl2) responses of 
internal stores to (E) BH3I-2’ or (F) HA14-1 were markedly reduced but resolvable. 
Grey dashed lines show amplitudes of the responses to BH3 mimetics alone. 
(G) A typical trace obtained upon treatment with 10 µM BH3I-3' after depletion of 
calcium from the ER by thapsigargin in intact pancreatic acinar cells.  (H) A typical 
cytosolic calcium response recorded upon treatment with 5 µM BH3I-2' in the 
presence of 100 µM EGTA with no extracellular Ca
2+
 in intact pancreatic acinar 
cells. [Adapted from Gerasimenko JV, Ferdek PE, 2010]
207
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from male CD1 mice were loaded with calcium sensitive dye fluo-5N AM under 
conditions that promote endoplasmic localization of the dye. The cells were then 
permeabilized with two photon laser light (as described in Chapter 2) and perfused 
with KHEPES solution containing 100 µM 2-aminoethoxydiphenyl borate (2-APB) 
or 10 µM ruthenium red, or both inhibitors. Application of 2-APB and ruthenium red 
aimed to block IP3Rs and RyRs, respectively
208
. The results were presented as 
reduction in green fluorescence of fluo-5N at the plateau normalized to the baseline 
values. The presence of 2-APB resulted in decreased amplitude of Ca
2+
 release as 
compared to BH3I-2’ alone (from 18.5 % to 13 % ± 1.9 SE, n = 8) as well as HA14-
1 alone (from 20 % to 11.7 % ± 0.9 SE, n = 5), but did not inhibit the responses 
completely (Fig. 3.6.A-B).  10 µM ruthenium red also caused a slight reduction in 
BH3I-2’- (12.5 % ± 1.2 SE, n = 5) and HA14-1-evoked (12 % ± 1.4 SE, n = 5) 
calcium release (Fig. 3.6.C-D). Simultaneous application of 100 µM 2-APB and 
10 µM ruthenium red resulted in even stronger inhibitory effect – the responses were 
reduced to 8.8 % ± 0.5 SE, n = 5 for BH3I-2’; and 7.3 % ± 0.9 SE n = 5 for HA14-1 
(Fig. 3.6.E-F). The results indicate that both IP3Rs and RyRs are partially involved in 
BH3 mimetic-induced calcium release from the intracellular stores. Their role in 
BH3 mimetic-elicited response is most likely restricted to amplification of the 
calcium signal through CICR process. The primary calcium release might be 
associated with potentiated calcium leak from the ER. This notion is developed in 
Chapter 6. All data obtained from the experiments on permeabilized pancreatic 
acinar cells (Fig. 3.5 and Fig. 3.6) are summarized in a bar chart (Fig. 3.6.G). 
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Fig. 3.6. Involvement of IP3Rs and RyRs in BH3 mimetic-induced Ca
2+
 release 
Pre-incubation of permeabilized pancreatic acinar cells with 100 µM 2-APB partially 
reduced responses to (A) 5 µM BH3I-2’ and (B) 30 µM HA14-1. Pre-incubation of 
permeabilized cells with 10 µM ruthenium red (RR) partially reduced responses to 
(C) 5 µM BH3I-2’ and (D) 30 µM HA14-1. Grey dashed lines show amplitudes of 
the responses to BH3 mimetics alone.  [Adapted from Gerasimenko JV, Ferdek PE, 
2010]
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Fig. 3.6. (continues) 
Pre-incubation of permeabilized cells with mixture of 100 µM 2-APB and 10 µM 
ruthenium red substantially reduced responses to (E) 5 µM BH3I-2’ (n = 5) and 
(F) 30 µM HA14-1 (n = 5). Grey dashed lines show amplitudes of the responses to 
BH3 mimetics alone. (G) Summary of data obtained on permeabilized cells 
(presented as traces on Fig. 3.5 and Fig. 3.6). [Adapted from Gerasimenko JV, 
Ferdek PE, 2010]
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3.7. CICR type of response and cytosolic calcium plateau induced by 
BH3I-2' are substantially reduced in AR42J cells overexpressing Bcl-2 
In order to test whether BH3 mimetic-induced CICR could be reduced by the excess 
of Bcl-2, GFP-tagged human Bcl-2 protein was transiently overexpressed in 
pancreatic cancer cell line AR42J. GFP fluorescence was used to distinguish between 
transfected and untransfected cells. The latter served as controls. The cells were 
loaded with AM ester form of ratiometric calcium sensitive dye fura-2 and treated 
with different concentrations of BH3I-2' (1, 2, 5 and 15 µM) in NaHEPES solution, 
without the presence of external Ca
2+
. The results show that BH3I-2' induces calcium 
release in both transfected and untransfected cells. 1 µM BH3I-2' has only a modest 
effect on both control and Bcl-2-overexpressing cells. However, the effect of higher 
doses of BH3I-2' (2, 5 and 15 µM) on CICR in AR42J cells shows dependence on 
the level of intracellular Bcl-2. In cells overexpressing Bcl-2-GFP the initial phases 
of the responses were substantially reduced (Fig. 3.7.A-E). This result suggests that 
Bcl-2 can be at least partially involved in the regulation of the CICR component of 
BH3 mimetic-induced responses. 
What is more, it was observed that in AR42J cells overexpressing Bcl-2-GFP 
cytosolic calcium plateau induced by higher concentrations of BH3I-2’ (5 and 
15 µM) was diminished as compared to control cells (Fig. 3.7.F). However, the 
decrease in cytosolic plateau (Fig. 3.7.F) was slightly more substantial with 5 µM 
BH3I-2' treatment (33.9 % reduction ± 5.4 SE) and less pronounced with 15 µM 
BH3I-2' (26.5 % reduction ± 7.0 SE). Since Bcl-2 is a target for BH3 mimetics 
higher dose of BH3I-2' is required to overcome effects of Bcl-2 overexpression. This 
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Fig. 3.7. Overexpression of Bcl-2 affects CICR 
Representative traces of responses to (A) 1 µM BH3I-2’, (B) 2 µM BH3I-2', 
(C) 5 µM BH3I-2' and (D) 15 µM BH3I-2' in control (blue traces) and in Bcl-2 
overexpressing AR42J cells (red traces). [Adapted from Gerasimenko JV, Ferdek 
PE, 2010]
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Fig. 3.7. (continues) 
(E) Comparison of CICR type of response in control and Bcl-2 overexpressing 
AR42J cells to different doses of BH3I-2’ presented as average rates of the 
increasing phase of responses (1 µM BH3I-2': nCtrl = 19, nBcl2 = 16; 2 µM BH3I-2': 
nCtrl = 21, nBcl2 = 19; 5 µM BH3I-2': nCtrl = 21 nBcl2 = 17; 15 µM BH3I2': nCtrl = 19 
nBcl2 = 19). (F) Comparison of calcium plateau induced by 5 µM (nCtrl = 21, 
nBcl2 = 17) and 15 µM BH3I-2' (nCtrl = 19, nBcl2 = 19) in control AR42J cells and cells 
overexpressing Bcl2-GFP. [Adapted from Gerasimenko JV, Ferdek PE, 2010]
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suggests that even though CICR is substantially reduced in Bcl-2 overexpressing 
cells in dose-dependent manner, treatment with high doses of BH3 mimetics can still 
lead to development of delayed cytosolic Ca
2+
 plateau. 
3.8. Bcl-2 family protein-dependent CICR is crucial for apoptosis 
induction in pancreatic acinar cells 
Since the main function of Bcl-2 proteins is apoptosis regulation, a natural question 
to ask is whether attenuated CICR affects apoptosis induced by BH3I-2'. Freshly 
isolated pancreatic acinar cells were seeded on glass bottom petri dishes and loaded 
with general caspase substrate. Then the cells were treated for an hour with 15 µM 
BH3I-2' alone or BH3I-2' in the presence of inhibitors of IP3Rs and RyRs - 100 µM 
2-APB and 10 µM ruthenium red, respectively. Apoptosis was determined based on 
fluorescence of cleaved general caspase substrate in three series of independent 
experiments with 20 to 80 cells each. BH3I-2' alone caused substantial apoptosis 
(58.4 % ± 2.5 SE) among plated pancreatic acinar cells (Fig. 3.8). However, the 
presence of 2-APB and ruthenium red significantly reduced the level of apoptosis to 
15.8 % ± 0.7 SE, which was only slightly higher than control values (7.3 % 
± 3.7 SE). The results suggest that CICR process and calcium release from the 
intracellular stores promotes BH3I-2'-dependent apoptosis induction. 
3.9. Discussion 
The results presented in this chapter demonstrate functions of Bcl-2 proteins in the 
process of Ca
2+
 release from the intracellular stores. The investigation is mainly 
based on inhibition of Bcl-2 by BH3 mimetics BH3I-2' and HA14-1. Two different 
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Fig. 3.8. Inhibition of IP3Rs and RyRs decreases BH3I-2'-induced apoptosis 
The graph shows apoptosis detection via measurement of general caspase substrate 
cleavage by activated caspases upon treatment with 15 µM BH3I-2’ in the presence / 
absence of the mixture of 100 µM 2-APB and 10 µM ruthenium red. 15 µM BH3I-2' 
caused substantial apoptosis (red bar, 58.4 % ± 2.5 SE). In the presence of the RR + 
2-APB percentage of apoptotic cells was reduced to 17.8 % ± 0.7 SE (green bar), 
which was only slightly higher than control values (blue bar, 7.3 % ± 3.7 SE). 
[Adapted from Gerasimenko JV, Ferdek PE, 2010]
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approaches (cell fractionation and staining of live cultured cells) independently 
confirm that anti-apoptotic members of Bcl-2 family are present not only in 
mitochondria but also in other cell compartments of mouse pancreatic acinar cells 
and rat pancreatic cancer  cell line AR42J. 
Also, the results of immunoprecipitation independently show that BH3 mimetics 
BH3I-2' and HA14-1 indeed cause dissociation of pro-apoptotic protein Bax from 
anti-apoptotic Bcl-2 or Bcl-xL. Interestingly, treatment of pancreatic acinar cells 
with BH3 mimetics and therefore disruption of the interaction between anti- and pro-
apoptotic Bcl-2 proteins was associated with Ca
2+
 release from the intracellular 
stores, mainly the ER, which was demonstrated by the experiments on both intact 
and permeabilized pancreatic acinar cells. 
In the literature there is very well established that Bcl-2 family proteins play a major 
role in regulation of apoptosis and mitochondrial homeostasis. Indeed treatment with 
BH3 mimetics eventually leads to mitochondrial depolarization and cytochrome c 
release, as was previously demonstrated
209
. However, the described effects of BH3 
mimetics on calcium release from the intracellular stores appear to be independent on 
mitochondrial functions, because inhibition of ATP synthesis by combined 
application of rotenone and oligomycin neither affected BH3 mimetic-induced Ca
2+
 
release nor released Ca
2+
 on its own. 
Single and simultaneous inhibition of IP3Rs and RyRs by 2-APB and ruthenium red 
revealed that these receptors play a role in Ca
2+
 response to BH3 mimetics. 
Pharmacological inhibition of one of the receptors substantially reduced Ca
2+
 release 
from the intracellular stores in permeabilized cells; and simultaneous block of both 
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receptors had additive effect confirming that both receptors are involved in the 
response. However, BH3 mimetic-induced Ca
2+
 release was never completely 
eliminated suggesting that the role of IP3Rs and RyRs is only restricted to the 
amplification of already existing Ca
2+
 signal. What is more, overexpression of Bcl-2 
in cell line AR42J clearly attenuated CICR induced by treatment with BH3I-2'. 
Therefore immediate interpretation of the data presented in this chapter could be that 
BH3 mimetics, which cause dissociation of pro-apoptotic proteins from anti-
apoptotic Bcl-2 and Bcl-xL, increase the sensitivity of IP3Rs and RyRs to activation 
by Ca
2+
. In other words, anti-apoptotic Bcl-2 proteins seem to be involved in 
regulation of CICR process, because their pharmacological inhibition by BH3 
mimetics significantly potentiates CICR leading to Ca
2+
 release from the stores. 
Importance of IP3Rs and RyRs in BH3 mimetic responses is underlined by the fact 
that their inhibition dramatically influences cell viability. Application of 2-APB and 
ruthenium red together dramatically increased survival of the cells challenged with 
BH3I-2' by reducing CICR type of response. 
In intact cells BH3 mimetics induce sudden Ca
2+
 release, which is followed by 
sustained cytosolic Ca
2+
 plateau, even in the absence of extracellular Ca
2+
. 
Explanation of this sustained cytosolic Ca
2+
 is not straightforward. Pancreatic acinar 
cells are indeed capable of maintaining responses for a long time in calcium-free 
medium
210
. However, cytosolic calcium plateau in such conditions suggests 
inhibition of Ca
2+
 extrusion from the cytosol in pancreatic acinar cells
211
. Bcl-2 
family members might indeed be involved in the regulation of Ca
2+
 transport across 
the membranes. The exact role of Bcl-2 protein in calcium fluxes across the plasma 
membrane is a subject of investigation described in Chapter 7. It has not yet been 
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investigated whether other ions, such as Zn
2+
, could be released from the intracellular 
compartments upon treatment with BH3 mimetics. With no efficient extrusion 
pathways, such ions might accumulate in the cytosol and can be bound by Ca
2+
-
sensitive probes (although with much lower affinity) producing a signal that can be 
taken for Ca
2+
 increase. In this study it was demonstrated that a modest dose of 
EGTA (100 µM) effectively removes the plateau, which suggests that the effect is 
predominantly caused by Ca
2+
 released from the intracellular stores. 
This chapter constitutes a coherent demonstration that Bcl-2 family proteins are 
involved in the regulation of CICR. Although the role of Bcl-2 proteins in different 
aspects of intracellular calcium homeostasis is already relatively well 
established
204,212
, some issues still remain unclear. It is agreed that Bcl-2 family 
proteins regulate resting ER calcium levels. However the exact effect is a subject of 
disagreement. It was reported that Bcl-2 overexpression decreased Ca
2+
 
concentration in the ER and diminished Ca
2+
 entry to this cell compartment
157,158
. 
However, other studies support the opposite effects of Bcl-2 on ER calcium: 
preservation of ER calcium by upregulation of SERCA
159
. Bcl-2 most likely controls 
multiple events in calcium signalling; therefore different conditions and experimental 
systems could explain that apparent controversy. Previous studies provided 
invaluable evidence that Bcl-2 and Bcl-xL can physically interact with the IP3R and 
affect its ability to release Ca
2+
 from the intracellular stores
213-215
. In the recent study 
BH4 domain of Bcl-2 was demonstrated to bind to the regulatory domain of the IP3R, 
which was associated with decreased Ca
2+
 release from the ER and attenuated 
apoptosis
215
. Those findings are in agreement with the data obtained in this study 
demonstrating that overexpression of Bcl-2 in AR42J cells decreases CICR, and with 
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the fact that application of pharmacological inhibition of anti-apoptotic Bcl-2 family 
members has the opposite effect leading to Ca
2+
 release form the stores. Taken 
together, accumulating evidence supports a model whereby anti-apoptotic Bcl-2 
members such as Bcl-2 itself and Bcl-xL regulate Ca
2+
 releasing channels as a 
function of their interaction with pro-apoptotic Bcl-2 members such as Bax and Bak, 
or perhaps also with certain BH3-only proteins. When associated with its pro-
apoptotic partner anti-apoptotic Bcl-2 protein might inhibit Ca
2+
 channels, whereas 
dissociation of pro- and anti- apoptotic proteins increases sensitivity of the receptors 
promoting Ca
2+
 release
207
. It could also be speculated that different sensitivity of 
distinct regions in pancreatic acinar cells might be associated with specific 
intracellular distribution of certain Bcl-2 family members. Alternatively, differential 
regulation of inhibitory functions of Bcl-2 proteins located in the basolateral area in 
contrast to those from the apical area could be suggested
207
. However, up to now 
there is no direct evidence for such distribution or regulation of Bcl-2 family 
members in pancreatic acinar cells and thus this subject constitutes an exciting 
opportunity for further development of the present study. 
In summary this chapter provides new insights into anti-apoptotic Bcl-2 protein-
dependent regulation of intracellular calcium homeostasis. Pharmacological 
inhibition of Bcl-2 and Bcl-xL by BH3 mimetics disrupts their interaction with anti-
apoptotic Bcl-2 proteins Bax and Bak, which is associated with increased sensitivity 
of IP3Rs and RyRs to activation by Ca
2+
 leading to actual Ca
2+
 release from the 
intracellular stores. 
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CHAPTER 4: 
CALMODULIN DEPENDENT MECHANISM OF CALCIUM 
RESPONSES INDUCED BY BH3 MIMETICS 
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Chapter 4: Calmodulin dependent mechanism of calcium responses 
induced by BH3 mimetics 
 
4.1. Overview of calmodulin 
Calmodulin (CaM) is a regulatory protein present in all eukaryotic cells. It is a 
relatively small protein of about 17 kDa, composed of 148 conserved amino acid 
residues. Importantly calmodulin has four EF hand motifs of helix-loop-helix 
structure, each of which is capable of binding a single Ca
2+
 ion. Two of the motifs 
(EF1 and EF2) are located at the N-terminal domain and bind Ca
2+
 with high affinity; 
two other (EF3 and EF4) are present on the other site of the polypeptide chain, at the 
C-terminal domain, and bind Ca
2+
 with markedly lower affinity. The two domains 
are separated by a flexible α-helical linker region (structure of calmodulin from 
Paramecium tetraurelia is shown in Fig. 4.1.A). Despite different affinity of EF 
motifs for Ca
2+
, the ions are bound in cooperative manner, meaning that the presence 
of a Ca
2+
 ion in one EF motif increases the affinity of other Ca
2+
 binding sites
216
. 
Therefore even slight elevation of cytosolic Ca
2+
 can activate calmodulin in vivo and 
affect its physiological functions. The protein is believed to be fully activated at the 
Ca
2+
 concentration as low as 500 nM
217
. The process of Ca
2+
 binding to calmodulin 
is associated with a significant conformational change of the protein, especially in its 
linker region. It is possible to distinguish at least two extreme conformational 
configurations
218
. Configuration without bound Ca
2+
 is called apocalmodulin 
(apoCaM) and is characterised by 'closed' conformation, in which EF hand motifs in 
  
 
 
127 
 
  
both domains are tightly packed
219
. In contrast, Ca
2+
-CaM has a Ca
2+
 ion interacting 
with every EF motif, resulting in four Ca
2+
 ions bound per molecule of calmodulin.  
In this configuration calmodulin adopts more open conformation: EF hand motifs are 
located further away than in apoCaM, which leads to the exposure of hydrophobic 
amino acid residues in both domains and rearrangements in the flexible linker 
between them
219
. Some neuronal proteins such as unconventional myosins or ion 
channels can interact with apoCaM. They possess an amphipathic CaM binding 
motif called IQ-motif enriched with hydrophobic amino acids such as Leu, Ile, Val, 
Trp or Phe. Prebound calmodulin can modify target protein activity within 
milliseconds. Alternatively, calmodulin can interact with target proteins after binding 
calcium and changing conformation to Ca
2+
-CaM. There is no conserved consensus 
sequence for Ca
2+
-CaM binding domains, but they usually consists of 15 to 30 amino 
acid residues and are both hydrophobic and basic in nature (calmodulin itself is more 
acidic and in its open conformation hydrophobic amino acid residues are exposed). 
Calmodulin is engaged in regulation of multiple intracellular processes including 
signalling and transcription pathways. As a multifunctional signal transducer it binds 
and activates various proteins, mainly phosphatases (such as calcineurin) and 
Ca
2+
 / calmodulin-dependent protein kinases (CaMKs)
220
. Calmodulin is also 
involved in regulation of intracellular calcium homeostasis by modulating Ca
2+
 
responses and affecting Ca
2+
 fluxes. For example it interacts with TRP channels, or 
regulates activity of the PMCA pump. Further, calmodulin interacts with RyRs and 
its functions depend on the receptor type. In type 1 RyRs apoCaM conformation is a 
partial agonist, whereas Ca
2+
-CaM acts as an inhibitor of the receptors
221
. In contrast, 
type 2 RyRs are inhibited by calmodulin in all its conformations
195
. What is more, 
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calmodulin plays a regulatory role in exocytosis mainly through modulation of 
membrane trafficking proteins. It was found to interact with synaptotagmin and 
synaptobrevin
222,223
. 
Calcium-like peptides (CALPs) are complementary peptides to EF-hand Ca
2+
-
binding sites. They were shown to interact with calmodulin and certain calcium 
channels inhibiting Ca
2+
-dependent cytotoxicity and cell death. CALPs were 
designed by inversion of the hydrophobic pattern of the EF-hands and thus they have 
a complementary surface contour to the original sequences. It has been demonstrated 
in the past that complementary peptides specifically interact with one another
224,225
; 
therefore the technique of hydrophatic pattern inversion can be used for generating 
specific ligands to the sequence of interest. 
So far four different CALPs have been designed and tested
226
. They all interact with 
calmodulin with moderate affinities but exert different effects. CALP-1 and CALP-3 
are calmodulin activators, whereas CALP-2 and CALP-4 act as antagonists. Since 
the octamer structure of the first peptide CALP-1 was based on the Ca
2+
-binding site 
of the troponin C, its hydrophatic profile is not perfectly complementary to EF-hands 
motifs of calmodulin. Therefore, CALP-2 and CALP-3 were designed as optimized 
peptides complementary to the EF-4 motif of human calmodulin. CALP-2 consists of 
12 amino acid residues, and CALP-3 is effectively its shorter version having only the 
first 8 amino acids. Finally, CALP-4 is another 12-mer peptide, which is composed 
of the sequence of CALP-1 with the last four amino acids of CALP-2. All four 
sequences are shown in Fig. 4.1.B. 
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A. 
 
B. 
Peptide Sequence 
CALP-1 VAITVLVK 
CALP-2 VKFGVGFKVMVF 
CALP-3 VKFGVGFK 
CALP-4 VAITVLVKVMVF 
 
 
Fig. 4.1. Calmodulin and CALPs 
(A) Molecular structure of calmodulin from Paramecium tetraurelia in complex with 
4 Ca
2+
 ions (cartoon display, Jmol, Protein Data Bank). Pink spirals represent α-
helical structures, yellow arrows are β-sheets, and Ca
2+
 ions are shown in green. 
(B) The table shows sequences of Ca
2+
-like peptides
226
 (full description in text). 
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Optimized inverted hydrophatic pattern of CALP-3 is reflected by its higher affinity 
for calmodulin as compared to CALP-1 (Kd = 33 µM and Kd = 52 µM, respectively). 
Also, CALP-2 has been demonstrated to have a 14-fold higher affinity to calmodulin 
than CALP-1. Importantly, CALPs interact only with low affinity Ca
2+
-binding sites 
in the carboxyl domain of calmodulin but not with the EF-hands in the N-terminal 
domain. Binding of CALPs to calmodulin is associated with conformational change, 
which, however, is not identical to that observed for Ca
2+
-CaM. Nevertheless, in case 
of CALP-1 and CALP-3, this conformational change of calmodulin is active and 
sufficient for phosphodiesterase activation. Interaction of CALP-2 or CALP-4 with 
calmodulin does not result in active conformation, which explains the fact why these 
peptides antagonise Ca
2+
 / CaM-dependent activation of phosphodiesterase. 
Application of CALPs requires their efficient delivery to the cytosol, where they can 
exert their functions. It has been demonstrated that fluorescently tagged CALP-1 can 
rapidly enter cultured rat neocortical neurones
227
. Interestingly, the intracellular 
effects of CALPs are not only restricted to modulation of calmodulin activity. These 
peptides can also interfere with calcium sensing mechanisms of certain Ca
2+
 channels 
and thus have inhibitory role on Ca
2+
 fluxes. This inhibition can be based on direct 
interaction of a peptide with the Ca
2+
-binding site of a channel; or it can be mediated 
through calmodulin, a primary target of CALPs
227
. 
This study applies CALPs to reduce toxic effects of elevated cytosolic Ca
2+
 induced 
by treatment with BH3 mimetics. It is known that BH3 mimetics inhibit the 
interaction between anti-apoptotic Bcl-2 members and pro-apoptotic Bax / Bak, 
which triggers induction of apoptosis. As was demonstrated in Chapter 3, treatment 
with BH3 mimetics such as BH3I-2' and HA14-1 is also associated with sudden Ca
2+
 
  
 
 
131 
 
  
release from the intracellular stores in pancreatic acinar cells followed by sustained 
Ca
2+
 plateau formation. Sustained cytosolic Ca
2+
 elevation leads to induction of 
necrosis, which is an undesirable cell death mode, since it is uncontrolled and 
characterised by release of the intracellular content, which in turn might trigger 
inflammatory response and further tissue damage. Therefore application of BH3 
mimetics as potential anti-cancer agents will inevitably be associated with toxic 
effects on pancreas and perhaps on other organs as well. The aim of the work 
presented in this chapter is to reduce the toxic effects of BH3 mimetics in order to 
diminish the levels of necrosis without affecting their pro-apoptotic functions. For 
that purpose Calcium-Like Peptides (CALPs) were applied to exert specific pre-
activation of calmodulin. 
4.2. Effects of Calcium-Like Peptides on BH3I-2'-releted Ca
2+
 responses 
Application of 5 µM BH3I-2' on intact pancreatic acinar cells causes a CICR-type of 
response followed by sustained cytosolic Ca
2+
 plateau formation, as was already 
depicted in the previous chapter in Fig. 3.4.A-B. Here the effects of BH3I-2' on 
calcium homeostasis in pancreatic acinar cells were investigated in the presence or 
absence of CALP-1 or CALP-3. Freshly isolated pancreatic acinar cells were loaded 
with fura-2 and then preincubated for 200 s with 100 µM CALP-1 (n = 25) or CALP-
3 (n = 28). Control cells (n = 22) were incubated for the same amount of time with 
NaHEPES (+ 1 mM Ca
2+
) only. Subsequently the cells were treated with 5 µM 
BH3I-2' and calcium responses were compared. BH3I-2' alone induced Ca
2+
 
responses in all treated cells: 82 % of cells developed major CICR-type of response 
followed by sustained Ca
2+
 plateau; and 18 % of cells responded with a delayed 
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increase in cytosolic Ca
2+
, which also was followed by prolonged cytosolic Ca
2+
 
elevation (Fig. 4.2.A and B). Pretreatment with 100 µM CALP-1 resulted in 
substantial change in type of Ca
2+
 responses. Only 32 % of cells developed major 
Ca
2+
 responses (Fig. 4.2.A); however the amplitude of the responses was lower than 
those elicited by BH3I-2' only (Fig. 4.2.C). 28 % of cells responded with a delayed 
Ca
2+
 increase in the cytosol, which was concluded with sustained Ca
2+
 plateau 
(Fig. 4.2.A and C). Interestingly, 20 % of cells pretreated with CALP-1 responded 
with only transient cytosolic Ca
2+
 increase, which quickly returned to the basal level 
without plateau formation. Finally, a fraction of cells (20 %) did not respond in the 
time course of the experiment (Fig. 4.2.A and C). Preincubation with CALP-3 had a 
slightly different effect: it decreased the fraction of cells that developed major Ca
2+
 
response to BH3I-2' from 82 % to 64 % (Fig. 4.2.A). Only 11 % of the cells 
developed a delayed Ca
2+
 response to treatment with the BH3 mimetic (Fig. 4.2.A 
and D, trace b). Importantly, 25 % of cells did not respond to BH3I-2' in the time 
course of the experiment (Fig. 4.2.A and D, trace c). Fig. 4.2.E shows average 
calcium responses to BH3I-2' in control cells and cells pretreated with 100 µM 
CALP-1 or CALP-3. In order to quantitatively compare the effects of CALPs, the 
average areas under the traces were calculated between 400 s and 1000 s (Fig. 4.2.F). 
Also, the amplitudes were taken at 900 s of calcium traces, averaged and compared 
in Fig. 4.2.G. The results show that the presence of 100 µM CALP-1 significantly 
reduces both the overall BH3I-2'-induced cytosolic Ca
2+
 elevation (p = 0.001, 
Fig. 4.2.F) and the amplitude of the response (p = 0.005, Fig. 4.2.G) as compared to 
control cells. In contrast, a slight reduction in both average BH3I-2'- elicited Ca
2+
 
response (p = 0.4, Fig. 4.2.F) and the average amplitude of Ca
2+
 plateau
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Fig. 4.2. Effects of CALPs on BH3I-2'-induced calcium responses 
(A) The chart shows distribution of different types of Ca
2+
 responses induced by 
treatment with 5 µM BH3I-2' in the presence / absence of 100 µM CALP-1 or 
100 µM CALP-3. (B) Two sample traces showing immediate response to BH3I-2' 
followed by sustained Ca
2+
 plateau (trace a) and a delayed response (trace b). 
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Fig. 4.2. (continues) 
(C) Four sample traces showing different types of responses to BH3I-2' in the 
presence of CALP-1: a major response (trace a), a delayed response (trace b), 
transient Ca
2+
 increase without forming sustained cytosolic Ca
2+
 plateau (trace c), 
and no response (trace d). (D) Three sample traces showing responses to BH3I-2' in 
the presence of CALP-3: a major calcium response followed by sustained cytosolic 
Ca
2+
 plateau (trace a), a response delayed in time (trace b), and no response (trace c). 
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Fig. 4.2. (continues) 
(E) Average traces of responses to 5 µM BH3I-2' only (n = 22, blue trace), and to 
BH3I-2' in the presence of 100 µM CALP-1 (n = 25, red trace) or 100 µM CALP-3 
(n = 28, green trace). Error bars represent standard errors of mean. (F) The bar chart 
shows average area under the traces depicted in E between 400 s and 1000 s of the 
recorded responses. Error bars represent standard error of mean. 
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Fig. 4.2. (continues) 
(G) The bar chart shows average amplitude obtained from the traces at 900 s of the 
recorded responses. 
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 at 900 s (p = 0.1, Fig. 4.2.G) in the presence of CALP-3 were statistically non-
significant. CALP-3 appears to interfere with Ca
2+
 release caused by BH3I-2', which 
is shown by the fraction of cells that did not respond to the treatment with the BH3 
mimetic. However, its effects are not as strong as those evoked by CALP-1. 
4.3. Effects of CALPs on BH3I-2'-induced cell death in pancreatic acinar 
cells 
CALPs modulate BH3I-2'-induced Ca
2+
 responses in pancreatic acinar cells. 
However, it is not clear whether induction of cell death is also affected. In order to 
address this issue the cell death assay was performed in pancreatic acinar cells. 
Pancreatic acinar cells were isolated as described above and were divided equally 
into 4 tubes. Two samples were pretreated with 100 µM CALP-1 or CALP-3 for 
15 min at room temperature. The other two were incubated for the same amount of 
time, but without any treatment. Subsequently the samples containing CALPs and 
one of the untreated samples were incubated with 5 µM BH3I-2' for 30 min. 15 min 
before the end of the incubation annexin-V-FITC and propidium iodide were added 
to all samples in amounts defined by Apoptosis Detection Kit (Sigma). Apoptotic 
and necrotic cells were visualized with Leica confocal microscope. The assay was 
repeated three times on different days. The combined results of the experiment are 
shown in Fig. 4.3. In control sample most of the cells are alive and healthy; low 
levels of apoptosis and necrosis result from the process of isolation. Treatment with 
BH3I-2' substantially decreases the amount of live cells (p = 0.0003), at the same 
time both apoptosis and necrosis are increased (p = 0.005 and p = 0.01, respectively). 
Preincubation with 100 µM CALP-1 does not change the fraction of live cells
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Fig. 4.3. Effects of CALPs on BH3I-2'-induced cell death in acinar cells 
The results of cell death assay performed on pancreatic acinar cells preincubated for 
15 min with 100 µM CALP-1, 100 µM CALP-3 or no CALPs and subsequently 
treated with 5 µM BH3I-2'. Control cells were incubated without CALPs and BH3I-
2'. Light green bars represent live cells, blue – apoptotic cells, and purple – necrotic. 
The chart is separated into four treatment groups, from the left: untreated control 
cells; cells treated with 5 µM BH3I-2' only; cells preincubated with CALP-1 and 
treated with BH3I-2'; and cells preincubated with CALP-3 and treated with BH3I-2'. 
Black error bars represent standard error of mean. Apoptosis is significantly 
increased in CALP-1 + BH3I-2 sample as compared to BH3I-2' (*p = 0.007); at the 
same time necrosis is substantially decreased (
@
p = 0.039). In CALP-3 + BH3I-2' 
sample necrosis is reduced (
##
p = 0.05) as compared to BH3I-2' alone; and the 
fraction of live cells is significantly increased (
#
p = 0.01). 
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as compared to treatment with BH3I-2' alone (p = 0.82); however in the presence of 
CALP-1 BH3I-2 induces substantially more apoptosis than BH3I-2' alone 
(*p = 0.007) and at the same time necrosis is decreased (
@
p = 0.039). In contrast, 
pretreatment with 100 µM CALP-3 does not affect the levels of apoptosis as 
compared to BH3I-2' alone (p = 0.88). However, in the presence of CALP-3, BH3I-
2'-induced necrosis is reduced (
##
p = 0.05), and the fraction of live cells is increased 
(
#
p = 0.01) as compared to the BH3 mimetic alone. These results suggest that CALP-
1 promotes apoptotic cell death over necrosis upon treatment with BH3I-2'; whereas 
CALP-3 does not affect apoptosis levels, but in turn promotes survival of the cells 
and reduces necrosis. 
4.4. The effects of gossypol on calcium homeostasis in pancreatic acinar 
cells 
Gossypol is a natural terpeniod aldehyde isolated from the seed, stem and root of the 
cotton plant (Gossypium). It is known to bind and inhibit anti-apoptotic proteins Bcl-
2, Bcl-xL and Mcl-1
228
; it promotes conformational change of Bcl-2 and induces loss 
of mitochondrial potential in a Bax/Bak-independent manner
229
. Naturally isolated 
gossypol is a racemic mixture of (+)-gossypol and (-)-gossypol. (-)-Gossypol has 
been shown to be more potent than its (+) optic isomer, with Ki values of 320 nM 
and 480 nM for Bcl-2 and Bcl-xL, respectively
230
. Interestingly, its affinity to Mcl-1 
is even higher (Ki = 180 nM)
230
. Initially gossypol was used as anti-fertility agent in 
China in 1950s
231
. Currently gossypol is under clinical trials in order to evaluate its 
application as potential anti-cancer drug. It can be administrated orally and is 
believed to have "acceptable and manageable toxicity"
230
. Therefore it represents a 
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very promising compound that can give rise to a new class of anti-apoptotic Bcl-2 
inhibitors. 
However, up to now the effects of gossypol on intracellular calcium homeostasis in 
pancreatic acinar cells have not yet been investigated. Just like other BH3 mimetics 
gossypol is expected to induce Ca
2+
 release from the intracellular stores followed by 
cytosolic Ca
2+
 plateau formation. In order to test this notion the effects of different 
doses of gossypol were assessed in fluo-4-loaded pancreatic acinar cells.  The cells 
were treated with increasing concentration of gossypol (1 - 15 µM) in the presence of 
1 mM Ca
2+
 in order to determine the effective dose of the drug. Fig. 4.4.A shows two 
(out of 5) representative traces obtained in the experiment. Although the effects of 
gossypol on Ca
2+
 release in pancreatic acinar cells vary, 5 µM concentration of the 
drug appears to be the lowest to induce a clear response (Fig. 4.4.B). Lower 
concentrations, such as 1 µM in most cases have no apparent effect on cytosolic Ca
2+
 
(82 % of cells did not respond to 1 µM gossypol, n = 11, Fig. 4.4.C). However, 18 % 
of cells treated with low dose of gossypol developed small Ca
2+
 oscillations confined 
to the granular area (n = 11, Fig. 4.4.C). In conclusion, micromolar doses of gossypol 
have a very similar effect on intracellular calcium homeostasis in pancreatic acinar 
cells as observed with synthetic BH3 mimetics such as BH3I-2' or HA14-1. 
4.5. Effects of CALPs on gossypol-induced Ca
2+
 responses 
As it has been shown above, treatment with gossypol induces Ca
2+
 release from the 
intracellular stores in pancreatic acinar cells followed by sustained Ca
2+
 plateau 
formation.  Therefore use of gossypol as an anti-cancer drug will also be associated 
with toxic effects on pancreas, similarly to synthetic BH3 mimetics. Gossypol has
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Fig. 4.4. Calcium responses to gossypol in pancreatic acinar cells 
(A) Two sample traces showing responses of pancreatic acinar cells to increasing 
concentrations of gossypol (1 - 15 µM). (B) A representative trace demonstrating a 
typical Ca
2+
 response of pancreatic acinar cells to 5 µM dose of gossypol; 5 µM 
gossypol is the lowest dose capable of inducing cytosolic Ca
2+
 plateau in pancreatic 
acinar cells. 
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Fig. 4.4. (continues) 
(C) Two sample traces obtained after treatment of pancreatic acinar cells with 1 µM 
gossypol; blue trace shows oscillations in the granular area. 
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been shown to induce apoptosis as a result of its inhibitory effects on anti-apoptotic 
Bcl-2 proteins. However, it is also expected to induce high levels of necrosis because 
of its toxic effects leading to formation of prolonged elevation of cytosolic Ca
2+
. The 
aim of the work presented in this chapter is to apply calcium-like peptides in order to 
reduce the toxicity of gossypol in the same way as it has been shown for BH3I-2'. 
20 µM dose of gossypol every time induces CICR-type of response followed by 
sustained cytosolic Ca
2+
 plateau in intact pancreatic acinar cells. Therefore here a 
20 µM dose was chosen to investigate the effects of gossypol on calcium 
homeostasis in pancreatic acinar cells in the presence or absence of CALP-1 or 
CALP-3. Freshly isolated pancreatic acinar cells were loaded with calcium sensitive 
dye fura-2 and then calcium responses to gossypol were recorded after 200 s of 
pretreatment with 100 µM CALP-1 (n = 15) or CALP-3 (n = 14). Control cells 
(n = 20) were preincubated for the same amount of time without CALPs. 
Subsequently, the cells were treated with 20 µM gossypol and the average calcium 
responses were compared (Fig. 4.5.A). For quantitative comparison of the effects of 
CALPs, the average areas under the traces were calculated between 400 s and 1500 s 
(Fig. 4.5.B). Also, the amplitudes were taken at 800 s of calcium traces, averaged 
and compared in Fig. 4.5.C. The results show that pre-incubation with 100 µM 
CALP-1 significantly reduces both the overall gossypol-induced cytosolic Ca
2+
 
elevation (p < 0.0001, Fig. 4.5.B) and the amplitude of the response (p < 0.0001, 
Fig. 4.5.C) as compared to gossypol alone - treated cells. Interestingly, CALP-3 
appears to delay the development of Ca
2+
 response to gossypol, which is reflected by 
reduction in average area under the trace as compared to control (p = 0.002, 
Fig. 4.5.B) as well as reduction in the average amplitude at 800 s
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Fig. 4.5. Effects of CALPs on gossypol-induced responses in acinar cells 
(A) The graph shows average Ca
2+
 responses in pancreatic acinar cells induced by 
20 µM gossypol only (n = 20), or 20 µM gossypol in the presence of 100 µM 
CALP-1 (n = 15) or 100 µM CALP-3 (n = 14). Error bars represent standard errors. 
(B) The bar chart shows average area under the traces depicted in (A) between 400 s 
and 1500 s of the recorded responses. Error bars represent standard error of mean. 
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Fig. 4.5. (continues) 
(C) The bar chart shows average amplitude obtained from the traces depicted in (A) 
at 800 s of the recorded responses. 
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(p = 0.001, Fig. 4.5.C). Prolonged exposure to gossypol in the presence of CALP-3 
leads to formation of cytosolic Ca
2+
 plateau with the average amplitude comparable 
to that of treatment with gossypol alone (Fig. 4.5.A). In conclusion both CALP-1 and 
CALP-3 interfere with action of gossypol on Ca
2+
 release from the intracellular 
stores, which is demonstrated by markedly reduced average amplitudes and areas 
under the traces of the responses in cells pretreated by one of the CALPs. However, 
the effect of CALP-1 on gossypol-induced responses appears more pronounced than 
the effect of CALP-3. 
4.6. Effects of CALPs on gossypol-induced cell death in pancreatic acinar 
cells 
As was shown above, CALPs modulate gossypol-induced Ca
2+
 responses in 
pancreatic acinar cells. However, in order to establish physiological significance of 
that observation, it is required to investigate the induction of cell death by combined 
treatment with gossypol and CALPs. Pancreatic acinar cells were isolated as 
described above and were divided equally into 4 tubes. Two samples were pretreated 
with 100 µM CALP-1 or CALP-3 for 15 min. The other two were incubated for the 
same amount of time, but without any treatment. Subsequently, the samples 
containing CALPs and one of the untreated samples were incubated with relatively 
low dose of gossypol (5 µM) for 30 min. 15 min before the end of the incubation 
annexin-V-FITC and propidium iodide were added to all samples in amounts defined 
by Apoptosis Detection Kit (Sigma). Apoptotic and necrotic cells were visualized 
with Leica confocal microscope. The cell death assay was repeated three times in 
order to obtain independent values. The results of the experiment are presented in
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Fig. 4.6. Effects of CALPs on gossypol-induced cell death in acinar cells 
The results of cell death assay performed on pancreatic acinar cells preincubated for 
15 min with 100 µM CALP-1, 100 µM CALP-3 or no CALPs and subsequently 
treated with 5 µM gossypol. Control cells were incubated without CALPs and 
gossypol. Light green bars represent live cells, blue – apoptotic cells, and purple – 
necrotic. The chart is separated into four treatment groups, from the left: untreated 
control cells; cells treated with 5 µM gossypol only; cells preincubated with CALP-1 
and treated with gossypol; and cells preincubated with CALP-3 and treated with 
gossypol. Black error bars represent standard error of mean. Apoptosis is 
significantly increased upon pre-treatment with CALP-1 as compared to gossypol 
alone (*p = 0.043); at the same time necrosis is substantially decreased (
@
p = 0.017). 
Pretreatment with CALP-3 reduces necrosis (
##
p = 0.0008) and increases the fraction 
of live cells (
#
p = 0.028) as compared to gossypol alone. 
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Fig. 4.6. In control sample most of the cells are alive; and low levels of apoptosis and 
necrosis are the result of the process of isolation. Treatment with gossypol alone 
substantially decreases the amount of live cells (p = 0.0028), at the same time both 
apoptosis (p = 0.005) and necrosis are increased (p = 0.0001). The presence of 
100 µM CALP-1 does not significantly change the fraction of live cells as compared 
to the treatment with gossypol alone (p = 0.163); however apoptosis is significantly 
increased (*p = 0.043); and at the same time necrosis is substantially reduced 
(
@
p = 0.017). Similarly to BH3I-2' data presented in Chapter 4.2, pretreatment with 
100 µM CALP-3 does not affect the levels of gossypol-induced apoptosis as 
compared to gossypol alone (p = 0.14). However, CALP-3 markedly reduced 
gossypol-induced necrosis (
##
p = 0.0008), increasing the fraction of life cells 
(
#
p = 0.028). The results suggest that CALP-1 promotes apoptotic cell death over 
necrosis upon treatment with gossypol; whereas CALP-3 does not affect apoptosis 
levels, but in turn promotes survival of the cells by reduction of necrosis. These 
effects are very similar to those obtained by induction of cell death by synthetic BH3 
mimetic BH3I-2' in the presence of CALPs. 
4.7. CALPs do not affect physiological calcium responses to ACh in 
pancreatic acinar cells 
As was shown above, preincubation of pancreatic acinar cells with CALP-1 or 
CALP-3 leads to pre-activation of calmodulin, which modifies the pattern of 
pathological cytosolic Ca
2+
 responses and thus affects cell death induction. However, 
as promising as CALPs appear to be in reduction of pathological Ca
2+
 responses in 
life cells, their successful application as potential therapeutic agents can only be 
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possible if physiological Ca
2+
 responses are not affected by the presence of calcium-
like peptides. For pancreatic acinar cells the most important physiological stimuli are 
acetylcholine (ACh) and cholecystokinin (CCK). As was described in detail in the 
introductory chapter, small doses of ACh induce Ca
2+
 oscillations in the cytosol and 
secretion of pancreatic enzymes. In order to investigate whether pre-activation of 
calmodulin with CALPs inhibits physiological Ca
2+
 signalling induced by ACh, 
freshly isolated pancreatic acinar cells were loaded with fura-2 and preincubated for 
200 s with either 100 µM CALP-1 or 100 µM CALP-3. Control cells were incubated 
for 200 s without CALPs. Subsequently the cells were treated with relatively small 
concentration of ACh (50 nM). 50 nM ACh normally induces global cytosolic Ca
2+
 
oscillations, which originate in the granular pole of pancreatic acinar cells and spread 
towards the basolateral area. The representative traces are presented in Fig. 4.7.A-C. 
All cells used in the experiment responded to ACh with repeated global cytosolic 
Ca
2+
 transients, which lasted for about 200 - 300 s. The major spikes were followed 
by tiny oscillations of the baseline. In all cases pretreatment with CALP-1 (n = 12) or 
CALP-3 (n = 10) did not block ACh-induced oscillations nor affected them 
substantially as compared to the responses of control cells (n = 15). 
4.8. CALPs have only a minor effect on CCK-induced calcium responses 
in pancreatic acinar cells 
Similarly to physiological doses of ACh, treatment with picomolar concentrations of 
CCK induces Ca
2+
 oscillations in pancreatic acinar cells, which are restricted to the 
apical area or spread towards the basolateral area as global Ca
2+
 spikes. In order to 
investigate whether pre-activation of calmodulin with CALPs inhibits physiological
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Fig. 4.7. Effects of CALPs on ACh-induced calcium responses 
Representative traces obtained upon treatment of pancreatic acinar cells with: 
(A) 50 nM ACh and (B) 50 nM ACh after preincubation with 100 µM CALP-1. 
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Fig. 4.7. (continues) 
(C) A representative trace obtained upon treatment of pancreatic acinar cells with 
50 nM ACh after preincubation with 100 µM CALP-3. 
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Ca
2+
 responses induced by CCK, freshly isolated pancreatic acinar cells were loaded 
with fura-2 and preincubated for 200 s with either 100 µM CALP-1 or 100 µM 
CALP-3. Control cells were incubated for 200 s without CALPs. Subsequently the 
cells were treated with 5 pM CCK. The responses obtained after treatment with CCK 
were classified into three different groups: (1) global Ca
2+
 oscillations, (2) Ca
2+
 
oscillations confined to the apical area only, (3) and Ca
2+
 oscillations consisting of 
mixture of both global and apical oscillations (Fig. 4.8.A). Treatment with CCK 
alone (without presence of CALPs) induced global Ca
2+
 oscillations in most of the 
cells used in the experiment (56 %, 5 out of 9 cells, Fig. 4.8.B); 22 % of cells (2 out 
of 9) responded with small Ca
2+
 oscillations restricted to the apical area; and the 
same amount of cells (22 %) responded with mixed type of oscillations, where 
propagation of Ca
2+
 signal in some cases was restricted to the apical area, and in 
other cases spread throughout the basolateral region. Pretreatment with CALP-1 
(n = 15) or CALP-3 (n = 11) did not block Ca
2+
 responses to 5 pM CCK. However, 
the pattern of CCK-induced Ca
2+
 responses in the presence of CALPs is not identical 
to responses induced by CCK alone. Preincubation with 100 µM CALP-1 led to a 
slight decrease in proportion of cells responding with global Ca
2+
 oscillations (47 %, 
7 out of 15 cells, Fig. 4.8.A and C); at the same time more cells responded with 
oscillations confined to the apical region only (33 %, 5 out of 15, Fig. 4.8.A and D); 
and similar proportion of cells produced mixed type of oscillations in response to 
CCK (20 %, 3 out of 15, Fig. 4.8.A). The effect of 100 µM CALP-3 was even more 
pronounced. In the presence of CALP-3 treatment with 5 pM CCK resulted in only 
few cells responding with global Ca
2+
 oscillations (18 %, 2 out of 11, Fig. 4.8.A and 
E) and the amplitude of those Ca
2+
 transients was substantially lower as compared to
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Fig. 4.8. Effects of CALPs on CCK-induced calcium responses 
(A) The bar chart shows distribution of different types of oscillatory responses 
obtained in pancreatic acinar cells after treatment with 5 pM CCK. The responses are 
divided into three groups: global oscillations, mixed oscillations and apical 
oscillations. Treatment with CALPs promotes apical oscillations over global Ca
2+
 
transients. (B) A sample trace showing typical global Ca
2+
 oscillations induced by 
treatment with 5 pM CCK in pancreatic acinar cells.  
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Fig. 4.8. (continues) 
(C) A sample trace showing global Ca
2+
 oscillations induced by treatment with 5 pM 
CCK in pancreatic acinar cells pretreated with 100 µM CALP-1. 
(D) A sample trace showing CCK-induced small Ca
2+
 oscillations confined to the 
apical area in pancreatic acinar cells pretreated with 100 µM CALP-1. 
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Fig. 4.8. (continues) 
(E) A sample trace showing global Ca
2+
 oscillations induced by treatment with 5 pM 
CCK in pancreatic acinar cells pretreated with 100 µM CALP-3. (F) A sample trace 
showing mixed Ca
2+
 oscillations induced by treatment with 5 pM CCK in pancreatic 
acinar cells pretreated with 100 µM CALP-3. 
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Fig. 4.8. (continues) 
(G) A sample trace showing small apical Ca
2+
 oscillations induced by 5 pM CCK in 
pancreatic acinar cells pretreated with 100 µM CALP-3. 
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treatment with CCK alone. Further, higher proportion of cells responded to CCK 
with apical oscillations only (36 %, 4 out of 11, Fig. 4.8.A and G) or mixed type of 
oscillations (45 %, 5 out of 11, Fig. 4.8.A and F). In summary, it appears that 
pretreatment with CALPs, particularly with CALP-3, promotes small Ca
2+
 
oscillations confined to the apical area of pancreatic acinar cells over global Ca
2+
 
increases. However, CALPs do not inhibit CCK signalling completely. 
4.9. Discussion 
CALP-1 and CALP-3 are relatively well established modulators of calmodulin. They 
can bind to the EF hand motifs of the protein leading to its activation even without 
the increase in cytosolic Ca
2+
. Since calmodulin performs various functions in cells, 
its preactivation can affect many aspects of intracellular Ca
2+
 homeostasis. In this 
chapter it was tested whether preincubation with CALPs can protect cells against 
toxic increases in cytosolic Ca
2+
 induced by treatment with BH3 mimetics and thus 
decrease their necrotic effects in favour of apoptosis. Indeed it was demonstrated that 
preincubation with CALPs changed the pattern of Ca
2+
 responses induced by BH3I-
2'. The BH3 mimetic alone in majority of the cases triggered quick and substantial 
Ca
2+
 release from the intracellular stores followed by a sustained Ca
2+
 plateau. Only 
few cells responded with a Ca
2+
 release signal that was delayed in time. 
Preincubation with CALP-1 led to an increase in the amount of cells showing 
delayed responses and, even more importantly, 20 % of investigated cells responded, 
but did not develop sustained Ca
2+
 plateau; and another 20 % did not respond at all. 
Interestingly, effects of CALP-3 were not that pronounced, but even in this case as 
many as 25 % of cells did not develop any responses to BH3I-2'. Even the typical 
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BH3 mimetic-elicited responses with a clear plateau phase were reduced in the 
presence of CALPs, which is reflected by decreased average amplitude; although in 
the case of CALP-3 this decrease is statistically non-significant. 
CALPs showed very similar effects on Ca
2+
 responses induced by the natural Bcl-2 
inhibitor gossypol. Both CALP-1 and CALP-3 reduced average Ca
2+
 release from the 
intracellular stores in response to gossypol as well as the average amplitude of the 
responses. CALP-1 again appeared to be more potent than CALP-3. 
These effects of CALPs on BH3 mimetic-induced Ca
2+
 responses have a very 
important implication on induction of cell death. Reduced calcium responses to BH3 
mimetics in the presence of CALP-1 are also reflected by increased apoptosis levels 
and decreased necrosis as compared to treatment with BH3I-2' or gossypol alone. In 
fact necrosis levels are only slightly elevated as compared to untreated controls. 
Pretreatment with CALP-3 also reduces levels of necrosis induced by BH3 mimetics. 
However, in contrast to CALP-1, CALP-3 does not markedly affect apoptosis, but in 
turn increases the amount of cells that survived the treatment. 
It is not entirely clear why CALP-1 and CALP-3 have such different effects on Ca
2+
 
responses induced by BH3 mimetics. CALP-3 has been designed as a 
complementary peptide to EF hand motif of calmodulin and thus has higher affinity 
to the protein than CALP-1, which was designed to interact with troponin C
226
. 
CALPs bind to C-terminal domain of calmodulin and induce conformational change 
of the protein, which is not identical to that caused by Ca
2+
 binding
226
. It is likely that 
slight differences in active conformation of calmodulin elicited by CALP-1 and 
CALP-3 are responsible for differences in effects of CALPs on BH3 mimetic-
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dependent Ca
2+
 increases. What is more, since structure of CALP-1 is not absolutely 
complementary to EF hand motifs of calmodulin, the peptide might also interact with 
other intracellular targets containing EF hand motifs, such as Ca
2+
 channels. In that 
case, CALP-1 would not only activate calmodulin but also affect Ca
2+
 fluxes in 
calmodulin-independent mode. Therefore, the exact mechanism of CALP-mediated 
regulation of intracellular Ca
2+
 homeostasis requires further investigation. Resolving 
the mechanism is particularly important for development of effective therapeutic 
agents. 
When speculating about potential use of CALPs as drugs, first of all it has to be 
noted that application of CALPs themselves is probably limited by their 
unfavourable pharmacological properties. Although the pharmacokinetic properties 
of CALPs have not yet been fully investigated, short peptides are usually 
characterised by poor cell permeability, bioavailability and metabolic stability. They 
are prone to degradation in digestive system, which means that oral administration 
would not be effective. Full assessment of the suitability of CALPs for therapeutic 
use exceeds the scope of this thesis. Here, it is reported that pre-activation of 
calmodulin decreases Ca
2+
 overload caused by BH3 mimetics and affects the type of 
cell death induced upon the treatment. From that perspective, the effects of Ca
2+
-like 
peptides on Ca
2+
 responses are definitely worth attention and further investigation. 
The ultimate goal would be to develop compounds working similarly to CALPs, 
particularly CALP-1, which could potentially be used as attenuators of pathological 
calcium responses induced by BH3 mimetics and perhaps other drugs as well. Such 
compounds would be especially useful in situations where induction of apoptosis is 
beneficial, but necrosis is not, in particular in anti-cancer therapy. 
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Considering the vast spectrum of functions performed by calmodulin, it was 
important to test whether activation of calmodulin by CALPs affects physiological 
Ca
2+
 signalling. If physiological Ca
2+
 responses are inhibited in the same way or 
stronger than pathological responses, potential use of CALPs as therapeutic agents 
might be questioned. Course book examples of physiological responses in pancreatic 
acinar cells are ACh- and CCK-induced Ca
2+
 oscillations, which normally trigger 
pancreatic secretion. The results indicate that neither CALP-1 nor CALP-3 
substantially change ACh signalling. In the presence of CALPs all investigated cells 
responded to 50 nM ACh with global oscillations. It would, however, be surprising if 
CALPs had no effects at all on physiological signalling and at the same time their 
influence on pathological Ca
2+
 increases was so substantial. Experiments with CCK 
demonstrate that Ca
2+
-like peptides, particularly CALP-3, promote apical Ca
2+
 
oscillations over global Ca
2+
 increases, but do not block CCK signalling completely. 
Slightly stronger effect of CALPs on CCK signalling is not entirely clear. CCK 
responses are predominantly dependent on Ca
2+
 release through RyRs; whereas ACh 
releases Ca
2+
 mainly through IP3Rs. Both receptors are regulated by calmodulin and 
thus differences in the mechanisms of CaM-dependent regulation of RyRs and IP3Rs 
can be responsible for stronger inhibitory effect of CALPs on CCK signalling. 
Taken together, data shown in this chapter support the hypothesis that preactivation 
of calmodulin can protect cells from excessive Ca
2+
 increases in the cytosol caused 
by BH3 mimetics and thus extensive necrosis. Physiological Ca
2+
 responses might be 
slightly diminished by CALPs, but are not completely inhibited. 
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CHAPTER 5: 
PROTECTIVE ROLE OF CALMODULIN AGAINST ETHANOL 
IN PANCREATIC ACINAR CELLS 
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Chapter 5: Protective role of calmodulin against ethanol in 
pancreatic acinar cells 
 
5.1. Overview of ethanol actions on pancreas 
As was described in the introductory chapter, the incidence of acute pancreatitis is 
strongly associated with the level of alcohol intake. However, only a small 
percentage of heavy drinkers develop pancreatitis indicating that other factors are 
also important in the pathogenesis of this condition
232
. Repeated episodes of acute 
pancreatitis might result in chronic manifestation of the disease, which in turn 
increases the risk of pancreatic cancer
41
. The hallmark of pancreatitis is autodigestion 
of the organ, which is primarily initiated by intracellular activation of trypsin in 
pancreatic acinar cells. The main difference between chronic and acute pancreatitis 
lies in the extent and progression of necrosis in the organ. 
Also, as was already pointed out in the Introduction, cytosolic calcium signals 
control physiological functions of pancreatic acinar cells, such as enzyme secretion. 
However, global increases in cytosolic calcium, especially when sustained, might be 
toxic for cells leading to premature activation of intracellular digestive enzymes, 
extensive vacuolization, activation of NFκB, inflammatory response and induction of 
cell death
101,233-236
. Since abnormal Ca
2+
 signalling seems to play a crucial role in 
different models of acute pancreatitis, it is clear that either ethanol itself or some of 
its metabolites are responsible for induction of pathological Ca
2+
 responses
237
. 
Interestingly, ethanol even in very high concentrations has only minor effects on 
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Ca
2+
 homeostasis of pancreatic acinar cells
100
. Ethanol can be metabolised through 
two pathways: oxidative and non-oxidative. The main oxidative metabolite of 
ethanol, acetaldehyde, has been demonstrated to have no effect on cytosolic Ca
2+
 in 
pancreatic acinar cells
100
. Fatty acid ethyl esters (FAEE) are the products of non-
oxidative alcohol metabolism. They were found in high amounts in pancreas during 
post-mortem examination of individuals intoxicated with alcohol at the time of 
death
238
. Accumulating evidence supports the view that FAEE are the main 
mediators of ethanol toxicity in the pancreas. FAEE directly induce Ca
2+
 release 
from the intracellular stores, which results in cytosolic Ca
2+
 signals resembling those 
evoked by ACh or CCK. These signals can be blocked by caffeine, which clearly 
suggests involvement of IP3Rs in their generation (Fig. 5.1)
108
. Caffeine is a well 
known activator of RyRs, especially in cells characterised by high expression of 
these receptors, such as skeletal or cardiac muscle cells and neurons, where it 
increases Ca
2+
 release from the ER
239,240
. However, in intact pancreatic acinar cells 
20 mM caffeine does not induce Ca
2+
 release and blocks IP3R-dependent Ca
2+
 
signals
239,241
. A recent study has demonstrated that palmitoleic acid ethyl ester 
(POAEE) induces Ca
2+
 release from the intracellular stores, both the ER and the acid 
store; this release is dependent on type 2 and 3 IP3Rs and is associated with 
intracellular activation of trypsinogen in pancreatic acinar cells
242
. High doses of 
FAEEs can completely deplete the ER and consequently activate store-operated Ca
2+
 
entry mechanisms
243
. In contrast, non-esterified long chain fatty acids, such as 
palmitoleic acid, induce slow Ca
2+
 release from the ER, which is predominantly 
dependent on inhibition of mitochondrial functions and decrease in cellular ATP 
content
109
. This effect, however, can also be responsible for intracellular activation of 
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Fig. 5.1. Calcium responses induced by POAEE 
Palmitoleic acid ethyl ester (POAEE) induces cytosolic Ca
2+
 oscillations, which can 
be blocked by caffeine. The traces (on left) demonstrate typical Ca
2+
 responses 
evoked by intracellular injection (via patch clamp pipette) of POAEE into a 
pancreatic acinar cell (blue trace) and responses of a neighbour cell (red trace). The 
schematic diagram (on right) illustrates possible mechanism of POAEE-induced 
cytosolic Ca
2+
 oscillations, which involves CICR and engagement of IP3Rs and RyRs 
from the endoplasmic reticulum (ER) as well as from the acidic store. [Adapted from 
Criddle DN, 2006; Petersen OH, 2008 and Petersen OH, 2009]
108,243,244
. 
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trypsinogen. Since mitochondria can hydrolyse FAEEs and thus generate FAs, 
interpreting the mechanism of action of FAEEs is not straightforward
107
. It appears 
that a considerable part of toxic effects of FAEEs might involve FAs generated by 
mitochondria. Such combined action of FAEEs and FAs on Ca
2+
 homeostasis is 
especially significant, since FAEEs induce rapid Ca
2+
 release from the intracellular 
stores and FAs affect mitochondrial functions decreasing ATP levels and thus ATP-
dependent Ca
2+
 extrusion mechanisms
243
. 
The evidence for FAEEs being the major mediators of ethanol toxicity does not, 
however, exclude other effects of alcohol on pancreas. Since ethanol induces only 
small and very variable responses of cytosolic Ca
2+
 in intact pancreatic acinar cells 
this chapter provides evidence and explanation for severe effects of ethanol in two 
photon permeabilized acinar cells. 
5.2. Responses induced by ethanol in intact pancreatic acinar cells 
As was previously described by our group, even high concentrations of ethanol exert 
only very modest effects on intact pancreatic acinar cells
243
. The aim of this study is 
to present a detailed comparison of cytosolic Ca
2+
 responses in pancreatic acinar 
cells to 100 mM and 200 mM ethanol. Both concentrations are regarded as relatively 
moderate, with 100 mM being perfectly within the range of ethanol levels obtained 
from blood of individuals caught driving a vehicle while intoxicated with alcohol
245
. 
In the first experiment freshly isolated pancreatic acinar cells were loaded with 
calcium sensitive dye fura-2 and then exposed to 100 mM ethanol. 340/380 nm ratio 
values were recalculated to Ca
2+
 concentration in order to quantitatively compare the 
responses. Cytosolic calcium responses to 100 mM concentration of ethanol can be 
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Fig. 5.2. Calcium responses to ethanol in pancreatic acinar cells 
Cytosolic calcium responses of intact pancreatic acinar cells to ethanol: (A) typical 
trace that shows sustained cytosolic Ca
2+
 elevation upon treatment with 100 mM 
EtOH; (B) The chart compares frequencies of different types of cytosolic Ca
2+
 
responses in pancreatic acinar cells to 100 mM EtOH (n = 18). [Adapted from 
Gerasimenko JV, 2011]
246
. 
  
 
 
167 
 
  
C. 
0.5
0.75
1
1.25
1.5
0 100 200 300 400
F
/F
0
, F
lu
o
-4
Time [s]
200 mM EtOH
 
D. 
0.5
1
1.5
2
2.5
3
3.5
0 200 400 600 800 1000 1200
F
/F
0
, F
lu
o
-4
Time [s]
200 mM EtOH
 
E. 
0
10
20
30
40
50
60
70
T
y
p
e
 o
f 
C
a
2
+
re
s
p
o
n
s
e
to
 2
0
0
 m
M
 E
tO
H
 (
%
 o
f 
to
ta
l)
65 %
Sustained
Ca2+ elevation
No response
19 %
Oscillations
16 %
 
Fig. 5.2. (continues) 
Typical traces showing (C) sustained cytosolic Ca
2+
 elevation and (D) oscillatory 
type of response to 200 mM EtOH; (E) The chart compares frequencies of different 
types of cytosolic Ca
2+
 responses in pancreatic acinar cells to 200 mM EtOH 
(n = 43). [Adapted from Gerasimenko JV, 2011]
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divided into two groups: 56 % of cells (10 out of 18) developed a small sustained 
elevation of cytosolic Ca
2+
, just slightly higher than the baseline level. The average 
amplitude of the elevation was 31 nM ± 6 nM (n = 10). The other 8 cells (44 %) used 
in the experiment did not respond to ethanol at all. The traces are shown in Fig. 5.2.A 
and the chart comparing different types of responses is presented in Fig. 5.2.B. 
In the second experiment freshly isolated pancreatic acinar cells were loaded with 
calcium sensitive dye fluo-4 and subsequently were treated with 200 mM ethanol. 
Again, most of the cells (65 %, 28 out of 43) developed only a tiny sustained 
increase in cytosolic Ca
2+
 (Fig. 5.2.C); and small fraction of the cells (16 %, 7 out of 
43) did not respond to ethanol. Interestingly, 19 % of the cells in the experiment (8 
out of 43) developed delayed oscillatory type of response (Fig. 5.2.D). In these cells 
200 mM ethanol caused the same small rise in cytosolic Ca
2+
 as in the other 65 % of 
cells, but after 200 - 400 s robust cytosolic Ca
2+
 oscillations appeared on the top of 
Ca
2+
 elevation. The results are summarized in Fig. 5.2.E. 
5.3. Responses induced by ethanol in permeabilized pancreatic acinar 
cells 
It is surprising that even though ethanol intake is strongly correlated with acute 
pancreatitis, at the same time alcohol has only a minor effect on pancreatic acinar 
cells. In attempt to address this discrepancy the study was undertaken in order to test 
the exact effects of ethanol on the intracellular stores. For this purpose freshly 
isolated pancreatic acinar cells were loaded with a low affinity calcium sensitive 
indicator, fluo-5N, which preferentially locates into the intracellular stores. 
Subsequently, the cells were permeabilized by short application of two-photon light 
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Fig. 5.3. Responses of the intracellular stores in permeabilized pancreatic acinar 
cells to ethanol 
(A) Typical traces: 100 mM ethanol releases Ca
2+
 from the intracellular stores, which 
is reflected by reduction in Fluo-5N fluorescence (black trace); responses to ethanol 
are reduced by pretreatment of cells with 10 µM ruthenium red (red trace), 100 µM 
2-APB (blue trace), 250 µg/ml heparin (green trace), or mixture of 2-APB and 
ruthenium red (purple trace). (B) The chart compares the average amplitudes of 
responses to 100 mM ethanol in the presence of Ca
2+
 release channel inhibitors. 
Colours of the bars correspond to the traces from (A).The error bars represent 
standard errors of mean. [Adapted from Gerasimenko JV, 2011]
246
. 
  
 
 
170 
 
  
 
 
 
C. 
0
10
20
30
40
50
60
70
1 2 3 4 5 6
∆∆ ∆∆
F
/F
0
, 
%
  
F
lu
o
-5
N
10 20 50 100 400 850
mM EtOH
 
 
 
 
Fig. 5.3. (continues) 
(C) The chart shows average responses of the intracellular stores in permeabilized 
pancreatic acinar cells to different doses of ethanol (10 - 850 mM, n ≥ 6). The error 
bars represent standard errors. [Adapted from Gerasimenko JV, 2011]
246
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at a small region of the plasma membrane. This process led to disruption of 
illuminated region of the membrane and loss of cytosolic content. Successful 
permeabilization does not affect the intracellular stores. Application of 100 mM 
ethanol to permeabilized pancreatic acinar cells resulted in reduction in fluo-5N 
fluorescence of the intracellular stores, as depicted by the black trace in Fig. 5.3.A. A 
similar response has been previously recorded to palmitoleic acid ethyl ester
242
. 
Further, permeabilized pancreatic acinar cells were treated with different 
concentrations of ethanol (10 - 850 mM), all of which evoked marked dose-
dependent responses (depicted in Fig. 5.3.C). Therefore permeabilized cells exhibit 
increased sensitivity to ethanol levels as compared with intact pancreatic acinar cells. 
Average amplitudes of responses to ethanol (27.7 % ± 5.7 SE, n = 6, dark gray bar) 
and ethanol in the presence of Ca
2+
 receptor blockers are compared in Fig. 5.3.B, 
while typical traces are shown in Fig. 5.3.A. The responses evoked by ethanol in 
permeabilized cells were mediated by calcium release channels: IP3Rs and RyR. 
Application of 100 µM 2-aminoethoxydiphenyl borate (2-APB) or 250 µg/ml 
heparin, (both are effective blockers of IP3Rs), significantly reduced ethanol-elicited 
Ca
2+
 release from the intracellular stores (Fig. 5.3.B, 6.3 % ± 1.5 SE, n = 9 and 8.4 % 
± 0.9 SE, n = 7, for blue and green bar, respectively). Also, a reduction in Ca
2+
 
release was obtained by inhibition of RyRs with 10 µM ruthenium red (Fig. 5.3.B, 
10.2 % ± SE, n = 6, red bar). Simultaneous inhibition of both receptors resulted in 
even more reduction of Ca
2+
 release induced by ethanol than inhibition of RyRs 
alone (Fig. 5.3.B, 6.1 % ± 0.5 SE, n = 5, purple bar; p < 0.02). Responses of the 
intracellular stores to 10 µM thapsigargin are provided for comparison (Fig. 5.3.B, 
36.7 % ± 1.9 SE, n = 10, light gray bar). 
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5.4. Ethanol-induced responses are dependent on calmodulin 
As described in Chapter 4, calmodulin is an important regulatory protein and an 
efficient intracellular Ca
2+
 sensor. Because of its relatively small size (17 kDa) it is 
very likely to be lost from the cytosol of permeabilized pancreatic acinar cells. 
Therefore calmodulin might be responsible for the difference to ethanol sensitivity 
between intact and permeabilized cells. To test this hypothesis experiments on fluo-
5N-loaded and two-photon permeabilized pancreatic acinar cells were performed and 
the results are summarized in Fig. 5.4.C. 10 mM ethanol alone induces calcium 
release from the intracellular stores (Fig. 5.4.A and C, n = 8). The presence of 
2.5 µM calmodulin in KHEPES solution effectively abolishes responses to 10 mM 
ethanol, but 100 mM ethanol is still able to release calcium from the intracellular 
stores, but the responses are markedly reduced (Fig. 5.4.B and C, n = 9). The 
concentration of CaM in the cytoplasm of intact pancreatic acinar cells is close to 
2.5 µM
247
 and thus  the presence of 2.5 µM calmodulin in KHEPES solution should 
compensate the loss of the intracellular protein. Pretreatment of permeabilized cells 
with both 2.5 µM CaM and 20 µM CaM inhibitor peptide led to restoration of the 
responses to 10 mM ethanol as seen in permeabilized pancreatic acinar cells treated 
with ethanol alone (Fig. 5.4.C, n = 8). Additionally, the effects of calmodulin on 
IP3R-dependent Ca
2+
 release from the intracellular stores were investigated. 
Treatment of permeabilized pancreatic acinar cells with 10 µM IP3 induced Ca
2+
 
release from the stores (Fig. 5.4.C). Preincubation with 2.5 µM CaM led to 
significant inhibition of IP3-elicited responses (Fig. 5.4.C, n = 5). The responses to 
IP3 were restored when permeabilized cells were preincubated with both 2.5 µM 
calmodulin and 20 µM CaM inhibitor peptide (Fig. 5.4.C, n = 5).  
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Fig. 5.4. Effects of calmodulin on ethanol-induced responses in permeabilized 
pancreatic acinar cells 
Calmodulin reduces ethanol-induced responses of the intracellular stores in 
permeabilized pancreatic acinar cells. (A) Typical trace showing that 10 mM EtOH 
releases Ca
2+
 from the intracellular stores in permeabilized cells. (B) The trace 
demonstrates that in the presence of 2.5 µM CaM responses to 10 mM EtOH are 
abolished and responses to 100 mM EtOH are substantially reduced. [Adapted from 
Gerasimenko JV, 2011]
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Fig. 5.4. (continues) 
(C) Summary of the results showing inhibition of ethanol-elicited responses in 
permeabilized cells by CaM (full description in text). [Adapted from 
Gerasimenko JV, 2011]
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5.5. Activation of calmodulin in intact cells protects against ethanol-
induced responses 
Since inhibition of calmodulin abolishes its protective effects on ethanol-induced 
responses in permeabilized pancreatic acinar cells, it can be hypothesised that 
specific activation of intracellular calmodulin in intact cells could potentially 
decrease sensitivity of cells to ethanol. The experiments were preformed on freshly 
isolated fluo-4-loaded pancreatic acinar cells. Control cells were treated with 
200 mM EtOH, which induced three types of responses. As was described above, the 
majority of cells (65 %) responded with clear sustained elevation of baseline; 19 % 
of cells developed robust calcium oscillations on the top of the plateau; and 16 % did 
not respond (Fig. 5.2.E and Fig. 5.5.A). Preincubation with 50 µM calmodulin 
activator CALP-3 resulted in a dramatic decrease in sustained elevation type of 
responses (from 65 % in control to 11 %); whereas the levels of oscillatory responses 
(22 % of cells) remained on the similar level; and as many as 67 % of cell did not 
respond at all (Fig. 5.5.A-C). Further, 100 µM CALP-3 had even stronger effect on 
200 mM ethanol-induced responses. It completely abolished ethanol-elicited 
sustained elevations of baseline; 23 % of cells still developed oscillations, but the 
amplitudes of the transients were dramatically reduced as compared to those 
observed in control cells; finally, 77 % of the cell pretreated with 100 µM CALP-3 
showed no response at all (Fig. 5.5.A and D). Fig. 5.5.E compares the average 
responses in pancreatic acinar cells to 200 mM ethanol (dark blue trace, n = 10) and 
to ethanol in the presence of 100 µM CALP-3 (red trace, n = 18). CALP-3 
substantially reduces alcohol-induced calcium responses in pancreatic acinar cells. 
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Fig. 5.5. Activation of CaM by CALP-3 reduces 200 mM EtOH-induced 
responses in intact pancreatic acinar cells 
(A) The chart compares frequencies of different types of cytosolic Ca
2+
 responses in 
pancreatic acinar cells to 200 mM EtOH, and ethanol in the presence of 50 µM 
CALP-3 or 100 µM CALP-3. (B) Typical trace showing a sustained elevation type of 
calcium response to 200 mM ethanol in the presence of 50 µM CALP-3. 
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Fig. 5.5. (continues) 
(C) Typical trace showing an oscillatory type of calcium response to 200 mM 
ethanol in the presence of 50 µM CALP-3. (D) Typical trace showing small 
oscillations induces by 200 mM ethanol in the presence of 100 µM CALP-3. 
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Fig. 5.5. (continues) 
(E) Average responses to 200 mM EtOH alone (n = 10, dark blue trace) and EtOH in 
the presence of 100 µM CALP-3 (n = 18, red trace). [Adapted from Gerasimenko JV, 
2011]
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5.6. Involvement of the acidic stores in ethanol-induced Ca
2+
 release 
The endoplasmic reticulum is the major calcium store in all cell types. However, 
accumulating evidence indicates that the acidic compartment might also have an 
important input in cytosolic Ca
2+
 responses
53,248
. The acidic compartment is 
particularly significant in pancreatic acinar cells, which contain zymogen granules, 
where substantial amounts of Ca
2+
 and Zn
2+
 are stored
249
. Interestingly, it is known 
that Zn
2+
 uptake into zymogen granules is facilitated by a specific transporter named 
as ZnT2
249
; in contrast, pathways of Ca
2+
 transport are still not fully understood, but 
the evidence shows that they are dependent on vacuolar H
+
 pumps
202
. 
In order to investigate the involvement of the acidic store in calcium responses 
induced by ethanol, pancreatic acinar cells were loaded with fluo-5N and 
permeabilized using two-photon laser. Application of 10 µM thaspigargin inhibited 
the SERCA and led to depletion of the ER store. After calcium baseline levels were 
stabilized, the cells were treated with 100 mM ethanol. Interestingly, ethanol had no 
effect in the basal region of the cell, where the ER is located. In contrast, a 
substantial decrease in fluo-5N fluorescence was observed in the granular area, 
which can be explained as Ca
2+
 release from the acidic compartment (Fig. 5.6.A). 
This experiment demonstrates that the acidic store is involved in ethanol-induced 
calcium responses. 
Subsequently, experiments were designed to further characterise ethanol-elicited 
calcium release from the acidic compartment. First, it was tested whether liberation 
of Ca
2+
 is dependent on low pH of the acidic store. For that purpose 100 nM 
bafilomycin A1 was applied to fluo-5N-loaded permeabilized pancreatic acinar cells 
  
 
 
180 
 
  
in order to inhibit the vacuolar type H
+
 ATPase. After 30 min preincubation with 
bafilomycin A1 and after emptying the ER with thapsigargin, the cells were treated 
with 100 mM ethanol, which failed to induce any response (gray trace, Fig. 5.6.B). 
Importantly, it was previously demonstrated that the presence of bafilomycin A1 
does not affect ER store depletion caused by thapsigargin
250
. The results of the 
experiment indicate that calcium release requires low pH of the acidic store. 
Further, involvement of calcium channels in ethanol-elicited responses was 
investigated on permeabilized pancreatic acinar cells, whose ER store was depleted 
by thapsigargin. The cells were pretreated with inhibitors of IP3Rs: 250 µg/ml 
heparin (n = 6) or 100 µM 2-APB (n = 5) and then 100 mM ethanol was applied. The 
results presented in Fig. 5.6.B (blue and green traces) indicate that IP3Rs are 
involved in Ca
2+
 release from the acidic store, as upon IP3R inhibition the responses 
to ethanol were substantially reduced. When the cells were pretreated with 10 µM 
ruthenium red in order to block RyRs (n = 5), Ca
2+
 responses to ethanol were also 
reduced, but not as much as in case of preincubation with heparin or 2-APB (red 
trace, Fig. 5.6.B). Finally, simultaneous inhibition of IP3Rs and RyRs by 
pretreatment with a mixture of 100 µM 2-APB and 10 µM ruthenium red (n = 5) 
completely abolished Ca
2+
 release from the acidic store in response to 100 mM 
ethanol (purple trace, Fig. 5.6.B). The average amplitudes of responses are compared 
in Fig. 5.6.C. The pharmacological data accumulated on permeabilized pancreatic 
acinar cells suggest that alcohol-induced Ca
2+
 release from the acidic compartment is 
mediated by both IP3Rs and RyRs. 
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Fig. 5.6. Ethanol releases Ca
2+
 from thapsigargin-insensitive acidic store in 
permeabilized pancreatic acinar cells 
(A) The figure compares Ca
2+
 release in the basolateral area (b, red region) and the 
apical area (b, blue region). After depletion of the ER stores with 10 µM 
thapsigargin, 100 mM EtOH releases Ca
2+
 from the granular area containing 
zymogen granules (a, blue trace) but not from the basolateral region, which contains 
mainly the ER (a, red trace). (B) Typical traces showing the effects of 100 mM EtOH 
on the acidic store (granular area), after depletion of the ER with 10 µM 
thapsigargin. 100 mM EtOH is accompanied by various inhibitors: 100 nM 
bafilomycin A1 (gray trace), 10 µM ruthenium red (red trace), 100 µM 2-APB (blue 
trace), 250 µg/ml heparin (green trace) and both 10 µM ruthenium red and 100 µM 
2-ABP (purple trace). [Adapted from Gerasimenko JV, 2011]
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Fig. 5.6. (continues) 
(C) The chart compares the average amplitudes of the responses from (B). The error 
bars represent standard errors of mean. [Adapted from Gerasimenko JV, 2011]
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5.7. Ethanol induces activation of trypsinogen 
Intracellular conversion of trypsinogen to trypsin is one of the main hallmarks of 
acute pancreatitis. BZiPAR (Rhodamine 110, bis-(N-CBZ-L-isoleucyl-L-prolyl-L-
arginine amide), dihydrochloride) is a synthetic substrate for trypsin, which becomes 
fluorescent when the enzyme cleaves two oligopeptide residues. It has been used in 
the past for monitoring of the time course of trypsin activation
251
. Here it has been 
applied as a useful tool for investigation of trypsinogen activation upon treatment 
with ethanol in permeabilized pancreatic acinar cells. BZiPAR was added to the 
perfusion chamber after cell permeabilization and could enter the cytosol of cells 
with disrupted plasma membrane. The cells were exposed to different concentrations 
of ethanol: 10 mM, 50 mM and 100 mM and fluorescence of BZiPAR was measured. 
The results summarized in Fig. 5.7.C show that ethanol induced a dose-dependent 
activation of trypsin. Untreated control cells had only low background activity of 
trypsin (n = 7). Treatment with 10 mM ethanol was associated with small but clear 
activation of trypsin (n = 8); 50 mM ethanol induced higher activity of trypsin, which 
was reflected by increased fluorescence of BZiPAR (n = 5, Fig. 5.7.A); and treatment 
with 100 mM ethanol led to respectively increased activation of trypsin (n = 10) as 
compared to lower doses of alcohol (Fig. 5.7.C). Trypsin activity induced by 
100 mM ethanol treatment was completely abolished in the presence of 0.01 % 
trypsin inhibitor from soybean (n = 6, Fig. 5.7.C). Further, in order to investigate 
whether trypsin activation is dependent on Ca
2+
 signals, treatment with 100 mM 
ethanol was performed in strong Ca
2+
 buffering conditions, where cytosolic Ca
2+
 was 
clamped to physiological levels by application of 2 mM CaCl2 and 10 mM BAPTA. 
Under conditions of clamped calcium 100 mM ethanol did not induce trypsinogen
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Fig. 5.7. Ethanol induces trypsinogen activation 
(A) Typical trace showing trypsinogen activation induced by 50 mM ethanol in 
permeabilized cells. (B) Typical trace demonstrating trypsinogen activation upon 
treatment with 20 nM CCK. 
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Fig. 5.7. (continues) 
(C) The bar chart shows trypsin activation in untreated permeabilized pancreatic 
acinar cells (n = 7, left bar); cells treated with different concentrations of ethanol: 
10 mM (n = 8), 50 mM (n = 5), 100 mM (n = 10); cells stimulated with 20 nM CCK 
(n = 5, blue bar); trypsin activation by 100 mM ethanol in the presence of 0.01% 
trypsin inhibitor from soybean (n = 6); and trypsin activation by 100 mM ethanol in 
conditions of clamped calcium: 10 mM BAPTA and 2 mM CaCl2 (n = 6). Black 
error bars represent standard errors. [Adapted from Gerasimenko JV, 2011]
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conversion to trypsin (n = 6, Fig. 5.7.C). In contrast, supra-maximal dose of CCK 
(20 nM), which is known to induce quick Ca
2+
 release from the intracellular stores, 
was associated with very strong induction of trypsin activity seen as substantial 
increase in BZiPAR fluorescence (n = 5, Fig. 5.7.B and C). 
5.8. Trypsinogen activation by ethanol is inhibited by calmodulin 
As was described above, ethanol-induced Ca
2+
 responses are inhibited by 
calmodulin. Since trypsin activation is dependent on Ca
2+
 release from the acidic 
store, it is expected that conversion of trypsinogen to trypsin should also be blocked 
by calmodulin. Therefore experiments were performed to test the effects of CaM on 
trypsinogen activation in BZiPAR-loaded permeabilized pancreatic acinar cells. In 
control cells 10 mM ethanol (n = 8) induced noticeable trypsin activity (Fig. 5.8.A 
and D). Similar degree of trypsinogen activation by 10 mM ethanol was observed in 
the presence of 2.5 µM CaM and 20 µM CaM inhibitor peptide (n = 5, Fig. 5.8.D). In 
contrast, preincubation of cells with 2.5 µM CaM alone effectively abolished 
trypsinogen activation by 10 mM ethanol (n = 6, Fig. 5.8.B and D). 100 mM ethanol 
induced substantial trypsinogen activation in permeabilized pancreatic acinar cells 
(n = 10, Fig. 5.8.D) and in cells preincubated with both 2.5 µM CaM and 20 µM 
CaM inhibitor peptide (n = 5, Fig. 5.8.D). This effect was markedly reduced in the 
presence of 2.5 µM CaM alone (n = 6, Fig. 5.8.B and D); however, it was not 
abolished. Almost complete inhibition of ethanol-induced trypsinogen activation was 
observed in cells pretreated with 2.5 µM CaM and 100 µM CALP-3 (n = 10, 
Fig. 5.8.C and D). Treatment with 10 µM IP3 results in similar degree of trypsinogen 
activation to that observed upon application of 10 mM ethanol alone (n = 7, 
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Fig. 5.8. Calmodulin inhibits ethanol-mediated activation of trypsinogen 
(A) Typical trace showing 10 mM ethanol-induced trypsinogen activation in 
premeabilized pancreatic acinar cells. (B) Typical trace showing that the presence of 
2.5 µM calmodulin completely abolishes 10 mM ethanol-induced trypsinogen 
activation and substantially reduces 100 mM ethanol-elicited trypsinogen activation 
in permeabilized pancreatic acinar cells. [Adapted from Gerasimenko JV, 2011]
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Fig. 5.8. (continues) 
(C) Typical trace showing that in the presence of 2.5 µM calmodulin and 100 µM 
CALP-3 trypsinogen activation induced by 100 mM ethanol is substantially reduced. 
(D) The chart compares trypsinogen activation in permeabilized pancreatic acinar 
cells upon treatment with 10 mM or 100 mM ethanol in the presence / absence of 
2.5 µM CaM or 20 µM CaM inhibitor peptide; or upon treatment with IP3 in the 
presence / absence of CaM or CaM inhibitor peptide (full description in text). Black 
error bars represent standard error. [Adapted from Gerasimenko JV, 2011]
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Fig. 5.8.D). This effect was inhibited in the presence of 2.5 µM CaM (n = 6), but 
again restored when CaM was accompanied by 20 µM CaM inhibitor peptide (n = 7, 
Fig. 5.8.D). 
The importance of Ca
2+
 release from the acidic store for the process of trypsinogen 
activation is underlined by the fact, that 10 µM IP3 induces significantly less 
trypsinogen activation than 100 mM ethanol, even though IP3 has much stronger 
effect on Ca
2+
 release from the stores. However, IP3 releases Ca
2+
 mainly from the 
ER; its effects on the acidic store are much weaker
242
. 
5.9. Discussion 
Excessive alcohol consumption is strongly correlated with acute pancreatitis. 
However, so far even very high doses of ethanol have been demonstrated to exert 
only minor effects on pancreatic acinar cells
100
. Accumulating evidence supports the 
view that metabolites of ethanol, fatty acid ethyl esters, are the main mediators of 
ethanol toxicity in the pancreas. 
In this chapter it has been shown that ethanol in moderate concentration (100 mM) 
releases Ca
2+
 from the intracellular stores, both the ER and the acidic stores in the 
apical area. Although the effect of ethanol on intact cells is very modest, in 
permeabilized cells ethanol causes substantial dose-dependent Ca
2+
 release from both 
the ER and the acidic store. Further, the results presented in this chapter demonstrate 
that ethanol-induced Ca
2+
 release is crucial for pathological intracellular trypsinogen 
activation. This Ca
2+
 release is mediated and amplified by both RyRs and IP3Rs. The 
apparent discrepancy between modest effects of alcohol on intact pancreatic acinar 
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cells and its powerful effects on permeabilized cells has been here addressed. It is 
now clear that high levels of calmodulin in pancreatic acinar cells act inhibitory 
against ethanol actions on Ca
2+
 release from the intracellular stores in intact cells. In 
permeabilized cells calmodulin is lost and thus its protective effect abates. However, 
the exact mechanism of calmodulin-dependent inhibition of ethanol toxic effects is 
still unclear. It could be speculated that CaM can control Ca
2+
 release through 
regulation of IP3R opening, which has been previously reported
252,253
. 
What is more, the exact effects of calmodulin in the granular region of pancreatic 
acinar cells attract growing interest. It has been already reported that calmodulin is 
recruited from the basolateral cytoplasm to the apical region upon physiological 
stimulation that generates local calcium spikes in the apical pole
247
. Since calmodulin 
attenuates Ca
2+
 release from the intracellular stores and thus inhibits trypsinogen 
activation in zymogen granules, recruitment of CaM to the apical region might be 
viewed as protective mechanism that evolved in pancreatic acinar cells
254,255
. 
Interestingly, activation of calmodulin differs between physiological and 
pathological responses. It was observed that physiological Ca
2+
 oscillations in the 
granular region recruit calmodulin during each Ca
2+
 spike; in contrast excessive 
doses of CCK or ACh result in sustained calcium elevations with only one transient 
phase, and consistently calmodulin is recruited to the apical region only once
247
. That 
suggests importance of increasing phase of Ca
2+
 oscillations in calmodulin 
recruitment to the apical region. 
This study also provides important observations from medical point of view. The 
results on permeabilized cells demonstrate that specific pre-activation of calmodulin 
by calcium-like peptide CALP-3 results in even stronger inhibition of ethanol-
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mediated Ca
2+
 release from the stores and trypsinogen activation than does the 
presence of calmodulin alone in intact cells. Consistently, in Chapter 4 it was shown 
that CALP-3 reduces pathological Ca
2+
 responses, a side effect of BH3 mimetic 
application, and thus promotes pancreatic acinar cell survival. Taken these 
observations together it is conceivable that calmodulin activators might find their 
application as potential therapeutic approach for treatment of pancreatitis or perhaps 
for reduction of adverse effects of ethanol poisoning. 
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CHAPTER 6: 
BCL-2 FAMILY PROTEINS AND PASSIVE CALCIUM LEAK 
FROM THE ENDOPLASMIC RETICULUM 
  
 
 
193 
 
  
Chapter 6: Bcl-2 family proteins and passive calcium leak from the 
endoplasmic reticulum 
 
6.1. Overview of passive calcium leak form the ER 
Passive calcium leak from the ER is probably the most enigmatic process in calcium 
signalling field. Although it is unnoticeable in physiological conditions it can be 
unmasked by inhibition of the SERCA pump by thapsigargin (Fig. 6.1), which 
results in slow release of [Ca
2+
] from the ER, which often is amplified by the 
opening of IP3Rs and RyRs in CICR process. The leak itself, however, is not affected 
by inhibition of IP3Rs, RyRs or Ca
2+
 release by NAADP
175,256
. Up to now the nature 
of passive calcium leak from the ER remains elusive, since it does not appear to be 
mediated by any of the major Ca
2+
-releasing channels and thus the clear-cut evidence 
of the mechanism is still missing. 
However, in the literature data can be found, which demonstrates that passive 
calcium leak at least in some cell types is potentiated by ATP or glutathione
256,257
; 
and inhibited by Ni
2+
, which also blocks certain channels in the plasma membrane
258
. 
Also, the leak shows some temperature dependency, which suggests it might be 
mediated by an unidentified Ca
2+
 channel
258
. Interestingly, the leak rate is maintained 
relatively constant throughout a wide range of calcium concentration in the ER, but 
suddenly decreases when [Ca
2+
]ER drops to micromolar range
174
. The leak rates, 
however, differ in different cell types. In pancreatic acinar cells the leak is relatively
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Fig. 6.1. Passive calcium leak from the intracellular stores 
Recordings of the leak from mag-fura-2-loaded BHK-21 cells, permeabilized with 
streptolysin-O. Ca
2+
 leak can be unmask either by treatment with thapsigargin (upper 
trace) or by lowering of external calcium (lower trace). [Adapted from Hofer AM, 
1996]
256
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slow, up to 19 µM/min
259
; much higher values were found in sensory neurons: 
90 µM/min
260
, or in HeLa cells: 200 µM/min
261
. 
Recently, potential candidate channels for passive Ca
2+
 leak have been attracting a 
lot of attention. Accumulating evidence does not point to one channel; instead few 
candidates and mechanisms have been postulated. It is possible that what is 
perceived as passive ER Ca
2+
 leak is in fact a sum of effects mediated by more than 
one family of membrane proteins. 
One of the candidates includes the translocons, which are protein conducting 
channels present in rough ER membranes. The idea originated from the observation 
that the passive ER calcium leak was stimulated by treatment of pancreatic acinar 
cells with puromycin – an antibiotic that inhibits protein synthesis by premature 
termination of growing polypeptide chain in the ribosome
175
. This indicates that at 
least one component of passive calcium leak could be mediated by translocon 
complex. However, translocon should not be permeable for Ca
2+
 during the 
translocation process, when the channel pore is occupied by growing polypeptide 
chain
262
. Also, when the translocon channel is not engaged in protein synthesis, it is 
closed by the BiP protein at the ER lumen, which excludes the possibility of ion 
transfer
263
. A possible explanation is that Ca
2+
 leak is a consequence of imperfections 
in translocation system, which allows Ca
2+
 ions to escape from the ER. 
Presenilins (PS1 and PS2) are extensively studied proteins due to their involvement 
in pathogenesis of Alzheimer's disease. Mutations in the genes encoding presenilins 
are responsible for the most of familial Alzheimer disease cases
264-267
. Presenilins are 
aspartic proteases, which together with other proteins form γ-secretase complex 
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responsible for regulated intramembrane proteolysis. γ-secretase complex is 
transported to the plasma membrane or endosomes, where it cleaves type I 
transmembrane proteins including amyloid precursor protein. Mutations in 
presenilins might result in a shift in the proteolysis pattern of the latter leading to 
generation of hydrophobic fragments of amyloid, which tend to spontaneously 
aggregate. Some data suggest that presenilins can also function as channels in the ER 
membranes and thus mediate passive Ca
2+
 leak
268
. Therefore, mutations in presenilin 
genes not only affect their proteolytic properties but also might block Ca
2+
 leak 
leading to Ca
2+
 overload in the ER and potentiated release of Ca
2+
 from the store 
upon treatment
269,270
. Hydrophilic catalytic cavity of presenilins could also serve as 
the Ca
2+
 conductance pore
266
. 
Another potential targets responsible for ER Ca
2+
 are polycystins: polycystin-1 
(PKD1) and polycystin-2 (PKD2). Mutations in the genes encoding these proteins 
result in Autosomal Dominant Polycystic Kidney disease characterised by formation 
of cysts in kidney tubules
271
. Both polycystins are transmembrane proteins located to 
the ER membranes as well as the plasma membrane at the primary cilia
272
. PKD1 is 
larger in size with 11 transmembrane domains, as compared to 6 transmembrane 
domains of PKD2. The latter, however, bears substantial similarity to transient 
receptor potential (TRP) channels, and thus it functions as a cation channel and 
perhaps can sustain ER Ca
2+
 leak
273
. What is more, PKD2 was demonstrated to 
interact with IP3Rs and prolong the IP3-elicited Ca
2+
 release
274
. PKD1, on the other 
hand, was shown to bind to STIM1, which caused inhibition of store operated Ca
2+
 
entry
275
 and increased STIM1 interaction with IP3R
276
. 
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Further, a strong link exists between ER Ca
2+
 leak and Bcl-2 family proteins. It was 
demonstrated that overexpression of Bcl-2 protein is associated with a decrease in 
calcium content of the ER, which was explained by increased leakiness of the 
intracellular stores
157,204
. However, the exact mechanism of Bcl-2-dependent Ca
2+
 
leak has not yet been clarified. One of the explanations assumes that Bcl-2 can 
function as an ion channel and thus increased expression of the protein simply 
introduces more leak channels in the ER
204
. Indeed, some members of Bcl-2 family, 
particularly Bcl-xL and Bax, exhibit substantial structural similarities with pore-
forming bacterial toxins
277,278
. Bcl-2 itself was demonstrated to form channels in 
artificial lipid bilayers, capable of conducting Na
+
, but not Ca
2+
, leaving the 
mechanism unclear
279
. Alternatively, Bcl-2 family members instead of being Ca
2+
 
channels themselves might be involved in the regulation of other proteins mediating 
the leak. This chapter provides preliminary data demonstrating possible involvement 
of Bcl-2 family members in the regulation of passive Ca
2+
 leak from the ER in 
pancreatic acinar cells. 
6.2. Loss of Bax protein inhibits BH3 mimetic-induced calcium release 
Data presented in Chapter 3 show that treatment with BH3 mimetics BH3I-2' and 
HA14-1 cause slow Ca
2+
 release from the intracellular stores, which eventually is 
amplified by IP3Rs and RyRs. Although Ca
2+
 release was decreased upon inhibition 
of IP3Rs and RyRs, it was not completely blocked, which suggests the involvement 
of other Ca
2+
 channels in the response to BH3 mimetics. In an attempt to understand 
the nature of the leak and the exact mechanism of its regulation by Bcl-2 family 
proteins the effects of loss of Bcl-2, Bak or Bax proteins on BH3I-2'- or HA14-1- 
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induced calcium plateau were investigated. Pancreatic acinar cells were isolated from 
C57BL/6J wild type mice and from transgenic mice having loss-of-function mutation 
of one of the following genes: bcl-2, bax or bak.  The cells were loaded with AM 
ester form of calcium sensitive fluorescent dye fluo-4, plated into a perfusion 
chamber and perfused with 5 µM BH3I-2' or 30 µM HA14. All experiments were 
performed in NaHEPES solution, which contained no Ca
2+
; therefore all changes in 
cytosolic calcium were dependent only on calcium release from the intracellular 
stores. The results are presented in Fig. 6.2. Upon treatment with 5 µM BH3I-2' wild 
type (n = 12), bak
-/-
 (n = 27) and bcl-2
-/-
 (n = 28) cells responded with a substantial 
increase in cytosolic calcium followed by sustained Ca
2+
 plateau, whereas bax
-/-
 
(n = 20) cells showed significant resistance to the treatment with BH3I-2' and did not 
develop dramatic Ca
2+
 responses (Fig. 6.2.A). In order to quantitatively compare 
Ca
2+
 responses the areas under the traces were calculated between 602 and 1000 s of 
the recorded signals, averaged, normalized to the baseline and presented in 
Fig. 6.2.B. Ca
2+
 responses in pancreatic acinar cells lacking functional Bax were 
almost completely abolished as compared to the wild type cells (p < 0.0001) and 
other knockouts. 
Similarly, treatment with 30 µM HA14-1 led to Ca
2+
 release from the intracellular 
stores and cytosolic Ca
2+
 responses concluded with sustained plateau in wild type 
cells (n = 25), bak
-/-
 (n = 43) and bcl-2
-/-
 (n = 23), but not in bax
-/-
 (n = 17) cells 
(Fig. 6.2.C). The same quantitative analysis was performed as for BH3I-2' treatment 
- the areas under the traces were calculated between 602 and 1000 s of the recorded 
responses, averaged and normalized to the baseline as shown in Fig. 6.2.D. Again,
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Fig. 6.2. Loss of Bax inhibits calcium release caused by BH3I-2' and HA14-1 
(A) The graph shows average calcium responses to 5 µM BH3I-2' in pancreatic 
acinar cells isolated from C57BL6/J wild type (n = 12) mice and animals lacking 
functional Bak (n = 27), Bax (n = 20) or Bcl-2 (n = 28). Error bars represent standard 
errors. (B) The responses to 5 µM BH3I-2' were compared as the average sums of 
relative fluorescence values recorded between 602 and 1000, which corresponds to 
the areas under the curves. Black error bars represent standard errors. 
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Fig. 6.2. (continues) 
(C) The graph shows average calcium responses to 30 µM HA14-1 in pancreatic 
acinar cells isolated from C57BL6/J wild type (n = 25) mice and animals lacking 
functional Bak (n = 43), Bax (n = 17) or Bcl-2 (n = 23). Error bars represent standard 
errors. (B) The responses to 30 µM HA14-1 were compared as the average sums of 
relative fluorescence values recorded between 602 and 1000 s, which corresponds to 
the areas under the curves. Black error bars represent standard errors.  
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Ca
2+
 responses in pancreatic acinar cells lacking functional Bax were dramatically 
lower as compared to the wild type cells (p = 0.002) and other knockouts. 
The results clearly indicate that loss of Bax protein blocks Ca
2+
 responses induced by 
inhibition of anti-apoptotic Bcl-2 members by BH3 mimetics. 
6.3. BH3 mimetic-induced Ca
2+
 release in only partially mediated by 
IP3Rs or RyRs 
As was described in the Introduction, IP3Rs and RyRs are the major types of 
channels responsible for calcium release from the ER in pancreatic acinar cells. In 
permeabilized pancreatic acinar cells inhibition of IP3Rs by 2-APB, or RyRs by 
ruthenium red was associated with a marked decrease in BH3 mimetic-induced Ca
2+
 
release from the intracellular stores. Combined inhibition of both receptors reduced 
responses even more, but did not block them completely (see Chapter 3). Here, 
experiments on freshly isolated intact pancreatic acinar cells were performed. The 
cells were loaded with fluo-4, and then simultaneous inhibition of IP3Rs and RyRs 
together with inhibition of anti-apoptotic Bcl-2 protein with BH3 mimetics was 
applied. It is already well established that in acinar cells 20 mM caffeine and 10 µM 
ruthenium red efficiently block IP3Rs and RyRs, respectively. Therefore, as 
predicted, perfusion of the cells with a mixture of caffeine and ruthenium red 
completely abolishes 10 pM CCK-induced calcium spikes (Fig. 6.3.A). 
In the main experiment pancreatic acinar cells isolated from C57BL6/J wild type and 
bax
-/-
 mice were loaded with fluo-4 AM and then treated with 5 µM BH3I-2' or 
30 µM HA14-1 after short preincubation with 20 mM caffeine and 10 µM ruthenium 
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red. All experiments were performed in NaHEPES solution, which contained no 
Ca
2+
, in order to exclude Ca
2+
 influx from the extracellular environment. The results 
demonstrate that even upon inhibition of both IP3Rs and RyRs treatment with 5 µM 
BH3I-2' induces cytosolic calcium plateau in wild type cells (n = 8, Fig. 6.3.B). As 
predicted, cells lacking functional Bax protein did not develop any responses to 
BH3I-2' in the conditions of the experiment (n = 8). The responses were compared as 
the average sums of relative fluorescence values recorded between 802 and 1200 s, 
which corresponds to the average area under the traces (Fig. 6.3.C). In condition of 
blocked IP3Rs and RyRs treatment with BH3I-2' caused substantial responses in wild 
type cells, whereas bax
-/-
 cells were completely resistant to the BH3 mimetic 
(p = 0.0028). 
Treatment with 30 µM HA14-1 in the presence of caffeine and ruthenium red still led 
to formation of cytosolic calcium plateau in wild type cells (n = 10); however, in 
bax
-/-
 cells (n = 9) the responses were completely abolished (Fig. 6.3.D). The 
comparison of the average areas under the traces recorded between 802 and 1200 s 
demonstrates that the significant difference between responses induced by HA14-1 in 
wild type cells and Bax KOs remains under condition of inhibited IP3Rs and RyRs 
(Fig. 6.3.E, p < 0.0001). 
The results presented here, together with the data from Chapter 3, indicate that BH3 
mimetics, BH3I-2' and HA14-1, release calcium from the intracellular stores primary 
not through IP3Rs / RyRs (Fig. 3.6.A-G) but through a novel mechanism, which is 
dependent on Bax protein. IP3Rs and RyRs only potentiate BH3 mimetic-dependent 
calcium release through the phenomenon of CICR. Since Bcl-2 family proteins were 
suggested to be involved in the regulation of passive Ca
2+
 leak from the ER, it might 
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Fig. 6.3. BH3 mimetic-induced Ca
2+
 release is mediated by IP3Rs and RyRs 
(A) Sample traces showing inhibition of 10 pM CCK-induced Ca
2+
 oscillations by 
application of 20 mM caffeine and 10 µM ruthenium red. Caffeine and ruthenium red 
are efficient blockers of IP3Rs and RyRs, respectively. (B) Average traces showing 
effects of 5 µM BH3I-2' on Ca
2+
 homeostasis in pancreatic acinar cells isolated from 
wild type mice (blue trace, n = 8) and Bax knockouts (red trace, n = 8) under 
inhibition of IP3Rs and RyRs. Error bars represent standard errors. 
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Fig. 6.3. (continues) 
(C) The bar chart shows comparison of the average sums of relative fluorescence 
values recorded between 802 and 1000 (p = 0.0028) in WT and bax
-/-
 cells treated 
with 5 µM BH3I-2' under inhibition of IP3Rs and RyRs (shown in (B)). Black error 
bars represent standard errors of mean. (D) Average traces showing effects of 30 µM 
HA14-1 on Ca
2+
 homeostasis in pancreatic acinar cells isolated from wild type mice 
(blue trace, n = 10) and Bax knockouts (red trace, n = 9) under inhibition of IP3Rs 
and RyRs. Error bars represent standard errors. 
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Fig. 6.3. (continues) 
(E) The bar chart shows comparison of the average sums of relative fluorescence 
values recorded between 802 and 1000 (p < 0.0001) in WT and bax
-/-
 cells treated 
30 µM HA14-1 under inhibition of IP3Rs and RyRs (shown in (D)). Black error bars 
represent standard errors of mean. 
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be speculated that treatment with BH3 mimetics increases release of Ca
2+
 through the 
leak channels. 
6.4. Discussion 
In Chapter 3 it was demonstrated that BH3 mimetics: BH3I-2' and HA14-1 induce 
release of calcium from the intracellular stores, which leads to formation of sustained 
cytosolic calcium plateau in both pancreatic acinar cells as well as in AR42J cells. 
Ca
2+
 release caused by BH3 mimetic was shown not to be exclusively dependent on 
IP3Rs or RyR, because inhibition of both receptors did not block cytosolic calcium 
plateau formation in wild type pancreatic acinar cells. This finding is particularly 
surprising, since it indicates that other Ca
2+
 channels have to mediate Ca
2+
 release 
from the intracellular stores in response to treatment with BH3I-2' and HA14-1. 
Therefore the aim of this chapter was to provide more insights into the mechanism of 
BH3 mimetic-dependent Ca
2+
 responses. Here it has been tested how loss of certain 
Bcl-2 family proteins, Bax, Bak and Bcl-2 itself, would affect responses to 
pharmacological inhibition of anti-apoptotic Bcl-2 protein members. The data 
presented in this chapter reveal that loss of Bax, but not Bak or Bcl-2, has a profound 
effect on Ca
2+
 responses to BH3 mimetic. The responses were markedly reduced and 
in most of the cases BH3I-2' as well as HA14-1 failed to induce any Ca
2+
 release in 
bax
-/-
 cells. At the same time wild type cells developed substantial responses even 
under conditions of inhibited IP3Rs and RyRs. 
The results described here provide a very important observation that could 
potentially be linked to the enigmatic Ca
2+
 leak channel. It seems apparent that loss 
of Bax inhibits Ca
2+
 release in response to BH3 mimetic treatment. The simplest 
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explanation of this phenomenon is that Bax could form a channel, which upon 
inhibition of anti-apoptotic Bcl-2 members mediates slow Ca
2+
 leak from the ER, 
further amplified by main Ca
2+
 release channels: IP3Rs and RyRs. This suggestion is 
supported by the observations that Bax has a similar structure to pore-forming 
bacterial toxins and thus in principle should be able to form ion channels in 
membranes
204,280
. To be able to form a channel permeable to ions, a protein needs to 
have amphipathic helices long enough to span lipid bilayer. Indeed Bax has seven 
helices. Helices α2, α3 and α4 form a hydrophobic groove; helix α1 is connected to 
α2 by a long unstructured loop; and helix α9 binds to the hydrophobic groove of the 
protein hiding both hydrophobic residues of the groove and its own residues inside 
the structure, which increases Bax solubility and makes it possible for the protein to 
be present as a monomer in the cytosol
281
. The two remaining helices α5 and α6 meet 
the criteria for transmembrane fragments and are considered to be a putative pore-
forming domain
282,283
. α5-α6 region is positioned in the core of the protein and is 
characteristic not only for Bax but also for other members of Bcl-2 family such as 
Bcl-2 and Bcl-xL. It has been demonstrated that deletion of homological region to 
α5-α6 in Bcl-2 protein abolishes its ability to form ion conducting channels in 
artificial lipid bilayers
277
. Two α-helices are obviously insufficient to create an 
aqueous pore; and therefore it is unlikely that a single Bax monomer could conduct 
ions across membranes. However, Bax could potentially form dimers or oligomers, 
so α5-α6 regions from more than one protein might efficiently contribute to the pore 
of Bax membrane channel
282
. 
Somewhat in contrast to its ability to form ion pores, it was demonstrated that Bax 
overexpression increases resting Ca
2+
 levels in the ER
204
. It was shown that this 
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effect of Bax is independent on its presumed channel-forming region, as the insertion 
of homological α5-α6 fragment from other Bcl-2 members protein did not change the 
above mentioned effect of Bax on ER Ca
2+
 content
283
. Considering this finding, an 
alternative mechanism might be postulated, which would explain Bax-dependent 
BH3 mimetic-induced Ca
2+
 release from the intracellular stores. Rather than acting 
as a channel itself, Bax could directly or indirectly activate Ca
2+
 leak from the ER 
mediated by other proteins. According to that mechanism application of BH3 
mimetics such as BH3I-2' or HA14-1 increases unbound and activated fraction of 
Bax protein, which in turn acts on a calcium channel in the ER membrane and 
potentiates calcium release from the ER (Fig. 6.4). Importantly, Bcl-2 inhibition is 
absolutely crucial to reveal Bax-dependent Ca
2+
 leak. This indicates that under 
normal conditions anti-apoptotic Bcl-2 members suppress Bax functions related to 
the leak, most likely via sequestration of Bax by Bcl-2 / Bcl-xL. 
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Fig. 6.4. Schematic illustration of possible interactions between Bcl-2 family 
members and calcium channels / pumps 
Bax, which is activated by treatment with BH3 mimetics, either forms a channel in 
the ER membrane or acts on a channel formed by another protein. As a result 
calcium release is induced and subsequently amplified by RyRs and IP3Rs. Inhibition 
of IP3Rs and RyRs by caffeine and ruthenium red eliminates CICR-type of response; 
however calcium leak persists. 
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Chapter 7: The role of Bcl-2 protein in regulation of calcium fluxes 
across the plasma membrane 
 
7.1. Overview of calcium extrusion mechanisms through the plasma 
membrane 
As described in the introduction, movement of Ca
2+
 ions across the plasma 
membrane is strictly regulated and crucial for maintenance of cell functions. In all 
eukaryotic cells calcium extrusion from the cytosol to the extracellular space is 
mainly facilitated by the PMCA, which is a P-type plasma membrane Ca
2+
 pump. 
Na
+
/Ca
2+
 exchanger is an alternative Ca
2+
 extrusion pathway, which is especially 
important in excitable cells, where it exports calcium even more efficiently than the 
PMCA. 
Na
+
/Ca
2+
 exchangers are membrane transporters that utilize Na
+
/K
+
 gradient across 
the plasma membrane to export cytosolic Ca
2+
. They can be divided into two main 
types depending on stoichiometry and nature of exported cations. The transporter 
commonly present in neurons and cardiac cells facilitates exchange of three Na
+
 for 
one Ca
2+
 and is referred as NCX
284
. The other type was originally discovered in 
retinal rods and cones and is named NCKX, since it exchanges four Na
+
 ions from 
the extracellular space for one Ca
2+
 and K
+
 from cytosol
285
. 
The NCX transporter has three known isoforms encoded by different genes (NCX1, 
NCX2 and NCX3)
286,287
; however, they exhibit only minor differences in their 
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biochemical properties. They all have nine transmembrane domains and cytosolic 
Ca
2+
-binding domain located in the middle of the polypeptide. NCX is mainly 
present in heart and neurons, where it is engaged in regulation of intracellular Ca
2+
 
homeostasis. It also prevents pathological Ca
2+
 overload, and thus protects against 
cell death. The NCKX transporter can be found in retinal photoreceptors. 
Interestingly, NCX and NCKX are characterised by different affinity for Ca
2+
. 
NCKX has high affinity and thus controls Ca
2+
 levels at nanomolar range. On the 
other hand, NCX transports large amounts of Ca
2+
 out of the cell but with low 
affinity, which means it efficiently reduces cytosolic Ca
2+
 overload leaving the fine 
tuning of intracellular Ca
2+
 to the PMCA
288
. 
The PMCA is closely related to the SERCA, which is present in the ER membranes 
and functions as the Ca
2+
 store replenishment mechanism. Both Ca
2+
 pumps have 
similar topology - they are single polypeptides with ten transmembrane domains and 
four main cytosolic domains that catalyse phosphorylation of a conserved aspartate 
residue in the core of the pump. This phosphorylation forms a high-energy aspartyl-
phosphoranhydride intermediate required for the conversion between two different 
conformations described as E1 and E2.  In E1 state the pumps have high affinity to 
Ca
2+
 ions at the cytosolic site, whereas conformational change in E2 promotes 
opening of the pumps on the luminal / extracellular site and release of bound Ca
2+
.  
In contrast to the SERCA, which transports two Ca
2+
 ions per one hydrolyzed ATP 
molecule, the PMCA transports only one Ca
2+
 ion per cycle
289
. This is because the 
PMCA has only one Ca
2+
-binding site instead of two
290
. However, the PMCA has 
been reported to be more efficient than the SERCA in decreasing cytosolic [Ca
2+
]
291
. 
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Just like all the other P-type pumps, the PMCA can be inhibited by orthovanadate 
and by lanthanum. 
In mammalian cells four PMCA isoforms can be found, each of which is encoded by 
a separate gene and has a specific expression pattern. PMCA1 and PMCA4 are more 
ubiquitously expressed, whereas PMCA2 and PMCA3 are characteristic for neurons. 
Another level of complexity is introduced by alternative PMCA mRNA splicing, 
which generates additional pump variants. There are two main splicing sites: in the 
first intracellular loop (referred as site A) and in the C-terminus of the pump (site C). 
Splicing at site A most likely influences the membrane targeting of the PMCA
292
; 
whereas C splicing variants might exhibit different sensitivity to calmodulin 
regulation and could specifically interact with additional regulatory proteins
293,294
. 
Under normal physiological conditions the PMCA has very low affinity for Ca
2+
 
(Kd > 10 µM); and therefore it is effectively inactive. Interestingly, the C-terminal 
region of the pump contains a calmodulin-binding domain (CaM-BD), which has an 
autoinhibitory functions. The CaM-BD domain simultaneously interacts with two 
different sites in the main body of the pump: one is located on the second 
intracellular domain, and the other - on the third domain
295
. The binding of 
calmodulin to the CaM-BD disrupts that interaction and abolishes autoinhibition 
leading to the decrease of the Kd to 0.4 - 0.5 µM
296
. Interestingly, certain isoforms of 
the PMCA have higher affinity for calmodulin than the others; for example PMCA2 
binds this regulatory protein 5 - 10 times stronger than PMCA4
297
. Calmodulin 
appears to be the main activator of the PMCA. Other mechanisms of activation 
include for instance phosphorylation at serine, threonine and tyrosine residues. The 
main kinases involved in that process are protein kinase A (PKA), protein kinase C 
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(PKC) and the focal adhesion kinase (FAK)
298-300
. Phosphorylation on its own (in the 
absence of calmodulin) can decrease the Kd to values around 1 µM. What is more, 
modification of a Thr residue in the CaM-BD of the pump by PKC efficiently 
prevents autoihnibition. Another interesting mechanism that modulates PMCA 
activity is based on oligomerization of the pump via the CaM-BDs. It abolishes 
autoinhibition and makes the PMCA insensitive to calmodulin. Such process, 
however, requires relatively high concentration of the pump in the membrane and 
thus is believed to occur only in the caveolae
301
. Finally, phospholipids present in the 
surrounding plasma membrane can influence PMCA activity. Acidic phospholipids 
and polyunsaturated fatty acids interact with two sites of the pump: one is located on 
the CaM-BD, and the other lies within the first cytosolic domain
302
. That leads to 
decrease of the Kd to values close to physiological Ca
2+
 concentration (about 
100 nM). 
In this chapter it is postulated that Bcl-2 family proteins could potentially be novel 
regulators of calcium extrusion across the plasma membrane. This notion is based on 
(1) the fact that Bcl-2 family proteins play crucial roles in the intracellular calcium 
homeostasis by regulating Ca
2+
 fluxes across the ER membrane; and therefore they 
could be expected to influence calcium fluxes across the plasma membrane as well; 
(2) and preliminary data depicted in Fig. 7.1 demonstrating that pancreatic acinar 
cells lacking functional Bcl-2 protein exhibit increased cytosolic Ca
2+
 extrusion 
across the plasma membrane in comparison to control cells. 
Pancreatic acinar cells for the above mentioned experiment were isolated from 
pancreas of wild type and bcl-2
-/-
 mice on C57BL6/J x 129S background. The cells 
were subsequently loaded with AM form of calcium sensitive dye fluo-4, as 
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described in Material and Methods. Combined treatment with 10 µM ACh and 
10 µM thapsigargin was applied in order to quickly empty the intracellular stores and 
inhibit SERCA-dependent Ca
2+
 clearance. Under these conditions Ca
2+
 can only be 
removed from the cytosol through extrusion mechanism of the plasma membrane. 
High dose of ACh makes calcium release mainly dependent on IP3Rs and potentiated 
by CICR process. Importantly, since fluo-4 measurements are non-ratiometric, 
obtained fluorescence values were normalized to the initial values, which fixed the 
baselines at F/F0 = 1. Therefore this approach allows for comparison of amplitudes 
and rates of increase / decrease of calcium responses. However, comparison of 
baseline cytosolic Ca
2+
 concentration is impossible due to the nature of the 
fluorescent dye and normalization of the obtained traces. Nevertheless, the results in 
Fig. 7.1.A, which represent average responses of pancreatic acinar cells from wild 
type mice (blue trace, n = 11) and from Bcl-2 knockout mice (red trace, n = 23) 
clearly show that the latter extrude cytosolic Ca
2+
 much quicker than the wild type 
cells. Fig. 7.1.B compares Ca
2+
 responses in a form of a bar chart. Areas between 
200 s and 400 s under the traces from Fig. 7.1.A were calculated. Baseline values 
correspond to 100 % and any increase above it represents the actual calcium 
response. Since Ca
2+
 remains elevated for longer in wild type cells, their cytosolic 
calcium responses to combined treatment with Tg and ACh appear significantly 
larger than the responses in bcl-2
-/-
 pancreatic acinar cells (p = 0.002). Elevated Ca
2+
 
returned to the baseline levels after about 300 s in wild type cells and after 150 s in 
bcl-2
-/-
 cells. This chapter aims to describe the detailed investigation of that 
interesting phenomenon. 
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Fig. 7.1. Loss of Bcl-2 affects Tg-induced Ca
2+
 responses 
(A) Average traces (with standard errors) showing cytosolic calcium responses to a 
mixture 10 µM ACh and 10 µM thapsigargin in pancreatic acinar cells isolated from 
wild type (blue trace, n = 11) and bcl-2
-/-
 (red trace, n = 23) mice and loaded with a 
calcium sensitive dye fluo-4. 
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Fig. 7.1. (continues) 
(B) The responses from (A) are shown as average sums of fluo-4 fluorescence values 
obtained in the experiment between 200 and 400 s and normalized to the baseline 
(100%), which reflects the difference in areas under the traces from (A) (p = 0.002). 
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7.2. Loss of Bcl-2 affects calcium release from the intracellular stores and 
calcium extrusion from the cytosol 
In order to perform more detailed investigation of the interesting phenomenon 
indicated by the preliminary data, calcium sensitive dye fura-2 was applied instead of 
fluo-4 for fluorescent Ca
2+
 measurements in freshly isolated pancreatic acinar cells. 
In contrast to fluo-4, fura-2 is used for ratiometric measurement of cytosolic calcium 
changes, which enables more reliable comparison of baseline values. What is more, 
together with specific calibration techniques and mathematical calculation (see 
Material and Methods for reference) fura-2 is a dye of choice for estimation of free 
calcium concentrations within the cells. 
In the first experiment fura-2-loaded pancreatic acinar cells were treated with 10 µM 
Tg in order to inhibit the SERCA, empty the ER and induce cytosolic calcium 
increase due to passive Ca
2+
 leak. Average responses with standard errors are 
depicted in Fig. 7.2.A, where blue trace represents responses of wild type pancreatic 
acinar cells (n = 35) and red trace refers to cells isolated from Bcl-2 knockout mice 
(n = 27). The data immediately bring to attention three important observations. First 
of all, similarly to the preliminary results, cytosolic Ca
2+
 extrusion in bcl-2
-/-
 
pancreatic acinar cells is more efficient than in wild type cells. Secondly, baseline 
cytosolic Ca
2+
 values appear to be decreased in bcl-2
-/-
 pancreatic acinar cells as 
compared to the wild type cells, which is indicated by average initial 340/380 ratio 
values. And finally, the average amplitude of the Tg-elicited responses in bcl-2
-/-
 
cells is slightly lower than the amplitude of the same responses in wild type cells. 
Since the ER stores are empty and the SERCA is inhibited, potentiated cytosolic 
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Ca
2+
 extrusion and decreased resting Ca
2+
 levels in bcl-2
-/-
 cells suggest increased 
Ca
2+
 efflux across the plasma membrane. On the other hand, decreased amplitude of 
the responses to Tg might indicate substantial changes of ER calcium content of 
bcl-2
-/-
 pancreatic acinar cells. 
In order to provide a rough comparison of the rates of cytosolic calcium clearance in 
wild type and bcl-2
-/-
 cells, decrease of 340/380 nm-induced fluorescence ratio per 
unit of time was calculated. These values are referred in text as -d(Ratio)/dt and were 
obtained  from Ca
2+
 extrusion phases of the average wild type and bcl-2
-/-
 traces 
shown in Fig. 7.2.A. -d(Ratio)/dt values were then plotted against corresponding 
temporal cytosolic fluorescence ratio values recorded in pancreatic acinar cells. The 
results are presented as a graph in Fig. 7.2.B, where blue and red points represent 
values obtained from wild type trace and bcl-2
-/-
 trace from Fig. 7.2.A, respectively. 
Linear fits were calculated using linear regression least square method. The 
difference between the series is reflected in the equations of the linear fits: 
baxy += . Wild type linear equation is 0008.00019.0 −= xy  and bcl-2
-/-
 is 
0027.00081.0 −= xy . Comparing coefficients a allows for assessment of the rates of 
cytosolic Ca
2+
 extrusion in pancreatic cells isolated from wild type and bcl-2
-/- 
mice. 
Clearly  abcl2-/- > aWT, therefore for the same ratio values the rate of ratio decrease is 
higher in bcl-2
-/-
 cells than in wild type cells. And since the changes of ratio reflect 
the changes of cytosolic Ca
2+
, bcl-2
-/- 
cells clear intracellular Ca
2+
 faster than wild 
type cells. 
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Fig. 7.2. Loss of Bcl-2 increases Ca
2+
 clearance from the cytosol 
(A) Average cytosolic Ca
2+
 responses (with standard errors) to 10 µM thapsigargin in 
pancreatic acinar cells isolated from wild type (blue trace, n = 35) and bcl-2
-/-
 (red 
traces, n = 27) mice and loaded with fura-2. (B) The dependence of rate of fura-2 
ratio decrease on the temporal ratio values in wild type (shown in blue) and bcl-2
-/- 
(shown in red) pancreatic acinar cells, which directly corresponds to calcium 
clearance from the cytosol. -d(Ratio)/dt values were calculated from the average 
traces depicted in (A). 
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7.3. Bcl-2 regulates calcium extrusion across the plasma membrane in 
pancreatic acinar cells. 
In order to fully understand the difference in handling of cytosolic Ca
2+
 elevation 
between bcl-2
-/-
 and wild type pancreatic acinar cells, detailed analysis of calcium 
fluxes in acinar cells was required. That analysis should be based on multiple 
experiments, high n number, and application of mathematical methods in order to 
accurately trace Ca
2+
 changes in the cytosol of the cells. Just like in the previous 
experiment, bcl-2
-/-
 and wild type pancreatic acinar cells were loaded with fura-2 dye 
in order to perform ratiometric calcium measurements. At the beginning of each 
experiment the cells were perfused with 2 µM Tg in the absence of extracellular Ca
2+
 
to inhibit the SERCA and empty the ER stores. Once cytosolic Ca
2+
 returned to the 
basal levels, the extracellular solution (NaHEPES) was rapidly changed from 
nominal 0 Ca
2+
 to 1 mM, 5 mM or 10 mM Ca
2+
. That induced immediate Ca
2+
 influx 
to the cytosol. After the stable cytosolic Ca
2+
 plateau was reached, extracellular Ca
2+
 
was again removed, causing Ca
2+
 efflux from the cytosol via plasma membrane 
extrusion mechanisms. As a result cytosolic calcium concentration returned to the 
baseline values. Examples of the traces recorded in this experiment for both wild 
type and bcl-2
-/-
 acinar cells are shown in Fig. 7.3.A (nWT = 45, nbcl2-/- = 109). In 
order to assess differences in calcium fluxes between wild type and bcl-2
-/-
 cells, the 
recovery phase of the high calcium transient from every trace was fitted with 
exponential decay function using Origin Pro 8 and the non-linear least-squares 
method: 
( )[ ]τ/exp 00 xxAyy −−×+=  
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Symbols: 
0x  – time at the peak 
0y  – resting calcium concentration 
τ – the decay time constant 
A – the amplitude associated to each exponential component 
Further, the derivatives -d[Ca
2+
]/dt were calculated from the fits and then plotted as 
functions of [Ca
2+
] values obtained from the exponential fits. Initial -d[Ca
2+
]/dt 
values obtained for the highest cytosolic [Ca
2+
] from each trace were collected and 
plotted together on a separate graph as single points. Each point referred to a 
different cell. Then linear regression fits were found, one for wild type and the other 
for bcl-2
-/-
 cells (Fig. 7.3.B). The results clearly demonstrate that calcium elevations 
in the cytosol induce much quicker calcium extrusion in bcl-2
-/-
 cells as compared to 
wild type cells. 
Above presented results indicate that Bcl-2 protein plays a role in regulation of 
calcium extrusion in pancreatic acinar cells. It could also be suspected that Bcl-2 
simultaneously controls calcium influx to the cytosol from the extracellular space in 
the process of store-operated Ca
2+
 entry; however this notion requires further 
investigation. In this experimental setup upon inhibition of the SERCA and with 
nominal 0 Ca
2+
 in the extracellular solution, influx component was removed and all 
changes in cytosolic Ca
2+
 were solely dependent on extrusion mechanism across the 
plasma membrane. Therefore it can be concluded that Bcl-2 protein is involved in 
regulation of calcium extrusion across the plasma membrane of pancreatic acinar 
cells. 
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Fig. 7.3. Bcl-2 regulates Ca
2+
 extrusion across the plasma membrane 
(A) Example traces showing cytosolic calcium extrustion after removal of high Ca
2+
 
from the external solution. The ER store was initially depleted with 2 µM 
thapsigargin in the absence of external Ca
2+
 and then cells were exposed for 400 s to 
10 mM CaCl2, which caused an increase in cytosolic Ca
2+
. Cytosolic Ca
2+
 returned 
towards basal values after removal of extracellular Ca
2+
. Responses of wild type cells 
are shown in blue and bcl-2
-/-
 in red.  
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Fig. 7.3. (continues) 
(B) The dependence of initial rate of cytosolic calcium extrusion (calcium decrease 
in time) on the cytosolic Ca
2+
 plateau levels in wild type (blue, n = 34) and bcl-2
-/-
 
(red, n = 109) pancreatic acinar cells. High cytosolic Ca
2+
 is cleared faster in 
pancreatic acinar cells lacking Bcl-2 as compared to wild type cells.  
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7.4. Cytosolic calcium extrusion in pancreatic acinar cells is mainly 
dependent on the plasma membrane calcium-activated ATPase 
The role of Bcl-2 protein in regulation of cytosolic Ca
2+
 has been clearly 
demonstrated. However, the exact mechanism is yet to be determined. In general, 
cytosolic Ca
2+ 
can be extruded across the plasma membrane by two proteins: the 
plasma membrane calcium-activated ATPase (PMCA) and the sodium-calcium 
exchanger (NCX)
288
. Therefore it is crucial to understand, (1) what the input of each 
of these mechanisms is in the overall cytosolic Ca
2+
 clearance in pancreatic acinar 
cells; (2) and which of those mechanisms is influenced by Bcl-2. In the literature it 
has already been stated that in Ca
2+
 transport in acinar cells Na
+
/Ca
2+
 exchange plays 
only a minor role, if any at all
303
. In this case calcium export across the plasma 
membrane should be mainly facilitated by the PMCA; and therefore the PMCA 
should also be the target for the Bcl-2-dependent regulation. However, this notion 
requires experimental confirmation, which is the main task of this chapter. 
In order to assess the input of Na
+
/Ca
2+
 exchange in the overall Ca
2+
 extrusion in 
pancreatic acinar cells two different experiments were designed. The first experiment 
aimed to inhibit the NCX without affecting PMCA functions. Unfortunately, up to 
now there is no specific inhibitor available, which would selectively target the NCX. 
Some compounds have been synthesised such as SEA400 and KB-R7943; however 
they are not suitable for complete blockage of all isoforms of the NCX
288
. Since the 
NCX functions are dependent on the presence of extracellular Na
+
, indirect inhibition 
of the exchanger could be achieved by complete substitution of Na
+
 with NMDG
+
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(N-methyl D-glucamine) in the extracellular solution. In fact, this approach was 
frequently used in the past
304,305
. 
Freshly isolated pancreatic acinar cells were loaded with calcium sensitive dye fura-
2. Similarly to the previous experiments, the cells were initially perfused with 
NaHEPES solution containing no Ca
2+
; and that was followed by treatment with 
2 µM Tg in order to block the SERCA and empty the ER. After Tg-induced cytosolic 
Ca
2+
 elevation returned to the resting levels, extracellular NaHEPES solution was 
replaced by NMDG-HEPES with no Ca
2+
. Then, the cells were exposed to 5 mM 
Ca
2+
, which induced rapid influx of Ca
2+
 to the cytosol. Abrupt removal of 
extracellular Ca
2+
 resulted in cytosolic Ca
2+
 clearance. Fig. 7.4.A shows the average 
control trace (n = 18) and Fig. 7.4.B depicts the average trace under conditions of 
Na
+
 substitution with NMDG
+
 (n = 24). In both cases removal of 5 mM CaCl2 form 
the extracellular solution results in comparable average rates of cytosolic calcium 
extrusion (shown in Fig. 7.4.C). 
The second experiment aimed to specifically inhibit the PMCA without affecting 
NCX functions. As it was mentioned in Chapter 7.1, P-type pumps can be efficiently 
inhibited by orthovanadate and by lanthanum. However, this inhibition targets many 
proteins, not just the PMCA. Recently a novel class of selective PMCA inhibitors has 
been developed. They are called caloxins, and are peptide-based inhibitors selective 
for different PMCA isoforms
306
. Unfortunately, they are characterised by relatively 
low affinity for the pump and thus their application in this study would be limited. 
Therefore La
3+
 appears to be a much better choice, although it targets other P-type 
pumps in the cells.  
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Fig. 7.4. Involvement of the PMCA and the NCX in Ca
2+
 extrusion in pancreatic 
acinar cells 
(A) Average trace showing cytosolic calcium extrusion in pancreatic acinar cells 
after removal of high extracellular Ca
2+
 in the presence of external Na
+
 (n = 18; bars 
are standard errors). Initially the ER store was depleted with 2 µM thapsigargin in 
the absence of external Ca
2+
. (B) Average trace recorded in pancreatic acinar cells 
using similar protocol as in (A); however here extracellular Na
+
 was substituted by 
NMDG
+
 200 s before application of 5 mM Ca
2+
 in order to inhibit the NCX (n = 24; 
bars are standard errors). 
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Fig. 7.4. (continues) 
(C) The comparison of calcium extrusion phases from traces depicted on (A) and 
(B). Cytosolic calcium extrusion across the plasma membrane in pancreatic acinar 
cells is independent on the presence of Na
+
 in the extracellular solution. Therefore 
Na
+
/Ca
2+
 exchange does not play a major role in Ca
2+
 export. (D) Average trace 
showing inhibition of cytosolic calcium extrusion in pancreatic acinar cells upon 
treatment with 1 mM La
3+
, which is a blocker of the PMCA. (n = 12; bars represent 
standard errors). Similarly to (A) and (B) the ER was emptied by thapsigargin and 
the cells were exposed to 5 mM Ca
2+
. 1 mM La
3+
 was applied on top of cytosolic 
Ca
2+
 plateau. 
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For the purpose of the experiment, the cells were loaded with fura-2 dye and the ER 
was depleted by application of 2 µM Tg in NaHEPES solution with no Ca
2+
. When 
Tg-elicited Ca
2+
 elevation was completely cleared, 5 mM CaCl2 was used to induce 
high cytosolic calcium plateau. Then 1 mM LaCl3 was applied. In such high 
concentration lanthanum is a very potent blocker of the PMCA. Indeed its presence 
effectively inhibited all cytosolic calcium extrusion after removal of 5 mM CaCl2 
(Fig. 7.4.D). Removal of lanthanum by perfusion with fresh NaHEPES solution led 
to recovery of Ca
2+
 extrusion and caused the return of cytosolic Ca
2+
 to the resting 
levels. 
Both above described approaches, PMCA inhibition and Na
+
 substitution for 
NMDG
+
, independently confirm that Na
+
/Ca
2+
 exchange plays very little role in 
cytosolic Ca
2+
 extrusion in pancreatic acinar cells. Therefore effects of Bcl-2 on 
calcium extrusion are associated with PMCA functions. 
7.5. Bcl-2 regulates calcium extrusion independently on its roles in 
mitochondria 
Bcl-2 localizes both to mitochondria and to the ER, and is widely recognized for its 
anti-apoptotic functions associated with mitochondria. Further, mitochondria are 
engaged in regulation of many cell processes; they generate most of intracellular 
ATP; they are involved in cell death, growth and differentiation; what is more, they 
are known to efficiently buffer cytosolic calcium
307
. Loss of Bcl-2 protein might 
potentially affect mitochondrial functions; therefore it is possible that observed 
differences in calcium extrusion between wild type pancreatic cells and bcl-2
-/- 
cells 
are in fact a result of changes in conditions of mitochondria or ATP metabolism. In 
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order to exclude this possibility, cytosolic calcium clearance was investigated under 
conditions, where mitochondrial Ca
2+
 buffering functions were abolished. This can 
be achieved by selective inhibition of mitochondrial Ca
2+
 uniporter by a compound 
called Ru360. 
First, a control experiment was performed, which aimed to test whether Ru360 can 
eliminate mitochondria involvement in Ca
2+
 responses. Freshly isolated pancreatic 
acinar cells were loaded with rhod-2, a calcium sensitive dye, which preferentially 
localizes to mitochondria. Since the measurements were performed in intact cells, a 
fraction of the dye was also present in the cytosol and thus recorded mitochondrial 
Ca
2+
 responses in fact contained both mitochondrial and cytosolic components. 
Pancreatic acinar cells were preincubated with 10 µM Ru360 to block mitochondrial 
Ca
2+
 uniporter; and 10 µM ACh was used to induce rapid Ca
2+
 release from the 
stores. Mitochondrial and cytosolic responses to ACh were recorded in both Ru360-
treated cells and control (untreated) cells. The results are presented in Fig. 7.5.A. 
Mitochondrial responses of control cells (red trace, n = 9) are markedly longer with 
delayed clearance phase than cytosolic responses (dark blue trace, n = 6). 
Preincubation with Ru360 eliminates the actual mitochondrial component from the 
responses recorded on mitochondria (yellow trace, n = 6), leaving only cytosolic 
component similar to the responses recorded in the cytosol in the presence of Ru360 
(light blue trace, n = 5) (Fig. 7.5.A). This control experiment demonstrates that 
Ru360 is a potent blocker of mitochondrial Ca
2+
 uniporter and can indeed exclude 
the involvement of mitochondria in cytosolic Ca
2+
 responses. 
In order to investigate Ca
2+
 fluxes under inhibition of mitochondrial Ca
2+
 uniporter, 
pancreatic acinar cells were loaded with fura-2. After preincubation for 200 s with
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Fig. 7.5. Condition of mitochondria does not markedly affect Ca
2+
 extrusion 
(A) Average traces showing calcium responses in mitochondria and in the cytosol to 
10 µM acetylcholine in control cells and cells pretreated with 10 µM Ru360. 
Responses of control cells are presented as red (mitochondria, n = 9) and dark blue 
(cytosol, n = 6) traces; whereas responses of Ru360-pretreated cells are shown in 
yellow (mitochondria, n = 6) and light blue (cytosol, n = 5). Bars represent standard 
errors. (B) Average traces comparing cytosolic calcium responses after store 
depletion with 4 µM thapsigargin in control cells (n = 19, blue trace) and cells 
pretreated with 10 µM Ru360 (n = 19, red trace). Bars are standard errors. 
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C. 
 
 
 
Fig. 7.5. (continues) 
(C) The dependence of rate of cytosolic Ca
2+
 extrusion on the temporal Ca
2+
 level in 
control (blue line) and Ru360-pretreated (red line) pancreatic acinar cells. 
-d([Ca
2+
])/dt values were obtained from average traces depicted in (B). 
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10 µM Ru360, the ER was emptied by application of 4 µM Tg in NaHEPES solution 
containing no Ca
2+
. After the return of Tg-induced cytosolic Ca
2+
 increase to the 
basal levels, extracellular Ca
2+
 concentration was changed from 0 to 5 mM CaCl2, 
which induced rapid Ca
2+
 influx to the cytosol. Then the extracellular solution was 
changed again to NaHEPES with no Ca
2+
 leading to Ca
2+
 extrusion from the cytosol. 
Fig. 7.5.B shows response patterns recorded in control cells and cells treated with 
Ru360. Although the amplitudes of cytosolic Ca
2+
 elevations clearly differ, the rates 
of Ca
2+
 extrusion (calculated as described in Chapter 7.3) are similar for both control 
conditions and inhibition of mitochondrial calcium uniporter (Fig. 7.5.C). In 
summary this experiment demonstrates that although mitochondria are involved in 
cytosolic Ca
2+
 responses, they do not substantially affect Ca
2+
 export across the 
plasma membrane. Therefore it is very unlikely that increased rate of cytosolic 
calcium extrusion in bcl-2
-/-
 is a result of changed mitochondrial functions by loss of 
Bcl-2 protein. 
7.6. Bcl-2 regulates resting calcium levels in the cytosol and in the ER 
One of the observations from calcium extrusion experiments described in Chapter 
7.2. was the clear difference in the resting cytosolic Ca
2+
 levels between bcl-2
-/-
 cells 
and wild type cells. Detailed comparison of the baseline calcium levels from wild 
type and bcl-2
-/-
 traces revealed that loss of Bcl-2 protein in pancreatic acinar cells 
was associated with significantly lower basal cytosolic calcium concentration 
(57.5 nM ± 3 SE) as compared to wild type cells (100.3 nM ± 5.6 SE). The 
difference is illustrated in Fig. 7.6.A. Calcium extrusion is one of the main 
mechanisms responsible for the maintenance of cytosolic calcium levels
303
. 
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Therefore one of the possible explanations of this phenomenon is increased activity 
of calcium pumps in bcl-2
-/-
 pancreatic acinar cells, which obviously would be in 
agreement with observed differences in cytosolic calcium clearance between the Bcl-
2 KO cells and wild type cells. Additionally, resting cytosolic calcium concentration 
can be influenced by changes in calcium content and release from the ER. In the 
literature there is an established agreement that Bcl-2 protein indeed regulates Ca
2+
 
levels in the ER; however the exact mechanism appears to be complex and we only 
begin to understand some of the aspects of Bcl-2-dependent regulation. The most 
popular approach of [Ca
2+
]ER assessment is indirect, since it is based on comparison 
of Ca
2+
 release from the intracellular stores. The aim of this part of the study was to 
present direct and thus more accurate measurements of Ca
2+
 in the ER. For this 
purpose an independent analysis of ER calcium concentration in stabilized rat 
pancreatic cancer cell line AR42J was conducted. Although morphologically slightly 
different from freshly isolated pancreatic acinar cells, AR42J cell line is a relatively 
good model of pancreatic cells, which was frequently used by our research group on 
multiple occasions
44,207
. For accurate [Ca
2+
]ER measurements AR42J cells were 
transfected with ER-targeted cameleon plasmid, which is a calcium sensitive probe. 
ER-cameleon consists of two fluorescent components: CFP and YFP, separated by 
Ca
2+
-responsive motif constructed from modified calmodulin and calmodulin 
binding peptide M13
83,308,309
. Calcium binding leads to conformational change of 
ER-cameleon probe resulting in a new orientation of its fluorescent components CFP 
and YFP, which increases fluorescence resonance energy transfer (FRET) between 
them. That leads to decrease in cyan fluorescence and increase in yellow 
fluorescence, which allows ratiometric measurements of calcium changes in the ER. 
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Exclusive expression of cameleon probe in the ER is accomplished both by (1) N-
terminal calreticulin signal sequence that targets the protein to the ER on the first 
place and (2) C-terminal ER retention sequence KDEL, which ensures that the probe 
will remain in the ER. The expression pattern of ER-cameleon in AR42J cells is 
shown in Fig. 7.6.B. Blue colour represents cyan component and yellow - YFP 
fluorescence. 
In order to test the effects of Bcl-2 overexpression on ER calcium levels, AR42J cells 
were stably transfected with pcDNA3 plasmid with human bcl-2 insert. At the same 
time transient transfection with Bcl-2 siRNA was performed to attenuate Bcl-2 
expression in AR42J cells. For the purpose of experiments untransfected AR42J cells 
were used as a control for the effects of overexpression; whereas cells transiently 
transfected with scrambled siRNA served as reference for Bcl-2 silencing. All the 
cells were plated on small 60 mm
3
 glass-bottom petri dishes and transiently 
transfected with ER-targeted cameleon plasmid. In fact transfections with the 
plasmid and siRNAs were performed simultaneously. In each group cells expressing 
cameleon plasmid were visualized using Leica confocal microscope. Images of 
yellow and cyan fluorescence were taken from a number of untreated cells (from 
62 to 97 per group) and YFP/CFP ratio was calculated. The ratio directly reflects the 
resting ER calcium levels in AR42J cells. Additionally, in each group some of the 
cells were treated with 20 µM cyclopiazonic acid (CPA), a fungal toxin that similarly 
to thapsigargin blocks the SERCA. CPA causes inhibition of store replenishment; 
and since the passive Ca
2+
 leak continues, treatment with CPA leads to ER depletion 
of calcium. Therefore application of CPA allows for assessment of the total amount 
of releasable Ca
2+
 in the ER. Fig. 7.6.C shows average YFP/CFP ratio values 
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obtained in resting conditions and after CPA treatment in untransfected AR42J cells 
(dark gray and light blue bar, respectively); and in AR42J cells overexpressing Bcl-2 
(dark green and light green bar). Fig. 7.6.D shows average YFP/CFP ratio values 
obtained in resting conditions and after CPA treatment in AR42J cells transfected 
with Bcl-2 siRNA (presented as red bars) or control (scrambled) siRNA (blue bars). 
Bcl-2-dependent differences in resting [Ca
2+
]ER are presented as ∆YFP/CFP ratio 
values obtained by subtraction of average "after CPA" values in each group from 
resting YFP/CFP ratio values; normalized to the appropriate controls (Fig. 7.6.E). 
Overexpression of Bcl-2 caused a statistically significant decrease in resting Ca
2+
 
concentration in the ER (untransfected AR42J 1.00 ± 0.018 SE, n = 78; Bcl-2-
overexpressing AR42J 0.83 ± 0.013 SE, n = 97, p < 0.001). In contrast, silencing of 
Bcl-2 expression in AR42J cells resulted in elevated levels of resting Ca
2+
 in the ER 
(AR42J cells transfected with control siRNA: 1.00 ± 0.015 SE, n = 69; cells 
transfected with Bcl-2 siRNA: 1.10 ± 0.014 SE, n = 62, p < 0.001). These results 
demonstrate that attenuated expression of Bcl-2 protein causes opposite effects on 
the resting Ca
2+
 levels in different cell compartments: a decrease in the cytosol and 
an increase in the ER. Therefore it seems unlikely that changes in cytosolic calcium 
are only a secondary effect to Bcl-2-dependent changes in the ER calcium. At this 
point it might be speculated that Bcl-2 regulates both Ca
2+
 pumps: the PMCA in the 
plasma membrane and the SERCA in the ER membranes. Loss of Bcl-2 protein 
results in increased activity of both pumps, leading to potentiated Ca
2+
 uptake to the 
intracellular stores and increased Ca
2+
 export from the cell. 
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Fig. 7.6. Bcl-2 regulates resting Ca
2+
 levels in the cytosol and in the ER 
(A) Comparison of the initial (resting, baseline) cytosolic calcium levels in wild type 
pancreatic acinar cells (blue bar, n = 34) and bcl-2
-/-
 cells (red bar, n = 109, 
p < 0.0001). The values were obtained from the experiment depicted in Fig. 7.3. 
(B) Two AR42J cells transfected with ER-targeted cameleon. Blue colour represents 
CFP fluorescence and yellow colour - YFP. On the right: a transmitted light image of 
the AR42J cell doublet. 
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Fig. 7.6. (continues) 
The charts show initial YFP/CFP ratio values reflecting resting Ca
2+
 concentration in 
the ER and final YFP/CFP ratio values obtained upon treatment with 20 µM CPA, 
which corresponds to the ER depleted of calcium. The experiments were performed 
in (C) untransfected AR42J cells (dark gray bar for initial and light gray bar for final 
ratio values) and in AR42J cells stably overexpressing Bcl-2 (dark and light green, 
respectively); (D) AR42J cells transfected with scrambled siRNA (dark and light 
blue bars) and in AR42J cells transfected with Bcl-2 siRNA (dark and light red). 
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Fig. 7.6. (continues) 
(E) Bar chart shows differences in resting levels of Ca
2+
 in the ER (full description in 
text). From the left: gray bar represents control (untransfected) AR42J cells (n = 78); 
green bar refers to stably transfected cells, which overexpress Bcl-2 (n = 97); blue 
bar – AR42J cells transiently transfected with control siRNA (n = 69); red bar – 
AR42J cells transiently transfected with siRNA against Bcl-2 (n = 62). 
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7.7. Bcl-2 is present in close proximity to the plasma membrane 
The results presented so far in this chapter strongly support the hypothesis that Bcl-2 
protein regulates activity of the PMCA. However, the exact mechanism still remains 
obscure. There is not enough data in the literature to state whether regulation of the 
PMCA by Bcl-2 requires direct interaction of the proteins, or is indirect, which 
means that other factors mediate Bcl-2 dependent effects on PMCA activity. Direct 
interaction mechanism could only be postulated if both proteins can be found in close 
proximity that allows binding. Since the proteins are present in different cell 
compartments (the PMCA is localized to the plasma membrane and Bcl-2 is 
associated with mitochondrial and ER membranes) their interaction might seem 
unlikely. However, ER membranes can potentially be found close to the plasma 
membrane and direct interactions between ER and plasmalemmal proteins were 
already demonstrated in the past
310,311
. What is more, cytosolic localization of Bcl-2 
is also a possibility. In order to test whether Bcl-2 might interact with the PMCA, 
intracellular distribution of fluorescently labelled Bcl-2 was investigated. For this 
purpose different approaches based on fluorescent imaging were applied. 
AR42J cells were transfected with pEGFP-Bcl-2 protein as described above. On the 
second day after transfection RPMI medium was replaced with NaHEPES containing 
1.5 µM dextran conjugated with AlexaFluor 647. Dextran does not penetrate into the 
cells, but instead stains the extracellular environment in red. This simple method 
should allow for indirect visualization of the plasma membrane, which obviously 
should be found on the border of red colour from extracellular dextran. Since Bcl-2 
in known to mainly localize to mitochondria, these structures were specifically 
  
 
 
241 
 
  
stained with 50 nM TMRE. Images of AR42J cells were obtained using Leica 
confocal microscope and Leica software. Fig. 7.7.A shows the staining and Bcl-2 
expression pattern in an AR42J cell. It is clear that Bcl-2-GFP is predominantly 
localized to mitochondria, which is shown by the yellow colour on the overlay of 
green fluorescence from GFP and red TMRE (Fig. 7.7.A.e). However, Bcl-2 is also 
present throughout the cell (with exception of the nucleus), which corresponds to the 
ER localization (for comparison see Fig. 3.2.B). A fraction of that Bcl-2 from the ER 
is present very close to the plasma membrane, which is shown by the overlay of red 
and green fluorescence (Fig. 7.7.A.f,i).  
In order to stain the plasma membrane more specifically, AR42J cells were 
transfected with Bcl-2-GFP and simultaneously infected with baculovirus expressing 
RFP targeted to the plasma membrane (Invitrogen, BacMam 2.0 - RFP). On the third 
day after transfection / infection, cell medium was removed and replaced with 
NaHEPES supplemented with 1 mM Ca
2+
. AR42J cells were visualized using Leica 
confocal system. Fig. 7.7.B shows an image of two AR42J cells expressing both Bcl-
2-GFP and RFP at the plasma membrane, which is depicted by green and red colour, 
respectively. The overlay of green and red fluorescence (Fig. 7.7.B.c) demonstrates 
that Bcl-2-GFP is expressed close enough to the plasma membrane that allows green 
and red colour on the picture to merge into yellow. Further, Bcl-2-GFP and RFP 
fluorescence values were obtained from a cell cross-section (see white line in 
Fig. 7.7.B.c) and presented on the graph as function of distance (Fig. 7.7.C). Peaks at 
the red trace (RFP fluorescence) indicate localization of the plasma membrane. 
Importantly, these red peaks overlap with green peaks from Bcl-2-GFP traces, which 
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Fig. 7.7. Bcl-2 is present in close proximity to the plasma membrane 
(A) A single AR42J cell transfected overexpressing Bcl-2-GFP. (A.a) Transmitted 
light image of the cell. (A.b) Mitochondria were visualized using 50 nM TMRE (red 
colour). (A.c) Extracellular space was stained with 1.5 µM dextran AlexaFluor (red 
colour). (A.d) Expression of Bcl-2-GFP is shown in green. (A.e) Overlay of 
fluorescence of TMRE (red) and Bcl-2-GFP (green) shows that most of Bcl-2 is 
concentrated in mitochondria. (A.f) Overlay of fluorescence of dextran AlexaFluor 
(red) and Bcl-2-GFP (green). (A.g-i) Magnification of the marked part of the cluster 
from (f): (A.g) shows Bcl-2-GFP fluorescence (green) of the marked fragment; (A.h) 
shows red dextran fluorescence; and (A.i) is an overlay of (g) and (h), where yellow 
colour demonstrates that fraction of Bcl-2-GFP is located close to the plasma 
membrane. 
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Fig. 7.7. (continues) 
(B) Two AR42J cells transfected with pcDNA3 Bcl-2-GFP plasmid and infected 
with baculovirus (BacMam 2.0) expressing RFP targeted to the plasma membrane. 
(B.a) Expression of Bcl-2-GFP is shown in green and (B.b) RFP fluorescence is 
shown in red. (B.c) Overlay of red fluorescence of membrane RFP and green Bcl-2-
GFP results in yellow colour at the plasma membrane. (C) The graph shows 
fluorescence of Bcl-2-GFP (green trace) and RFP (red trace) collected from the 
cross-section depicted by the white line on image (B.c). RFP peaks indicate location 
of the plasma membrane and they overlap with Bcl-2-GFP. 
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Fig. 7.7. (continues) 
(D) Figure shows a section of a pancreatic acinar cell transiently expressing Bcl-2-
GFP: (D.a) green colour represents fluorescence of Bcl-2-GFP; (D.b) red colour at 
the edge of the cell comes from FM 1-64 dye, which specifically stains the plasma 
membrane. (D.c) Overlay of green and red fluorescence demonstrates close 
localization of Bcl-2-GFP and the plasma membrane (yellow colour). 
 
  
 
 
245 
 
  
can be explained as accumulation of Bcl-2 protein in close proximity to the plasma 
membrane in AR42J cells. 
Demonstrating close localization of Bcl-2 and the plasma membrane is particularly 
challenging in pancreatic acinar cells due to their very low efficiency of transfection 
as well as short lifespan when cultured. Nevertheless, the attempts were undertaken 
to express GFP-tagged Bcl-2 protein in overnight cultured acinar cells. Transfection 
of pancreatic acinar cells with Bcl-2-GFP plasmid was performed by electroporation 
using Amaxa Kit and following the manufacturer's protocol. Subsequently the cells 
were plated onto 5 cm
3
 glass bottom petri dishes. After overnight incubation at 32
o
C, 
the cell membrane was stained with FM 1-64 dye and images of the cells exhibiting 
green fluorescence were taken. On average there was at least one transfected cell per 
petri dish. In Fig. 7.7.D a section of a life pancreatic acinar cell expressing Bcl-2-
GFP is presented, which shows that green fluorescence from the fusion protein 
partially overlaps with red fluorescence of the plasma membrane. That makes 
possible the speculation of direct interaction between Bcl-2 and the PMCA in 
pancreatic acinar cells. 
7.8. Bcl-2 is localized in close proximity to the PMCA at the plasma 
membrane in AR42J cells 
As it was demonstrated above, Bcl-2 can localize in close proximity to the plasma 
membrane in life AR42J cells as well as in pancreatic acinar cells. For confirmation 
of those results, immunostaining in fixed cells was performed. AR42J cells were 
plated onto 13 mm glass cover slips, which were placed at the bottom of separate 
wells in 24-well plate. The cells were transiently transfected with Bcl-2-GFP plasmid 
  
 
 
246 
 
  
using PromoFectin 2000 as described above and incubated in tissue culture incubator 
for 24 h in order to allow the cells to attach and produce detectable levels of Bcl-2-
GFP fluorescence. On the second day after transfection the cells were fixed with ice-
cold methanol for immunostaining as described in Chapter 2. The PMCA was 
specifically stained with primary mouse anti-PMCA antibody followed by secondary 
goat anti-mouse antibody conjugated to AlexaFluor 635. After 24 h incubation at 4
o
C 
the cells were visualized using confocal imaging system. A small cluster of AR42J 
cells is shown in Fig. 7.8.A, where green colour demonstrates the fluorescence of 
GFP and thus distribution of Bcl-2 protein; and the PMCA staining is depicted in red. 
The overlay in Fig. 7.8.A.c shows close localization of Bcl-2 and the PMCA. 
Fig. 7.8.A.d presents transmitted image of the cells. Just like in the example in 
Chapter 7.7., Bcl-2-GFP and AlexaFluor 635 fluorescence values were obtained from 
a cell cross-section (see white line in Fig. 7.8.A.c) and presented on the graph as 
function of distance (Fig. 7.8.B). Peaks at the red trace indicate localization of the 
PMCA and they overlap with green traces of Bcl-2-GFP fluorescence. 
Finally, immunostaining in fixed pancreatic acinar cells was performed. Following 
methanol fixation and removal of unspecific binding sites (as described in Materials 
and Methods) Bcl-2 was stained with primary rabbit anti-Bcl-2 antibody and 
secondary goat anti-rabbit antibody conjugated to Alexa Fluor 488; whereas for the 
detection of the PMCA primary mouse and secondary anti-mouse (AlexaFluor 635-
conjugated) antibodies were used. After 24 h incubation at 4
o
C the cells were 
visualized using Leica confocal imaging system. The results are presented in 
Fig. 7.8.C-G. Fig. 7.8.C shows a doublet of pancreatic acinar cells; and Fig. 7.8.D - a 
single cell, where green colour demonstrates the distribution of Bcl-2 protein (a); and 
  
 
 
247 
 
  
A. 
a b
c d
 
B. 
0
1000
2000
3000
4000
0 2 4 6 8 10 12 14
Bcl-2
PMCA
F
lu
o
re
sc
e
n
ce
Distance [μm]
 
Fig. 7.8. Bcl-2 is present in close proximity to the PMCA in AR42J cells 
(A) A small cluster of fixed AR42J cells overexpressing Bcl-2-GFP and 
immunostained with antibody against the PMCA: (A.a) Expression pattern of Bcl-2-
GFP is shown in green and (A.b) localization of the PMCA is depicted by red colour. 
(A.c) Overlay of red fluorescence of the PMCA and green Bcl-2-GFP results in 
yellow colour at the plasma membrane. (B) The graph shows fluorescence of Bcl-2-
GFP (green trace) and AlexaFluor 635 form the PMCA staining (red trace) collected 
at the cross-section depicted by the white line on image (A.c). 
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Fig. 7.8. (continues) 
(C) A doublet of fixed pancreatic acinar cells immunostained with antibody against 
Bcl-2 (green) and the PMCA (red): (C.a) expression pattern of Bcl-2; 
(C.b) localization of the PMCA; (C.c) overlay of red and green fluorescence; (C.d) 
transmitted light image. (D) A single fixed pancreatic acinar cell immunostained 
with antibody against Bcl-2 (green) and the PMCA (red): (D.a) expression pattern of 
Bcl-2; (D.b) localization of the PMCA; (D.c) overlay of red and green fluorescence; 
(D.d) transmitted light image. 
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Fig. 7.8. (continues) 
(E) The same cell as in (D.c) with marked two regions of interest (white lines). 
(F-G) The graphs show fluorescence of AlexaFluor 488 from Bcl-2 (green traces) 
and AlexaFluor 635 form the PMCA staining (red traces) collected at (F) region of 
interest 1 (ROI1) and (G) region of interest 2 (ROI2) as depicted by the white lines 
on image (E). 
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the PMCA staining is depicted in red (b). The overlay (c) demonstrates close 
localization of Bcl-2 and the PMCA. Transmitted light images of the cells are 
presented in (d). Green and red fluorescence values were obtained from cross-
sections depicted in Fig. 7.8.E (see white lines) and presented on the graphs as 
function of distance (Fig. 7.8.F and G, for ROI1 and ROI2, respectively). Peaks at 
the red trace indicate localization of the PMCA and they overlap with peaks at the 
green traces of Bcl-2 fluorescence. According to the staining of a single pancreatic 
acinar cell, the PMCA is present in both basolateral and apical membranes; however 
it appears to be more concentrated in the neighbourhood of the granular area, which 
is also shown as higher and wider peaks in Fig. 7.8.F and G. 
In conclusion immunolocalization data from fixed cells support the results obtained 
from live cells, and thus together demonstrate the accumulation of Bcl-2 protein in 
close proximity to the plasma membrane and the PMCA. Since Bcl-2 protein can be 
present very close to the PMCA, it makes feasible the speculation of direct 
interaction between the PMCA and Bcl-2, which is important in regulation of the 
activity of the pump and thus cytosolic calcium extrusion. 
7.9. Loss of Bcl-2 promotes apoptosis and protects against necrosis 
Bcl-2 is well known for its anti-apoptotic functions. Interestingly, data presented in 
this chapter suggest that Bcl-2 decreases activity of the PMCA, which leads to 
slower calcium extrusion from the cytosol that might promote cell death. Therefore 
the pathophysiological importance of Bcl-2-dependent regulation of the PMCA 
seems counterintuitive. In order to explain this phenomenon cell death assays on 
pancreatic acinar cells were performed. The cells were isolated from wild type and 
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bcl-2
-/-
 mice and challenged with (1) 30 µM menadione, which promotes production 
of reactive oxygen species and induces apoptosis via intrinsic pathway; (2) high Ca
2+
 
(5 mM) in order to increase calcium gradient across the plasma membrane and 
potentiate calcium influx, which could reveal effects dependent on different PMCA 
regulation; (3) menadione and high Ca
2+
 together. The cells were incubated for 
30 min at room temperature with gentle agitation. This also includes control groups, 
which were incubated in the same conditions but without any treatment. Then cells 
were spun, resuspended in binding buffer and incubated with annexin-V-FITC and 
propidium iodide according to the protocol of apoptosis kit (Sigma). Multiple images 
of the cells were taken using Leica confocal system and the numbers of live / 
apoptotic / necrotic cells were obtained based on the staining pattern with annexin-V-
FITC and propidium iodide. Annexin binds to phosphatidylserine exposed on the 
outer leaflet of the plasma membrane in apoptotic cells. Propidium iodide can only 
label cells when the plasma membrane has been compromised; therefore it is a good 
indicator of necrotic cells. The results are presented in Fig. 7.9.A-B. Untreated wild 
type and bcl-2
-/-
 cells have very similar percentages of apoptosis and necrosis. 
Treatment with 5 mM Ca
2+
 led to a decrease in wild type live cells as compared to 
untreated wild type cells (p = 0.019) as well as in comparison to bcl-2
-/-
 cells 
challenged with the same concentration of extracellular calcium (p = 0.05). Cells 
lacking Bcl-2 protein appear to have a slightly higher tolerance for conditions of high 
extracellular calcium. Treatment with menadione resulted in significant reduction in 
percentage of live wild type cells as compared to the untreated wild type control 
(p < 0.001); at the same time apoptosis (p < 0.001) as well as necrosis (p = 0.01) 
were markedly increased. Wild type cells challenged with both menadione and 5 mM 
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calcium had their necrosis levels increased even more substantially when compared 
to treatment with  menadione alone (p = 0.018). Cells lacking Bcl-2 responded to 
menadione with a decrease in percentage of live cells (p = 0.001). Interestingly, their 
apoptosis levels were substantially increased over control bcl-2
-/-
 values (p = 0.003), 
but percentage of necrosis was not significantly different from untreated bcl-2
-/-
 cells 
(p = 0.138). Further, combined treatment of bcl-2
-/-
 cells with menadione and high 
calcium did not increase their necrosis levels over treatment with menadione alone 
(p = 0.282), which is a major difference from wild type cells. Also important to note 
is that menadione had dramatically different effects on wild type cells than on bcl-2
-/-
 
cells. Cells lacking Bcl-2 developed markedly more apoptosis (p = 0.002) and 
substantially less necrosis (p = 0.016) than wild type cells treated in the same way. 
Finally, difference in necrosis levels between bcl-2
-/-
 and wild type cells is even more 
pronounced upon combined treatment with menadione and 5 mM Ca
2+
 (p = 0.008). 
Taken together these results confirm that loss of Bcl-2 promotes apoptosis induction 
under conditions of oxidative stress. Also, consistently with the hypothesis that Bcl-2 
decreases PMCA activity, bcl-2
-/-
 cells seem to exhibit better survival against the 
adverse effects of high extracellular calcium. Both wild type and bcl-2
-/-
 cells are 
sensitive to oxidative stress induced by menadione, which is well depicted by 
decreased levels of live cells that are comparable in both groups (26.33 % ± 2.50 % 
in wild type group and 27.39 % ± 1.14 % in bcl-2
-/-
). However, striking is the fact 
that although cells in both groups die, they utilize different cell death mechanisms. 
Loss of Bcl-2 strongly promotes apoptosis and protects against necrosis upon 
oxidative stress. Additionally, oxidative stress in combination with high extracellular 
calcium induces even more necrosis in wild type cells; whereas menadione-
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dependent cell death of bcl-2
-/-
 cells does not seem to be affected by the presence of 
high extracellular calcium. 
In order to fully understand the effects of Bcl-2 protein on cell death induction, 
cytosolic calcium responses to 5 mM Ca
2+
, and 30 µM menadione in the presence of 
1 mM or 5 mM extracellular Ca
2+
 were investigated in fura-2-loaded wild type and 
bcl-2
-/-
 pancreatic acinar cells. Typical traces are shown in Fig. 7.9.C-D. In the 
presence of 5 mM CaCl2 in the extracellular environment wild type pancreatic acinar 
cells developed a slow elevation of cytosolic Ca
2+
 (n = 18). In contrast, increased 
extracellular calcium had no effect on bcl-2
-/-
 cells (Fig. 7.9.C-D, n = 12). WT as 
well as bcl-2
-/-
 cells responded to menadione with an elevation of cytosolic Ca
2+
 
(nWT = 23 and nbcl-2 = 14). However, wild type cells additionally developed robust 
oscillations on top of the increasing calcium baseline (Fig. 7.9.C). What is more, 
menadione-induced oscillations were substantially potentiated in wild type cells in 
the presence of 5 mM Ca
2+
 (Fig. 7.9.C, n = 22). Interestingly, pancreatic acinar cells 
lacking Bcl-2 did not develop such robust Ca
2+
 oscillations in response to menadione 
(Fig. 7.9.D). The presence of high extracellular calcium had no further effect on 
responses evoked by menadione in those cells (Fig. 7.9.D, n = 12). The effects of 
menadione and high extracellular calcium on WT and bcl-2
-/-
 cells are summarized in 
Fig. 7.9.E. The results are shown as average areas under the traces calculated 
between 200 s (upon treatment with menadione) and 1200 s, and normalized to the 
average values obtained for treatment with 5 mM Ca
2+
 in wild type cells. Since 
5 mM Ca
2+
 has only a minor effect on wild type cells, the responses are not 
statistically significant from those recorded in bcl-2
-/-
 cells (p = 0.105), although the 
difference is noticeable. Treatment with 30 µM menadione in the presence
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Fig. 7.9. Loss of Bcl-2 promotes apoptosis and protects against necrosis 
(A) The chart shows the results of cell death assays performed on WT cells. Green 
bars represent percentage of live cells, blue – percentage of apoptotic cells, and red – 
percentage of necrotic cells. Four treatment groups are presented from left to right: 
control cells (no treatment); cells exposed to 5 mM Ca
2+
; cells treated with 30 µM 
menadione; and cells treated with 30 µM menadione in the presence of 5 mM Ca
2+
. 
(B) The results of cell death assays in bcl-2
-/-
 pancreatic acinar cell are presented in 
the same way as in (A). Cells with no functional Bcl-2 develop substantially more 
apoptosis and markedly less necrosis than WT cells upon treatment with 30 µM 
menadione or menadione in the presence of high calcium. 
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Fig. 7.9. (continues) 
(C) The figure shows typical calcium responses in WT pancreatic acinar cells to 
5 mM Ca
2+
 (blue trace, n = 18), to 30 µM menadione in 1 mM Ca
2+
 (red trace, 
n = 23) and 30 µM menadione in the presence of 5 mM Ca
2+
 (violet trace, n = 22). 
(D) The figure shows typical calcium responses in bcl-2
-/-
 pancreatic acinar cells to 
5 mM Ca
2+
 (blue trace, n = 12), to 30 µM menadione in 1 mM Ca
2+
 (red trace, 
n = 14) and 30 µM menadione in the presence of 5 mM Ca
2+
 (violet trace, n = 12). In 
both figures black arrows indicate the time point of treatment application. 
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Fig. 7.9. (continues) 
(E) The figure shows average calcium responses recorded between 200 and 1200 s to 
5 mM extracellular Ca
2+
, 30 µM menadione, and menadione in high extracellular 
Ca
2+
. The responses were normalized to the average values obtained for 5 mM Ca
2+
 
in WT cells. Blue bars represent cells exposed to 5 mM Ca
2+
, red bars refer to cells 
treated with 30 µM menadione, and violet bars represent cells challenged with 
30 µM menadione in the presence of 5 mM Ca
2+
. The responses of WT cells to 
menadione are clearly greater than those of bcl-2
-/-
 cells, and are even more 
potentiated by the presence of high extracellular calcium in the external solution. 
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of 1 mM as well as 5 mM extracellular Ca
2+
 resulted in substantially greater 
responses in WT cells as compared to cells lacking Bcl-2 (p = 0.007 and p << 0.001, 
for 1 mM and 5 mM Ca
2+
 respectively). In wild type cells responses to menadione in 
the presence of 5 mM extracellular Ca
2+
 were significantly greater than those caused 
by menadione alone (p = 0.017). In contrast, increased extracellular Ca
2+
 did not 
affect menadione-dependent responses in bcl-2
-/-
 (p = 0.38).  
Taken together, loss of Bcl-2 in pancreatic acinar cells protects against the adverse 
effects of increased external calcium, since such cells can extrude cytosolic calcium 
across the plasma membrane more efficiently than WT cells. In contrast to WT cells, 
bcl-2
-/-
 cells respond with increased levels of apoptosis and are protected against 
excessive necrosis, when challenged with 30 µM menadione. This protective effect is 
even more pronounced, when menadione treatment is combined with high 
extracellular calcium. 
7.10. Discussion 
Bcl-2 family proteins are very well known as the crucial regulators of apoptosis and 
mitochondrial integrity. However, recently their roles associated with other cell 
compartments have been attracting gradually more interest. Currently it is widely 
accepted that Bcl-2 proteins have heterogeneous intracellular distribution; they can 
be found not only at the outer mitochondrial membrane, but also at the ER, nuclear 
envelope and even in the cytosol
153,312,313
. The presence of Bcl-2 in the ER is 
especially interesting, since Ca
2+
 released from the intracellular stores can affect 
mitochondrial functions. Having calcium uniporter, mitochondria easily take up and 
accumulate increased cytosolic Ca
2+
, which in turn can trigger radically different 
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effects. Beneficial role of calcium in mitochondria is associated with activation of 
Ca
2+
-dependent enzymes of Krebs cycle, which leads to stimulation of aerobic 
metabolism and thus an increase in ATP production
314
. In contrast, calcium overload 
of mitochondria induces opening of permeability transition pore (PTP), which is 
involved in the release of proapoptotic factors
315
. It has been demonstrated by our 
group that apoptosis induction via intrinsic pathway indeed requires calcium 
responses in pancreatic acinar cells
45
. Therefore, Bcl-2 proteins seem to be involved 
in regulation of life and death signals at different cell compartments. 
Roles of Bcl-2 family members, however, are not limited to their proapoptotic / 
prosurvival functions. These proteins have been found to regulate many aspects of 
calcium signalling of profound importance for cell homeostasis. They are known to 
be involved in the regulation of calcium release form the intracellular stores
213,215
 as 
well as CICR process
207
 (which has been shown in Chapter 3). The role of Bcl-2 
proteins in controlling Ca
2+
 fluxes across the plasma membrane is less clear. It has 
been reported that Bcl-2 could be involved in the regulation of Ca
2+
 influx and store 
operated calcium entry
316
. Up to now the function of Bcl-2 protein in the regulation 
of calcium efflux from the cytosol across the plasma membrane has not been 
addressed. 
In this chapter some aspects of calcium signalling have been compared between wild 
type and bcl-2
-/-
 pancreatic acinar cells. Additionally, AR42J cell line has been used 
in order to manipulate the levels of intracellular Bcl-2 through transient or stable 
overexpression and RNA interference approach. The study originated from the initial 
observation described in Chapter 7.1., that loss of Bcl-2 protein resulted in increased 
cytosolic Ca
2+
 clearance in pancreatic acinar cells treated with a mixture of 10 µM 
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and 10 µM ACh. In the literature it has been suggested that Bcl-2 might affect Ca
2+
 
entry to the cytosol
316,317
; however its effects on calcium extrusion have not been 
previously described. Therefore the comprehensive study was undertaken in order to 
investigate this phenomenon in more detail. The results demonstrate that loss of Bcl-
2 protein has significant implications for cellular calcium homeostasis. Pancreatic 
acinar cells without functional Bcl-2 protein export cytosolic calcium across the 
plasma membrane more efficiently than wild type cells. In pancreatic acinar cells 
calcium extrusion across the plasma membrane is mainly facilitated by the PMCA
303
. 
Indeed, Na
+
 substitution by NMDG
+
 in the extracellular solution did not affect Ca
2+
 
export from pancreatic acinar cells, whereas lanthanum almost completely blocked it. 
Since Na
+
/Ca
2+
 exchange is negligible in pancreatic acinar cells, it is clear that the 
effects of Bcl-2 loss are associated with the PMCA. Bcl-2 appears to negatively 
regulate the PMCA, leading to increased activity of the latter in bcl-2
-/-
 cells and thus 
more efficient Ca
2+
 extrusion from the cytosol. Further, calcium extrusion is one of 
the main mechanisms maintaining cytoplasmic calcium levels. Therefore pancreatic 
acinar cells lacking Bcl-2 exhibit significantly lower resting calcium levels in the 
cytosol as compared to wild type cells. Studies on AR42J cell line revealed that 
Bcl-2 overexpression led to reduced resting levels of calcium in the ER; and 
silencing Bcl-2 expression resulted in increased resting [Ca
2+
]ER. These suppressive 
effects of Bcl-2 overexpression on resting [Ca
2+
] in the ER have also been observed 
by other research groups in different cell types
83,157,158
. In contrast, group of 
C. Distelhorst failed to find any differences in ionomycin-releasable intracellular 
store calcium between cells with and without functional Bcl-2
318,319
. One of the 
possible explanations of this apparent discrepancy could imply that the regulation 
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might slightly vary in different cell types. Additionally, previous measurements of 
ER calcium content were indirect, based on assessment of released Ca
2+
 from the ER. 
Here, more accurate direct measurement of resting Ca
2+
 levels in the ER has been 
applied by transient transfection of the AR42J cell line with ER-targeted cameleon 
plasmid. 
The results provide some general insights into a potential mechanism of Bcl-2-
dependent regulation of the PMCA, although they do not explain it completely. It is 
not clear whether this regulation is direct or indirect. Here, the possibility of the 
direct regulation was tested by analysing the distribution of Bcl-2 in AR42J cells and 
in acinar cells. While the substantial amount of Bcl-2 was localized to mitochondria, 
a fraction of it was also found in the ER in close proximity to the plasma membrane. 
Immunostaining of fixed cells demonstrated that at least small proportion of Bcl-2 
can be localized very close to the PMCA. This confirms that direct interaction is 
potentially feasible and cannot be excluded. 
Finally, the patho-physiological consequences of PMCA regulation by Bcl-2 protein 
have been investigated. Importantly, increase in extracellular calcium concentration 
to 5 mM leads to substantial increase in necrosis in wild type cells and wild type 
cells treated with menadione, but not in bcl-2
-/-
 cells. Cells lacking Bcl-2 are not 
affected by increased extracellular calcium and are more likely to die of apoptosis 
when challenged with menadione alone. Necrosis remains at low levels even upon 
combined treatment with menadione and high calcium. These results provide novel 
insights into understanding of the functions of Bcl-2 protein. On one hand, by its 
anti-apoptotic actions it promotes cell survival; and negative regulation of the PMCA 
might help preserving cellular energy resources. On the other hand, loss of Bcl-2 
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makes apoptosis the cell death mechanism of choice under cytotoxic conditions, 
which at the same time serves as protection against excessive necrosis. 
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Chapter 8: Concluding remarks 
 
8.1. Summary 
The present study aimed to investigate roles of Bcl-2 family proteins as well as some 
aspects of calmodulin actions on Ca
2+
 homeostasis in pancreatic acinar cells. 
Calmodulin is an ubiquitous regulatory protein engaged in regulation of multiple 
signalling pathways and cellular processes dependent on calcium
195,220-223
. And the 
roles of Bcl-2 proteins in regulation of intracellular calcium homeostasis have been 
recently gaining increasing attention
157,160,204
. Briefly, this thesis demonstrated that 
pharmacological inhibition of anti-apoptotic Bcl-2 and Bcl-xL by BH3 mimetics led 
to Ca
2+
 release from the intracellular stores followed by sustained cytosolic Ca
2+
 
plateau formation. This Ca
2+
 release was only partially and not primarily dependent 
on IP3Rs and RyRs, and it was almost completely abolished by loss of Bax protein. 
Anti-apoptotic Bcl-2 proteins were demonstrated to control sensitivity to CICR in 
pancreatic acinar cells. Simultaneously, Bcl-2 protein was shown to be involved in 
regulation of PMCA activity in pancreatic acinar cells and thus regulation of 
cytosolic Ca
2+
 extrusion across the plasma membrane. Further, the effects of 
calmodulin pre-activation by Ca
2+
-like peptides CALP-1 and CALP-3 have been 
assessed. Application of CALPs, particularly CALP-1, reduced toxic effects of BH3 
mimetics, which decreased levels of necrosis in favour of apoptosis in treated cells. 
Finally, the present study showed toxic effects of ethanol on intracellular Ca
2+
 
homeostasis. Ethanol induced Ca
2+
 release from the ER and the acidic store, which 
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subsequently led to premature trypsinogen activation within the cells. These toxic 
effects of alcohol were inhibited by calmodulin and even more substantially - by 
calmodulin preactivation with CALP-3. 
8.2. The effects of BH3 mimetics on calcium homeostasis in pancreatic 
acinar cells and their consequences 
It is generally accepted that the balance between pro- and anti-apoptotic Bcl-2 
proteins regulates the fate of cells: death and survival
116,166
. This regulation is 
mediated by specific protein interactions. Anti-apoptotic Bcl-2 members posses a 
characteristic hydrophobic groove formed by BH1, BH2 and BH3 domains
126
. The 
BH3 domain of pro-apoptotic proteins Bax and Bak specifically binds to that groove, 
which neutralizes their apoptotic functions. Upon reception of death or stress signals, 
BH3-only proteins are activated and competitively displace Bax and Bak from the 
anti-apoptotic Bcl-2 members
320
. Displacement of Bax and Bak leads to their 
oligomerization followed by mitochondrial outer membrane permeablization. 
Simultaneously, evidence suggests that several BH3-only proteins (such as Bid, Bim 
and PUMA) might also directly bind and activate Bax and Bak
134,140
. Since 
overexpression of anti-apoptotic Bcl-2 family members appears to be a very common 
feature of distinct cancer types, application of agents that inhibit their pro-survival 
functions is a promising anti-cancer approach. One of the first attempts to block anti-
apoptotic Bcl-2 members was application of antisense-based strategies
321
. Antisense 
oligodeoxynucleotides target and bind to specific mRNA sequences, which leads to 
the RNaseH-mediated degradation of DNA-RNA heteroduplexes. This approach, 
however, had only very little therapeutic success. 
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BH3 mimetics are compounds that bear structural similarity to BH3 domain from 
pro-apoptotic Bcl-2 members, which is responsible for interaction with hydrophobic 
groove in anti-apoptotic proteins. Treatment with BH3 mimetics aims to disrupt the 
interaction between anti- and pro-apoptotic Bcl-2 members, inhibit pro-survival 
functions of Bcl-2 and Bcl-xL, and thus sensitize cells to apoptosis induction. BH3 
mimetics are mainly synthetic chemicals such as HA14-1 and BH3I-2' that were 
generated by computer modelling. Some are natural theaflavins and 
epigallocatechins, such as gossypol, which can be found in cotton seeds. Gossypol 
also acts as an inhibitor of anti-apoptotic Bcl-2 members, exhibiting high affinity to 
Bcl-2, Bcl-xL and Mcl-1
322
. Its anti-cancer effects have been demonstrated in various 
cell types
323-325
. 
Previously it has been demonstrated that HA14-1 is capable of displacing Bax 
protein from Bcl-2 and induce apoptosis in cultured cells
167
. Similarly, members of 
BH3I family of synthetic BH3 mimetics were shown to displace Bak peptide from 
Bcl-xL and promote cell death
170
. However, it was proved that a substantial 
proportion of the cytotoxic effects of HA14-1 and BH3I-2' was not due to specific 
inhibition of anti-apoptotic Bcl-2 members, since the BH3 mimetics are able to kill 
cells also in a manner independent on Bax and Bak
326
. 
In the present study it has been observed that application of BH3 mimetics in 
pancreatic acinar cells is associated with Ca
2+
 release from the intracellular stores 
followed by sustained Ca
2+
 plateau
207
. These effects of BH3 mimetics were shown 
independent on mitochondrial functions, since inhibition of ATP synthesis by 
combined application of rotenone and oligomycin did not affect BH3 mimetic-
induced Ca
2+
 release from the intracellular stores. Surprisingly, the results presented 
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here indicate that the main ER channels responsible for Ca
2+
 release - IP3Rs and 
RyRs - are not primarily responsible for BH3 mimetic-induced Ca
2+
 release. 
Pharmacological inhibition of these receptors both in intact and permeabilized cells 
substantially reduced Ca
2+
 release from the intracellular stores, but did not 
completely abolish it, which suggests that the role of IP3Rs and RyRs is mainly 
restricted to amplification of already existing Ca
2+
 leak. 
At the same time results from Chapter 3 led to formulation of hypothesis that anti-
apoptotic Bcl-2 members regulate CICR process by sensitizing IP3Rs and RyRs for 
activation by Ca
2+
. The hypothesis is strongly supported by the previous studies, 
which clearly demonstrate that Bcl-2 and Bcl-xL can physically interact with the 
IP3R affecting its Ca
2+
 releasing abilities
213-215
. Recently, BH4 domain of Bcl-2 
protein was shown to bind to the regulatory domain of the IP3R, which decreased 
both Ca
2+
 release from the ER and apoptosis
215
. Those finding are further supported 
by experiments on AR42J cells, where overexpression of Bcl-2 protein attenuates 
both CICR and cytosolic Ca
2+
 plateau induced by BH3I-2'. Therefore application of 
BH3 mimetics affects cellular Ca
2+
 homeostasis in multiple ways. First, it potentiates 
passive Ca
2+
 leak from the ER, which, as shown in the present study, is dependent on 
pro-apoptotic Bax protein. Further, it increases sensitivity of Ca
2+
 release channels - 
IP3Rs and RyRs - for activation by Ca
2+
. These two effects explain CICR type of 
responses caused by BH3 mimetics. Finally, prolonged cytosolic Ca
2+
 increase, 
which is sustained even in the absence of extracellular calcium, is indeed unexpected 
and difficult to explain immediately. It appears that application of BH3 mimetics and 
thus anti-apoptotic Bcl-2 inhibition reveals important and previously unknown 
functions of Bcl-2 proteins in regulation of Ca
2+
 release from the ER as well as in 
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Ca
2+
 extrusion across the plasma membrane. These functions are investigated in 
more detail and described in the present study. 
Although the anti-cancer actions of BH3 mimetics have been extensively 
investigated in the past, this study demonstrates their adverse effects on Ca
2+
 
homeostasis. Global Ca
2+
 release followed by sustained cytosolic Ca
2+
 plateau is 
toxic and might explain previously observed induction of cell death by BH3 
mimetics in the manner independent on pro-apoptotic Bcl-2 members. Importantly, 
observed actions of BH3 mimetics on Ca
2+
 homeostasis in normal cells, particularly 
pancreatic acinar cells, are serious side effects that need to be taken care of before 
these compounds can be safely used as potential therapeutic agents. Therefore this 
study identifies previously overlooked problem associated with the application of 
small molecular weight BH3 mimetic compounds for anti-cancer therapy. 
8.3. The effects of ethanol on calcium homeostasis in pancreatic acinar 
cells 
Although the awareness of harmful impacts of alcohol drinking on health appears to 
have been increasing in recent years in the UK, mortality directly related to alcohol 
in 2008 showed an increase of 24 % as compared to 2001 (Statistics on Alcohol: 
England, 2010, NHS). Excessive alcohol consumption often leads to alcoholic liver 
disease and is strongly correlated with pancreatitis. Despite the clinical data 
indicating substantial toxicity of ethanol to pancreas, so far no major effects of 
alcohol on pancreatic acinar cells have been observed
100
. Therefore now it is 
accepted that the main mediators of ethanol toxicity in the pancreas are its 
metabolites
243
. Non-oxidative metabolites of ethanol – fatty acid ethyl esters – were 
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shown to induce a slow but substantial increase in cytosolic Ca
2+
 in pancreatic acinar 
cells. Also fatty acids cause a delayed dose-dependent Ca
2+
 rise in the cytosol, which 
is not mediated by IP3Rs; and induce severe cell damage indicated by uptake of 
propidium iodide
100,108
. 
In the present study it has been demonstrated that ethanol alone in high 
concentrations (10 mM - 100 mM) releases Ca
2+
 from the intracellular stores. The 
effects of ethanol on intact cells are very modest and cannot alone explain severe 
impacts of heavy alcohol drinking on health. However, the effects of ethanol in 
permeabilized cells are far more substantial. The results show that treatment of two-
photon permeabilized pancreatic acinar cells with ethanol causes Ca
2+
 release from 
both the ER and the acidic store in dose-dependent manner. This Ca
2+
 release is 
strongly associated with intracellular trypsinogen activation, which is the hallmark of 
pancreatitis. Activation of trypsin is crucial in pathogenesis of pancreatitis and the 
research shows this process is mediated by cathepsin B, a cysteine protease found in 
lysosomes
41,327
. Accumulating evidence suggests that autophagy might play a role in 
premature trypsinogen activation
328,329
. The mechanism of ethanol-mediated toxicity 
in pancreatic acinar cells is not yet fully understood and requires further 
investigation. This study provides only some insights into ethanol-related effects on 
pancreas. 
The difference in Ca
2+
 responses to ethanol between intact and permeabilized 
pancreatic acinar cells comes from calmodulin content. Intact pancreatic acinar cells 
have exceptionally high levels of calmodulin, which is inevitably lost upon cell 
permeabilization. High calmodulin content acts protectively against ethanol toxicity 
diminishing its effects on Ca
2+
 release from the intracellular stores. Therefore this 
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study provides important evidence for protective functions of calmodulin. Further 
investigation of the exact mechanism of calmodulin-dependent inhibition of ethanol 
mediated Ca
2+
 release and trypsinogen activation might provide us with an 
invaluable weapon in fight against ethanol toxicity and pancreatitis. 
8.4. Calcium-like peptides as a potential tool against toxic effects of 
calcium 
Calcium-like peptides (CALPs) show no structural resemblance to Ca
2+
 ion. Instead 
their name indicates functional similarities. Complementary surface contour to EF-
hand Ca
2+
-binding motifs allows them to interact with the Ca
2+
 binding sites and thus 
mimic or block effects of calcium
226
. EF-hand motifs are present in various proteins, 
whose activity is regulated by Ca
2+
, such as calmodulin and certain calcium 
channels. 
Four different Ca
2+
-like peptides have been designed by Villain et al
226
. Octamers 
CALP-1 and CALP-3 mimic the effects of Ca
2+
 binding to the carboxy-terminal EF-
hands in calmodulin. Binding of CALP-1 and CALP-3 to calmodulin is associated 
with conformational change of the protein, which differs from that observed for 
Ca
2+
-CaM. In contrast 12-mers CALP-2 and CALP-4 act as calmodulin antagonists 
and, consistently, do not induce active conformation of calmodulin
226
.  
In order to exert their functions CALPs have to be able to enter cells efficiently. This 
property of CALPs has been previously tested with a modified version of CALP-1, 
which was conjugated to fluorescein malemide. Using fluorescent microscopy the 
molecule was demonstrated to accumulate in different cell types: rat neocortical 
  
 
 
270 
 
  
neurons and Jurkat T cells
227
. In contrast, a hydrophilic control peptide modified in 
the same way was not taken up by the cells
227
.  
In this study CALP-1 and CALP-3 were used for specific pre-activation of 
calmodulin both in intact pancreatic acinar cells and permeabilized cells (CALP-3 
only). However the actions of Ca
2+
-like peptides seem to extend even further. They 
can act as inhibitors on certain channels affecting their Ca
2+
 sensing mechanisms. 
This inhibitory effect can be exerted either by direct interaction of the peptide with 
the EF-hand motif of the channel, or it can be indirect - mediated through 
calmodulin
227
. It has been postulated that the channel blocking function of CALPs 
can inhibit Ca
2+
 influx to the cytosol and therefore apoptosis dependent on Ca
2+
 
influx
227
.  
This study focuses on calmodulin-dependent functions of Ca
2+
-like peptides. CALPs 
have been applied here in order to reduce toxic effects of elevated cytosolic Ca
2+
 
induced by treatment with BH3 mimetics as well as toxic effects of ethanol on Ca
2+
 
homeostasis in pancreatic acinar cells. Sustained cytosolic Ca
2+
 elevation induced by 
BH3 mimetics or treatment with high doses of ethanol leads to intracellular 
trypsinogen activation in pancreatic acinar cells and further to induction of 
necrosis
243
. Necrosis results in loss of cell integrity and release of intracellular 
content, which promotes inflammation. 
The results presented here demonstrate that Ca
2+
-like peptides acting on calmodulin 
are capable of reducing pathological Ca
2+
 signals of different origin. Preincubation 
with CALP-1 or CALP-3 on average decreased the amplitude of Ca
2+
 responses 
induced by BH3 mimetics: BH3I-2' and gossypol; and that was also reflected by the 
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results of cell death assays. CALP-1 appeared to protect against necrotic cell death 
promoting apoptosis; whereas CALP-3 reduced necrosis and increased the numbers 
of cells that survived the treatment. Experiments on permeabilized cells show that 
not only re-admission of calmodulin has a protective effect on ethanol-induced Ca
2+
 
release, but more importantly pre-activation of calmodulin by calcium-like peptide 
CALP-3 brings even stronger inhibitory effect on both ethanol-mediated Ca
2+
 release 
from the stores and trypsinogen activation
246
. The mechanisms of Ca
2+
 release 
induced by high doses of ethanol and by treatment with BH3 mimetics markedly 
differ. BH3 mimetics release Ca
2+
 mainly from the ER and they do so in both intact 
and permeabilized cells. In contrast, ethanol induces Ca
2+
 release form the ER as 
well as from the acidic store. Ethanol-elicited effects are, however, strongly 
dependent on the presence of calmodulin. Consistently, ethanol has only a minor 
effect on intact cells, whereas in permeabilized cells, which have lost most of their 
calmodulin, ethanol induced substantial Ca
2+
 release from the intracellular stores. 
Taken together, the results indicate that Ca
2+
-like peptides are effective against 
pathological Ca
2+
 signals induced in different ways. 
In the present study it has also been tested whether Ca
2+
-like peptides could interfere 
with physiological Ca
2+
 signals. The results indicate that neither CALP-1 nor CALP-
3 substantially affect ACh signalling. Further, CALPs have only a minor effect on 
CCK signalling reducing global Ca
2+
 spikes in favour of apical oscillations. The 
latter might be beneficial, since localized oscillations are sufficient to induce 
exocytosis of digestive enzymes and secretion of fluid
244
. 
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Although CALPs have been designed more than 10 years ago, surprisingly they have 
not been extensively used in research. The current study rediscovers these 
compounds by providing important evidence that specific pre-activation of 
calmodulin by Ca
2+
-like peptides is protective against pathological Ca
2+
 responses. 
This application of CALPs has not yet been previously suggested. And the data 
presented in this study demonstrate that CALPs could potentially be used as drugs 
against pancreatitis by reducing pathological Ca
2+
 responses resulting in intracellular 
trypsinogen activation and extensive cell death. Moreover, CALPs might find their 
application in cancer therapy, as agents modulating toxicity of BH3 mimetics. 
Treatment with CALP-like drugs together with a BH3 mimetic would protect healthy 
cells from adverse effects of the latter and would increase the levels of apoptosis 
induced by BH3 mimetics in cancer cells reducing levels of necrosis and thus 
inflammation. As was described in Chapter 4, peptides are not ideal drugs, since they 
are usually characterised by poor pharmacokinetic properties and are prone to 
degradation. However, development of synthetic compounds of structure and 
functions resembling that of CALPs might contribute to the development of 
therapeutic agents against acute pancreatitis as well as support BH3 mimetic-based 
anti-cancer therapy. From that perspective compounds analogical to CALP-3 would 
serve better for the first purpose, as they improve cell survival and decrease necrosis. 
On the other hand, CALP-1-based compounds could be applied for reduction of BH3 
mimetic-induced toxicity, as they decrease necrosis but promote apoptosis. 
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8.5. Novel roles of Bcl-2 family protein in cellular Ca
2+
 homeostasis 
Bcl-2 protein was identified in 80s during analysis of a frequent chromosomal 
translocation in B cell lymphoma
122,330
, and gave rise to a novel family of proteins. 
Initially believed to be present exclusively in mitochondria
313
, Bcl-2 has been 
subsequently found in other intracellular compartments such as the ER, the nuclear 
envelope and even a small fraction of it could be found in the cytosol
153,207,312
. 
Functionally, Bcl-2 proteins are well known regulators of apoptotic cell death; they 
either promote cell survival (Bcl-2, Bcl-xL, Bcl-w, Mcl-1, A1 ) or cell death (Bax, 
Bak, and BH3-only proteins such as Bid, Bim, PUMA and many others)
118,331
. 
Additionally, they regulate integrity of mitochondria and promote or antagonize 
formation of the permeability transition pore (PTP)
332,333
. 
Although apoptosis-related functions of Bcl-2 family proteins are very well 
established, accumulating evidence suggests that the proteins perform additional 
functions. For example in the ER Bcl-2 family proteins play a role in unfolded 
protein response, induced by protein misfolding. Bax and Bak proteins were shown 
to interact with IRE1 – one of the ER stress sensor protein
154
. Even more importantly 
Bcl-2 family members are involved in the regulation of intracellular calcium 
homeostasis including Ca
2+
 release from the stores
158,159,204
. The exact nature of this 
regulation remains controversial and is a subject of interest of many world leading 
research groups. Bcl-2 has been previously suggested to decrease Ca
2+
 concentration 
in the ER
157,158
. At the same time, several studies reported the opposite effects of 
Bcl-2 on ER calcium content: preservation of ER calcium by upregulation of the 
SERCA
176
. Finally, some studies showed no effects of Bcl-2 on ER Ca
2+
 content
334
. 
Interaction between Bcl-2 and IP3Rs is already well established and is associated 
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with the inhibition of Ca
2+
 release from the ER
160
. Further, overexpression of Bax 
and Bak leads to mobilization of Ca
2+
 from the ER to mitochondria during 
apoptosis
161
. And loss of the two proteins results in dramatically reduced calcium 
concentration in the ER and decreased Ca
2+
 uptake by mitochondria. It appears that 
Bcl-2 proteins have complex roles in calcium signalling, which might depend on cell 
types and even experimental conditions, such as extracellular Ca
2+
 concentration. 
In the current study different aspects of Bcl-2 functions were investigated, which 
particular focus on calcium release from the intracellular stores and cytosolic calcium 
extrusion in pancreatic acinar cells as well as on pharmacological Bcl-2 inhibition by 
BH3 mimetics. The results suggest that Bcl-2 family members are crucial for proper 
maintenance of intracellular Ca
2+
 homeostasis. This thesis provides data indicating 
that anti-apoptotic Bcl-2 members such as Bcl-2 and Bcl-xL are involved in 
regulation of CICR in pancreatic acinar cells. It has been postulated here that 
pharmacological inhibition of Bcl-2 and Bcl-xL can sensitize IP3Rs and RyRs for 
activation by Ca
2+
. Although Bcl-2 proteins have been suspected to influence Ca
2+
 
release from the ER, their role in regulation of CICR has not been previously 
addressed. Inhibition of anti-apoptotic Bcl-2 members has profound consequences 
for the intracellular Ca
2+
 homeostasis. As described above, pharmacological 
blockade of anti-apoptotic functions of Bcl-2 leads to Ca
2+
 release from the 
intracellular stores and causes formation of sustained cytosolic Ca
2+
 plateau even in 
the absence of extracellular calcium. Interestingly, the data presented in this study 
demonstrate that BH3 mimetic-induced Ca
2+
 release from the intracellular stores is 
dependent on the presence of Bax protein. Loss of Bax substantially increases 
resistance of pancreatic acinar cells to treatment with BH3 mimetics. This 
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unexpected role of Bax might shed some light to the enigmatic process of passive 
Ca
2+
 leak. Bax appears to play a role in regulation of ER leakiness, most likely by 
interaction with ER calcium channels other than IP3Rs or RyRs. 
Importantly, formation of sustained cytosolic Ca
2+
 plateau in pancreatic acinar cells 
upon Bcl-2 inhibition immediately suggests that anti-apoptotic Bcl-2 members might 
be involved in regulation of Ca
2+
 extrusion from the cytosol across the plasma 
membrane.  This notion has been further investigated and the results indicate that 
loss of Bcl-2 protein enhances Ca
2+
 extrusion through the plasma membrane. The 
PMCA is the major Ca
2+
 extrusion mechanism in non-excitable cells, and pancreatic 
acinar cells are considered to have very little, if any, NXC activity. Therefore it has 
been postulated here that Bcl-2 is involved in the regulation of the PMCA. This 
notion is supported by the studies of subcellular distribution of GFP-tagged Bcl-2 in 
life cells and immunostaining in fixed cells. The data demonstrate close localization 
of Bcl-2 and the PMCA, which potentially enables direct interaction between the 
proteins. Although in the literature there is some evidence of Bcl-2 controlling the 
SERCA, the potential link to the PMCA has not yet been demonstrated. Regulation 
of the PMCA has very important patho-physiological implications. It appears that 
cells lacking functional Bcl-2 protein are much less affected by increased 
extracellular calcium and have been shown to die mainly of apoptosis when 
challenged with menadione (an inducer of ROS production), or menadione and high 
calcium simultaneously. These results provide novel insights into the understanding 
of the functions of Bcl-2 protein. So far, anti-apoptotic Bcl-2 was generally 
considered as purely protective and pro-survival, since it antagonizes apoptotic cell 
death. By negative regulation of the PMCA, Bcl-2 might also help to preserve 
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cellular energy resources. However, at the same time inhibition of the PMCA can 
promote Ca
2+
 overload under pathological conditions. It appears that the cells heavily 
challenged with toxic agents or increased extracellular calcium are more likely to die 
via necrosis. Therefore loss of Bcl-2 under certain conditions might protect cells 
from extensive necrosis by promotion of more desirable apoptotic cell death. 
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